<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006944" GROUP_ID="MUSKEL" ID="544707022101225860" MERGED_FROM="" MODIFIED="2010-09-10 08:43:55 -0400" MODIFIED_BY="[Empty name]" REVIEW_NO="A036-R" REVMAN_SUB_VERSION="5.0.24" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.2">
<COVER_SHEET MODIFIED="2010-09-10 08:43:31 -0400" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<TITLE>Vitamin D supplementation for improving bone mineral density in children</TITLE>
<CONTACT>
<PERSON ID="D333C25182E26AA20080535F45D35AFA" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Tania</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Winzenberg</LAST_NAME>
<SUFFIX/>
<POSITION>Musculoskeletal Epidemiologist</POSITION>
<EMAIL_1>tania.winzenberg@utas.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>University of Tasmania</ORGANISATION>
<ADDRESS_1>Private Bag 23</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7001</ZIP>
<REGION>TAS</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+613 62267770</PHONE_1>
<PHONE_2>+613 6226 7700</PHONE_2>
<FAX_1>+613 62267704</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2010-09-10 08:43:31 -0400" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<PERSON ID="D333C25182E26AA20080535F45D35AFA" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Tania</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Winzenberg</LAST_NAME>
<SUFFIX/>
<POSITION>Musculoskeletal Epidemiologist</POSITION>
<EMAIL_1>tania.winzenberg@utas.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>University of Tasmania</ORGANISATION>
<ADDRESS_1>Private Bag 23</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7001</ZIP>
<REGION>TAS</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+613 62267770</PHONE_1>
<PHONE_2>+613 6226 7700</PHONE_2>
<FAX_1>+613 62267704</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="E1A9D2CA82E26AA2014D8C013D688C77" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Sandi</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Powell</LAST_NAME>
<SUFFIX/>
<POSITION>Junior Research Fellow</POSITION>
<EMAIL_1>sjpowell@utas.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>University of Tasmania</ORGANISATION>
<ADDRESS_1>Private Bag 23</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7001</ZIP>
<REGION>Tasmania</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 6226 7773</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 6226 7704</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14744" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kelly</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Shaw</LAST_NAME>
<SUFFIX/>
<POSITION>Honorary Associate</POSITION>
<EMAIL_1>kelly.shaw@scu.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>ASLaRC Aged Services Unit</DEPARTMENT>
<ORGANISATION>Southern Cross University and Menzies Research Institute, University of Tasmania</ORGANISATION>
<ADDRESS_1>Hogbin Drive</ADDRESS_1>
<ADDRESS_2/>
<CITY>Coffs Harbour</CITY>
<ZIP>2450</ZIP>
<REGION>Tasmania</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 6222 7678</PHONE_1>
<PHONE_2>+61 3 6659 3626</PHONE_2>
<FAX_1>+61 3 6222 7407</FAX_1>
<FAX_2>+61 3 6659 3622</FAX_2>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4728" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Graeme</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Jones</LAST_NAME>
<SUFFIX/>
<POSITION>Head, Musculoskeletal Unit</POSITION>
<EMAIL_1>G.Jones@utas.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>University of Tasmania</ORGANISATION>
<ADDRESS_1>Private Bag 23</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7004</ZIP>
<REGION>TAS</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+613 62267705</PHONE_1>
<PHONE_2>+61 362 267700</PHONE_2>
<FAX_1>+61 362 267704</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2010-01-27 00:46:06 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="30" MONTH="9" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="9" MONTH="8" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="9" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2010-07-18 21:48:52 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-07-18 21:48:52 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>CMSD ID: A036-P</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-10-16 10:46:28 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-10-16 10:46:28 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Menzies Research Institute</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-09-06 02:41:23 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2010-08-31 23:53:40 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-10-15 22:59:13 -0400" MODIFIED_BY="[Empty name]">Vitamin D for improving bone density in children</TITLE>
<SUMMARY_BODY MODIFIED="2010-08-31 23:53:40 -0400" MODIFIED_BY="[Empty name]">
<P>This summary of a Cochrane Review, presents what we know from research about the effect of vitamin D supplements on bone density in children.    </P>
<P>The review shows that in healthy children generally, vitamin D supplementation does not improve bone density at the hip, lumbar spine, forearm or in the body as a whole. </P>
<P>Some of the evidence suggests that vitamin D supplements may improve bone density in children who have low levels of vitamin D but this is uncertain. </P>
<P>We do not have precise information about side effects and complications but the available information suggests that vitamin D supplements are well tolerated. </P>
<P>
<B>What is osteoporosis and what is vitamin D?</B>
</P>
<P>Osteoporosis is a condition where bones are weak, brittle and break easily. The risk of osteoporosis and fractures (breaks) in later life depends on how much bone is built when a child and how much bone is lost when an adult. One way to prevent osteoporosis and fractures in later life is to build stronger bones when young. Vitamin D plays an important role in improving the body&#8217;s absorption of calcium from food, reducing losses of calcium from the body and getting calcium deposited into to bone to improve the quantity of bone developed. Therefore it is thought that if vitamin D levels in the body are low in childhood, less bone will be developed and that improving vitamin D levels by supplements would result in more bone being developed. Bone density is a major measure of bone strength and the amount of bone mineral present at different sites and so is used to measure the effects of interventions, like vitamin D supplementation, to improve bone health.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-09-06 02:41:23 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-10-16 01:56:35 -0400" MODIFIED_BY="[Empty name]">
<P>Results of randomised controlled trials (RCTs) of vitamin D supplementation to improve bone density in children are inconsistent. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-08-31 22:21:59 -0400" MODIFIED_BY="[Empty name]">
<P>To determine the effectiveness of vitamin D supplementation for improving bone mineral density in children, whether any effect varies by sex, age or pubertal stage, the type or dose of vitamin D given or baseline vitamin D status, and if effects persist after cessation of supplementation.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2010-09-06 02:39:08 -0400" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL Issue 3, 2009), MEDLINE (1966 to present), EMBASE (1980 to present), CINAHL (1982 to present), AMED (1985 to present) and ISI Web of Science (1945 to present) on 9 August 2009, and we handsearched key journal conference abstracts.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-08-31 22:22:11 -0400" MODIFIED_BY="[Empty name]">
<P>Placebo-controlled RCTs of vitamin D supplementation for at least three months in healthy children and adolescents (aged from one month to &lt; 20 years) with bone density outcomes.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-09-06 02:40:55 -0400" MODIFIED_BY="[Empty name]">
<P>Two authors screened references for inclusion, assessed risk of bias, and extracted data. We conducted meta-analyses and calculated standardised mean differences (SMD) of the percent change from baseline in outcomes in treatment and control groups. We performed subgroup analyses by sex, pubertal stage, dose of vitamin D and baseline serum vitamin D and considered these as well as compliance and allocation concealment as possible sources of heterogeneity.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-09-06 02:41:23 -0400" MODIFIED_BY="[Empty name]">
<P>We included six RCTs (343 participants receiving placebo and 541 receiving vitamin D) for meta-analyses. Vitamin D supplementation had no statistically significant effects on total body bone mineral content (BMC), hip bone mineral density (BMD) or forearm BMD. There was a trend to a small effect on lumbar spine BMD (SMD 0.15, 95% CI -0.01 to 0.31, P = 0.07). There were no differences in effects between high and low serum vitamin D studies at any site though there was a trend towards a larger effect with low vitamin D for total body BMC (P = 0.09 for difference). In low serum vitamin D studies, significant effects on total body BMC and lumbar spine BMD were approximately equivalent to a 2.6% and 1.7 % percentage point greater change from baseline in the supplemented group.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-10-16 02:10:46 -0400" MODIFIED_BY="[Empty name]">
<P>These results do not support vitamin D supplementation to improve bone density in healthy children with normal vitamin D levels, but suggest that supplementation of deficient children may be clinically useful. Further RCTs in deficient children are needed to confirm this.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-09-01 00:05:21 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Osteoporosis is a systemic skeletal disorder characterised by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture (<LINK REF="REF-NIH-1993" TYPE="REFERENCE">NIH 1993</LINK>). In other words, there is both less bone and poor bone quality. Osteoporosis is a major and growing public health problem, particularly in women (<LINK REF="REF-Jones-1994" TYPE="REFERENCE">Jones 1994</LINK>), with an estimated 9.0 million osteoporotic fractures worldwide occurring in the year 2000 (<LINK REF="REF-Johnell-2006" TYPE="REFERENCE">Johnell 2006</LINK>). It is a costly global problem. For example in the United States, more than two million incident fractures are predicted at a cost of $17 billion, and fracture costs are expected to rise by 50% by 2025 (<LINK REF="REF-Burge-2007" TYPE="REFERENCE">Burge 2007</LINK>). High costs are also reported in other countries (<LINK REF="REF-Access-2001" TYPE="REFERENCE">Access 2001</LINK>; <LINK REF="REF-Finnern-2003" TYPE="REFERENCE">Finnern 2003</LINK>).</P>
<P>Low bone mineral density (BMD) is a major risk factor for osteoporotic fracture (<LINK REF="REF-Marshall-1996" TYPE="REFERENCE">Marshall 1996</LINK>). It is well accepted that childhood factors are likely to have an impact on future risk of osteoporosis (<LINK REF="REF-NIH-2000" TYPE="REFERENCE">NIH 2000</LINK>). At least 90% of peak bone mass is obtained by the age of 18 years (<LINK REF="REF-Bailey-1999" TYPE="REFERENCE">Bailey 1999</LINK>). BMD in later life is a function of peak bone mass and the rate of subsequent bone loss (<LINK REF="REF-Hansen-1991" TYPE="REFERENCE">Hansen 1991</LINK>). Peak bone mass and rate of bone loss are equally important as risk factors for fracture in later life (<LINK REF="REF-Riis-1996" TYPE="REFERENCE">Riis 1996</LINK>). Peak bone mass is influenced by genetic factors, but also modifiable lifestyle factors such as adequate nutrition, body weight and physical activity (<LINK REF="REF-Javaid-2002" TYPE="REFERENCE">Javaid 2002</LINK>). Maximizing peak bone mass is therefore potentially a way to reduce the impact of age-related bone loss. It is estimated that a 10% increase in peak bone mass reduces the risk of an osteoporotic fracture in adult life by 50% (<LINK REF="REF-Cummings-1993" TYPE="REFERENCE">Cummings 1993</LINK>). In addition, there is evidence that low BMD is a risk factor for fracture in childhood (<LINK REF="REF-Goulding-1998" TYPE="REFERENCE">Goulding 1998</LINK>; <LINK REF="REF-Goulding-2001" TYPE="REFERENCE">Goulding 2001</LINK>; <LINK REF="REF-Ma-2003" TYPE="REFERENCE">Ma 2003</LINK>), suggesting that optimising age-appropriate bone mass may have a more immediate effect. Fractures in later life would be the ideal outcome measure in intervention studies for osteoporosis prevention, however for intervention studies in children this would require following large numbers of subjects for decades and these studies have not been performed. Therefore, BMD is commonly used as a surrogate outcome for intervention studies in children (<LINK REF="REF-Gilsanz-1998" TYPE="REFERENCE">Gilsanz 1998</LINK>) and is the outcome used in this review.</P>
<P>Strategies to maximise peak bone mass in children have been identified as a priority area for research (<LINK REF="REF-NIH-2000" TYPE="REFERENCE">NIH 2000</LINK>). While there is significant evidence from randomised controlled trials (RCTs) that physical activity interventions can improve bone health in children (<LINK REF="REF-Hind-2007" TYPE="REFERENCE">Hind 2007</LINK>), achieving increased physical activity in children outside of RCTs of imposed exercise interventions is problematic, both if specifically aimed at osteoporosis prevention (<LINK REF="REF-Ritenbaugh-2003" TYPE="REFERENCE">Ritenbaugh 2003</LINK>; <LINK REF="REF-French-2005" TYPE="REFERENCE">French 2005</LINK>) and more generally. Even complex interventions in children and adolescents do not necessarily improve levels of physical activity (<LINK REF="REF-Timperio-2004" TYPE="REFERENCE">Timperio 2004</LINK>), making it difficult to implement the evidence supporting a positive effect of physical activity on BMD into practice. While some individual RCTs have reported that calcium supplementation is effective at improving peak bone mass, in our meta-analysis of calcium supplement trials in children (<LINK REF="REF-Winzenberg-2006a" TYPE="REFERENCE">Winzenberg 2006a</LINK>; <LINK REF="REF-Winzenberg-2006b" TYPE="REFERENCE">Winzenberg 2006b</LINK>), we found that overall, calcium supplementation did not affect BMD at the two most important sites for fracture in later life, namely the femoral neck and lumbar spine. Although there is a small improvement in BMD at the upper limb (approximately 1.7%) from calcium supplementation, this is unlikely to result in a clinically significant decrease in fracture risk, either in children or in later life. We concluded that alternative nutritional or supplement interventions need to be explored, an opinion which has been supported by others (<LINK REF="REF-Lanou-2005" TYPE="REFERENCE">Lanou 2005</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="2">Vitamin D and bone health in children</HEADING>
<P>Vitamin D has a key role in bone metabolism and its impact on bone health in adults is well accepted (<LINK REF="REF-ANZBMS-2005" TYPE="REFERENCE">ANZBMS 2005</LINK>). Overt vitamin D deficiency in children leads to rickets and there is increasing evidence that sub-clinical vitamin D deficiency may also affect bone mineralisation (<LINK REF="REF-Jones-1998" TYPE="REFERENCE">Jones 1998</LINK>; <LINK REF="REF-Zamora-1999" TYPE="REFERENCE">Zamora 1999</LINK>; <LINK REF="REF-Outila-2001" TYPE="REFERENCE">Outila 2001</LINK>; <LINK REF="REF-Lehtonen-2002" TYPE="REFERENCE">Lehtonen 2002</LINK>; <LINK REF="REF-Cheng-2003" TYPE="REFERENCE">Cheng 2003</LINK>; <LINK REF="REF-Jones-2005" TYPE="REFERENCE">Jones 2005</LINK>). Vitamin D deficiency is best diagnosed by measurement of serum 25-hydroxyvitamin D (<LINK REF="REF-Munns-2006" TYPE="REFERENCE">Munns 2006</LINK>). Serum levels above 50 nmol/L are considered normal and largely prevent secondary hyperparathyroidism and elevated bone specific alkaline phosphatase levels (<LINK REF="REF-Munns-2006" TYPE="REFERENCE">Munns 2006</LINK>), although there remains debate about the level of this threshold (<LINK REF="REF-Holick-2007" TYPE="REFERENCE">Holick 2007</LINK>). Vitamin D deficiency is considered mild at 25 to 50 nmol/L, moderate at 12.5 to 25 nmol/L and severe at &lt; 12.5 nmol/L (<LINK REF="REF-Munns-2006" TYPE="REFERENCE">Munns 2006</LINK>). Evidence is growing that low vitamin D levels in children are common enough to be considered a significant public health issue in many parts of the world and across a range of latitudes, including numerous European countries (<LINK REF="REF-Zamora-1999" TYPE="REFERENCE">Zamora 1999</LINK>; <LINK REF="STD-Guillemant-2001" TYPE="STUDY">Guillemant 2001</LINK>; <LINK REF="REF-Outila-2001" TYPE="REFERENCE">Outila 2001</LINK>; <LINK REF="REF-Lehtonen-2002" TYPE="REFERENCE">Lehtonen 2002</LINK>; <LINK REF="REF-Cheng-2003" TYPE="REFERENCE">Cheng 2003</LINK>; <LINK REF="REF-Tylavsky-2006" TYPE="REFERENCE">Tylavsky 2006</LINK>), the USA (<LINK REF="REF-Looker-2002" TYPE="REFERENCE">Looker 2002</LINK>), Lebanon (<LINK REF="REF-El_x002d_Hajj-2001" TYPE="REFERENCE">El-Hajj 2001</LINK>), Australia (<LINK REF="REF-Jones-1999" TYPE="REFERENCE">Jones 1999</LINK>; <LINK REF="REF-Jones-2005" TYPE="REFERENCE">Jones 2005</LINK>) and New Zealand (<LINK REF="REF-Rockell-2005" TYPE="REFERENCE">Rockell 2005</LINK>; <LINK REF="REF-Munns-2006" TYPE="REFERENCE">Munns 2006</LINK>; <LINK REF="REF-Rockell-2006" TYPE="REFERENCE">Rockell 2006</LINK>).</P>
<P>While treatment of moderate to severe vitamin D deficiency with the aim of reaching serum levels of 50 nmol/L is accepted practice (<LINK REF="REF-Munns-2006" TYPE="REFERENCE">Munns 2006</LINK>), the effectiveness of vitamin D supplementation for improving bone density outcomes is unclear. Trials of vitamin D supplementation in healthy children measuring bone outcomes have inconsistent results (<LINK REF="REF-Ala_x002d_Houhala-1988" TYPE="REFERENCE">Ala-Houhala 1988</LINK>; <LINK REF="REF-El_x002d_Hajj-2004" TYPE="REFERENCE">El-Hajj 2004</LINK>; <LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>; <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>; <LINK REF="REF-El_x002d_Hajj-2006" TYPE="REFERENCE">El-Hajj 2006</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>). There are methodological differences in the studies, in particular in the choice of dose, compliance and whether subjects were identified as vitamin D deficient or replete. The effect sizes in those studies which do show an effect also vary, ranging from 1.3% and 5% at different sites. While individual RCTs suggest that vitamin D supplementation could increase bone density in children, there has been no systematic review performed previously and it is unclear whether there is an effect overall and, if so, what the effect size is and if methodological differences affect the effect size. There are no studies examining vitamin D supplementation in children with fracture outcomes.</P>
</SUBSECTION>
</BACKGROUND>
<OBJECTIVES MODIFIED="2010-01-27 00:33:25 -0500" MODIFIED_BY="[Empty name]">
<UL>
<LI>To determine the effectiveness of vitamin D supplementation for improving bone mineral density in children.</LI>
</UL>
<UL>
<LI>To determine if any effect of vitamin D supplementation varies by sex, age or pubertal stage, the type or dose of vitamin D given or baseline vitamin D status.</LI>
</UL>
<UL>
<LI>To determine if any effect of vitamin D supplementation persists after cessation of the intervention.</LI>
</UL>
</OBJECTIVES>
<METHODS MODIFIED="2010-09-01 00:05:21 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2009-09-23 23:28:16 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials of vitamin D supplementation compared with placebo, with a treatment period of at least three months (<LINK REF="REF-Munns-2006" TYPE="REFERENCE">Munns 2006</LINK>) were included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Trials in children and adolescents (aged &lt; 20 years) without co-existent medical conditions or treatments causing osteoporosis were to be included; we excluded studies performed exclusively in neonates (aged &lt; 1 month).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Trials of vitamin D supplementation regardless of regardless of type or dose of vitamin D supplement or method of administration, compared with placebo. We excluded trials with a treatment period of less than three months.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Main outcome measures were areal or volumetric bone mineral density (BMD and VBMD respectively), or bone mineral content. Quantitative ultrasound measures would also have been included but no studies used these measures. We included studies only if they measured a main outcome.</P>
<P>As discussed above, while fractures in later life would be the ideal outcome measure, for intervention studies in children this would require following large numbers of subjects for decades and these studies have not been performed and there are no studies with childhood fracture outcomes. Therefore, in this review BMD was used as a surrogate outcome, as is commonly seen in intervention studies in children (<LINK REF="REF-Gilsanz-1998" TYPE="REFERENCE">Gilsanz 1998</LINK>).</P>
<P>We extracted data on change in areal bone mineral density (BMD) and bone mineral content (BMC) (where possible taken as percent change from baseline) measured a minimum of six months after the study commenced. Measurement sites included femoral neck, total hip, total body, lumbar spine, proximal and distal forearm. Methods of measurement included dual x-ray absorptiometry (DXA), single photon absorptiometry, dual photon absorptiometry and peripheral quantitative computerised tomography. Studies must also have had a measure of variance for outcome measures to be included in the meta-analysis.</P>
<P>We also, where possible, determined sex, age, pubertal stage, baseline serum vitamin D and vitamin D assay used, physical activity, baseline height, baseline weight, dietary calcium intake including calcium supplement use, vitamin D intake, levels of sun exposure, ethnicity, type and dose of vitamin D given, levels of compliance and follow up after cessation of treatment as possible effect modifiers.</P>
<P>We collected data on adverse effects where available.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>The electronic literature search was last updated on 9 August 2009. The search strategies included a search of the Cochrane Central Register of Controlled Trials (CENTRAL Issue 3, 2009), MEDLINE (1966 to present), EMBASE (1980 to present), CINAHL (1982 to present), AMED (1985 to present) and ISI Web of Science (1945 to present). We handsearched conference abstract issues of key journals (<I>Osteoporosis International</I>, <I>Journal of Bone and Mineral Research</I>, <I>Asia Pacific Journal of Clinical Nutrition</I>, <I>Journal of the American Dietetic Association</I>, <I>Proceedings of the Nutrition Society</I>, <I>Journal of Nutrition</I>) for 2007-08 to identify recent trials that have not yet been published in full. There were no language restrictions.</P>
<P>The search strategy used for MEDLINE is outlined in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The strategy was adapted as appropriate for other databases.</P>
<P>We examined the reference lists and ISI citations of all included studies.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-09-01 00:05:21 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (TW, KS) assessed all potentially relevant articles against the study inclusion/exclusion criteria. Two review authors extracted data independently (TW, SP for all studies except <LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK> with extraction by TW/KS). We extracted details regarding the study population, treatment periods, baseline demographic data and baseline and end of study outcomes independently. Two review authors assessed each trial for risk of bias independently (TW, SP for all studies except <LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK> with extraction by TW/KS), addressing randomisation, allocation concealment, blinding of those providing treatment and of treatment subjects, completeness of outcome assessment, selective reporting and other potential sources of bias. When necessary, we contacted the authors of the primary studies to obtain additional information.</P>
<P>We converted outcome measures to standardised mean differences (SMD). For bone density, we calculated a standardised mean difference of the percent change from baseline in treatment and control groups for the various outcomes.</P>
<P>We calculated statistical heterogeneity of the data using a Chi<SUP>2</SUP> test on N-1 degrees of freedom, with significance conservatively set at 0.10. We also assessed inconsistency I<SUP>2</SUP> = [(Q-df)/Q] x 100%, where Q is the Chi<SUP>2</SUP> statistic and df is its degrees of freedom, to describe the percentage of the variability in effect estimates that is due to heterogeneity. A value greater than 50% was considered substantial heterogeneity.</P>
<P>We conducted meta-analysis according to a fixed-effect model. Where heterogeneity was considered substantial, we performed subgroup analyses which had been specified a priori to explore its causes where data were available, i.e. subgroups by sex, pubertal stage, dose of vitamin D and baseline vitamin D levels, compliance and adequacy of allocation concealment. There were insufficient data to consider ethnicity and sun exposure as possible sources of heterogeneity, as planned in the original protocol. Where there was substantial heterogeneity between studies, if there were not clear clinical reasons or study methodology reasons for this, we proceeded to meta-analysis using a random-effects model.</P>
<P>The a priori subgroup analyses by sex, pubertal stage, dose of vitamin D and baseline vitamin D levels were also used to determine whether the effects of supplementation varied by these factors. Where possible, we based the analyses on intention-to-treat data from the individual clinical trials, but if these were not available, in order of preference, data from available data or per protocol analysis. We performed a funnel plot for assessment of publication bias.</P>
<P>Where there were more than one vitamin D dosage group in the studies, we analysed the data after combining all dosage groups together, compared to placebo. One study (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>) had low variance compared to other studies in its outcome measures. We confirmed with the authors that the reported variance measure was a standard deviation. We also performed sensitivity analyses omitting this study.</P>
<P>One study was a cluster-randomised controlled with average cluster size of approximately 87 (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>). The data used in the meta-analysis were based on an analysis which did not take into account the effect of clustering. Subsequently, the authors published the intra cluster correlation for total body BMC in the study (<LINK REF="REF-Du-2005" TYPE="REFERENCE">Du 2005</LINK>) at 0.011. We performed a sensitivity analysis making an approximate correction for the effect of clustering by calculating the design effect as 1+(M-1)ICC where M = cluster size and ICC = intra cluster correlation (87 and 0.011 respectively) and correcting the sample size by the calculated design effect of 1.946 (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>For subgroup analyses by vitamin D dose, for those studies with an intervention group falling into each subgroup, we used the individual intervention group data and for the controls used the control group mean and standard deviation for each subgroup comparison but reduced the number in the control groups by half for each comparison.</P>
<SUBSECTION>
<HEADING LEVEL="3">Grading of evidence</HEADING>
<P>We graded evidence using the GRADE system as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2009" TYPE="REFERENCE">Higgins 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Clinical relevance tables</HEADING>
<P>The results of this review were not amenable to presentation in clinical relevance tables. Where appropriate, we used the SMD effect size to estimate an absolute benefit in mg/cm2 by estimating the pooled standard deviation (SD) from the means of the SD of the outcomes in treatment and control groups for each study, and multiplying the SMD by this (<LINK REF="REF-Alderson-2002" TYPE="REFERENCE">Alderson 2002</LINK>).</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Our initial search identified 1652 references to potential studies. A further reference to a potential additional study was obtained through author contact (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>) making a total of 1653 potential references (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>). Of these, we excluded 1599 after initial independent title and abstract screening (kappa = 0.66) with 25 disagreements. The disagreements were resolved by consensus and all 25 were excluded while still at abstract screening stage. Six references were in German and lacked an English abstract. These six abstracts were assessed by a fluent German speaking rheumatologist in conjunction with one author (TW) and all were excluded.</P>
<P>The remaining 23 references required full-text review, from which 12 references to seven studies were included. Reasons for excluding studies at full-text review are given in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table. We excluded four as they were not randomised controlled trials (<LINK REF="STD-Compston-1998" TYPE="STUDY">Compston 1998</LINK>; <LINK REF="STD-Calvo-2000" TYPE="STUDY">Calvo 2000</LINK>; <LINK REF="STD-Flynn-2003" TYPE="STUDY">Flynn 2003</LINK>; <LINK REF="STD-Clutterbuck-2005" TYPE="STUDY">Clutterbuck 2005</LINK>), three as participants were not aged between one month and 18 years of age (<LINK REF="STD-Fehily-1992" TYPE="STUDY">Fehily 1992</LINK>; <LINK REF="STD-Venkataraman-1992" TYPE="STUDY">Venkataraman 1992</LINK>; <LINK REF="STD-Matsumoto-2008" TYPE="STUDY">Matsumoto 2008</LINK>), two as primary bone density outcomes were not measured (<LINK REF="STD-Ho-1985" TYPE="STUDY">Ho 1985</LINK>; <LINK REF="STD-Duhamel-2000" TYPE="STUDY">Duhamel 2000</LINK>, one each for not studying a vitamin D intervention (<LINK REF="STD-Feliciano-1994" TYPE="STUDY">Feliciano 1994</LINK>) and one as no placebo was used (<LINK REF="STD-Guillemant-2001" TYPE="STUDY">Guillemant 2001</LINK>).</P>
<P>One study did not provide sufficient published data to be included in the meta-analysis (<LINK REF="STD-Ala_x002d_houlala-1988" TYPE="STUDY">Ala-houlala 1988</LINK>). This study was small (n = 60) and reported no effect of supplementation for BMC at the distal one-third radius.</P>
<P>Characteristics of included studies are given in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>The meta-analysis used data from six studies (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>; <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>; <LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>; <LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>) and included a total of 343 participants receiving placebo and 541 participants receiving vitamin D supplementation. Children in the studies ranged in age from eight to 17 years. One study was performed in Hong Kong Chinese (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>), two in white populations (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>), one in children of Pakistani origin (<LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>) and two studies were performed in Lebanon but ethnicity of participants was not reported (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>). Bone density was measured by dual energy x-ray absorptiometry in all studies with the exception of <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>, in which volumetric BMD was measured using peripheral quantitative CT at the distal radius.</P>
<P>All studies administered vitamin D<SUB>3</SUB>, with the dose administered ranging from 133 IU daily (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>) to 14000 IU per week (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>). Two studies had study groups not included in this review in which calcium supplementation was administered (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>; <LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>). Supplementation was for one year (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>; <LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>) or two years (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>; <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>). One study provided follow-up data after supplementation ceased (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>) with five years follow up and this study included a co-intervention of calcium in both vitamin D and comparator groups. Mean baseline serum vitamin D levels ranged from 17.7 to 49.5 nmol/L. Results from available data analysis were extracted for all studies except <LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK> which reported per protocol analysis, excluding 33 participants with poor compliance. No study reported a true intention-to-treat analysis with imputation of missing data.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>One study had clearly documented and adequate sequence generation, allocation concealment, blinding and reasons for withdrawals (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>).</P>
<P>Two other studies described adequate sequence generation and allocation concealment (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>) and in the remaining two studies this was unclear (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>; <LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>). All studies stated that they were double-blind, though the blinding process was not fully described. However, in any case it is unlikely that bone density outcomes could be influenced by lack of blinding and so we assessed the risk of bias arising from any deviations from a strict blinding process as very low. No study imputed for missing data in the analysis. However, loss to follow up was for the most part either evenly distributed across groups (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>; <LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>) or reasons for withdrawal were stated and unlikely to related to the true outcome (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>). Incomplete outcome data posed a risk of bias in one study (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>).</P>
<P>Though the number of studies were small, we performed funnel plots to examine for potential publication bias. These suggested that this was not present (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Overall, vitamin D supplementation did not have statistically significant effects on percentage change in total body BMC (SMD 0.10, 95% CI -0.06 to 0.26) (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>), hip BMD (SMD 0.06, 95% CI -0.18 to 0.29) (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>) or forearm BMD (SMD 0.04, 95% CI -0.36 to 0.45) (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). There was a trend to a small effect on percentage change in lumbar spine BMD (SMD 0.15, 95% CI -0.01 to 0.31, P = 0.07) (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). There was statistical heterogeneity in the results for percentage change in hip BMD (Chi<SUP>2 </SUP>= 6.09, df = 3, P = 0.11, I<SUP>2 </SUP>= 51%) and forearm BMD (Chi<SUP>2</SUP> = 7.82, df = 2,<SUP> </SUP>P = 0.02, I<SUP>2 </SUP>= 74%).</P>
<P>The use of data corrected for cluster effects in the study of Du (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>) did not materially effect the result for total body BMC (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Exploring heterogeneity</HEADING>
<P>Sex, baseline serum vitamin D and adequacy of allocation concealment did not explain the heterogeneity between studies seen for analyses of percentage change in hip and forearm BMD. There was a sole study in males. Studies in the female subgroups still had significant heterogeneity (Hip: Chi<SUP>2 </SUP>= 4.94, df = 2, P = 0.08; I<SUP>2 </SUP>= 60%; forearm: Chi<SUP>2 </SUP>= 4.32, df = 1, P = 0.04; I<SUP>2 </SUP>= 60%) (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>; <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>). There was a single study with participants with a mean baseline serum 25(OH)D less than 35 nmol/L with hip and forearm BMD outcomes. Significant heterogeneity remained in those studies whose participants had a baseline serum 25(OH)D above this level (Hip: Chi<SUP>2 </SUP>= 4.54, df = 2, P = 0.10; I<SUP>2 </SUP>= 56%; forearm: Chi<SUP>2 </SUP>= 7.66, df = 1, P = 0.006; I<SUP>2 </SUP>= 87%) (<LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>; <LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>). Subgroup analysis by adequacy of allocation concealment (adequate compared to inadequate or unclear allocation concealment) did not account for heterogeneity between studies for hip BMD (<LINK REF="CMP-012.02" TYPE="ANALYSIS">Analysis 12.2</LINK>). There were no studies with inadequate or unclear allocation concealment with forearm BMD outcomes, so a subgroup analysis could not be performed.</P>
<P>Subgroup analyses by compliance and by pubertal status of participants in the study as a whole resulted in identical subgroups. The only study purely in prepubertal children was that of <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK> and this was also the only study with low compliance. The others all had mixed pubertal status - no study was performed purely in post pubertal children. In the subgroup of studies with mixed pubertal stage/high compliance, there was no statistically significant heterogeneity at either the hip or forearm (Hip: Chi<SUP>2 </SUP>= 2.55, df = 2, P = 0.28; I<SUP>2 </SUP>= 22%; forearm: Chi<SUP>2 </SUP>= 0.64, df = 1, P = 0.42; I<SUP>2 </SUP>= 0%).(<LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK>; <LINK REF="CMP-009.04" TYPE="ANALYSIS">Analysis 9.4</LINK>; <LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>; <LINK REF="CMP-011.04" TYPE="ANALYSIS">Analysis 11.4</LINK>).</P>
<P>We were unable to perform a meaningful exploration of heterogeneity by vitamin D dose (&gt; 200 IU daily versus &#8804; 200 IU daily) or by pubertal status within individual studies, as extracting data on both these variables increased the degrees of freedom for the Chi<SUP>2</SUP> test for heterogeneity and decreased inconsistency. Therefore, comparisons with the heterogeneity observed in <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK> and <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK> are not interpretable.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analyses for differences in effects</HEADING>
<P>There were no statistically significant differences in the effects of supplementation at any site by dose of vitamin D administered (&gt; 200 IU daily versus &#8804; 200 IU daily) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>; <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>) or by sex (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>; <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>; <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>). However, in females there was a statistically significant effect on lumbar spine BMD (SMD 0.20, 95% CI 0.01 to 0.39, P = 0.04) but not in males (SMD 0.01, 95% CI -0.31 to 0.33, P = 0.93).</P>
<P>There were no statistically significant differences in effects between high and low baseline serum 25(OH)D studies at any site (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>; <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>; <LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>; <LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>) though there was a trend for larger effect with low serum vitamin for total body BMC (serum vitamin D &#8804; 35 nmol/L: SMD 0.21 (95% CI 0.01 to 0.41); vitamin D group &gt; 35 nmol/L: SMD -0.07 (95% CI -0.33 to 0.18), P = 0.09 for difference). In the low serum vitamin D studies, there was a significant effect for total body BMC (P = 0.04) and the lumbar spine BMD (SMD 0.31, 95% CI 0.00 to 0.61, P = 0.05).</P>
<P>As described above, subgroups of pre- versus mixed pubertal stage studies and low and high compliance studies were identical. Vitamin D supplementation had a greater effect in studies in prepubertal/low compliance children for forearm BMD (prepubertal: SMD 0.51 (95% CI 0.08 to 0.93), mixed pubertal stage: SMD -0.16 (95% CI -0.38 to 0.07), P = 0.02 for effect in prepubertal/low compliance children) (<LINK REF="CMP-009.04" TYPE="ANALYSIS">Analysis 9.4</LINK>; <LINK REF="CMP-011.04" TYPE="ANALYSIS">Analysis 11.4</LINK>). The effects were in the opposite direction for hip and lumbar spine BMD (hip: prepubertal/low compliance SMD -0.30 (95% CI -0.72 to 0.13); mixed pubertal stage/high compliance: SMD 0.14 (95% CI -0.06 to 0.34); lumbar spine : prepubertal/low compliance SMD -0.19 (95% CI -0.61 to 0.23; mixed pubertal stage/high compliance: SMD 0.21 (95% CI 0.04 to 0.38), P = 0.09 for difference and P = 0.02 for lumbar spine effect in mixed pubertal stage/high compliance children) (<LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK>; <LINK REF="CMP-009.03" TYPE="ANALYSIS">Analysis 9.3</LINK>; <LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>; <LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>). There was no difference in effects for total body BMC between prepubertal/low compliance and mixed pubertal stage/high compliance groups, though the direction of effect was the same as that seen at the hip and lumbar spine (prepubertal/low compliance SMD -0.22 (95% CI -0.64 to 0.20); mixed pubertal stage/high compliance: SMD 0.15 (95% CI -0.02 to 0.32), P = 0.11 for difference) (<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>; <LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>).</P>
<P>We also compared the effects in Tanner stage 1 or 2 children with Tanner stage 3 and 4 children derived from within individual studies. These did not demonstrate any significant differences in effects between groups at any site (<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>; <LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>;<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>; <LINK REF="CMP-010.04" TYPE="ANALYSIS">Analysis 10.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analyses</HEADING>
<P>In light of the above findingswe repeated (as post hoc analyses) subgroup analyses by sex (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>; <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>; <LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>; <LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>), baseline serum vitamin D (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>;<LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>; <LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>; <LINK REF="CMP-008.04" TYPE="ANALYSIS">Analysis 8.4</LINK>), vitamin D dose (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>; <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>; <LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>) and adequacy of allocation concealment (<LINK REF="CMP-013.02" TYPE="ANALYSIS">Analysis 13.2</LINK>) as sensitivity analyses omitting <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK> if there was heterogeneity in any subgroup and there were sufficient studies to allow for the analysis.</P>
<P>In the analysis for hip BMD by sex, heterogeneity was reduced to non-significant levels by omitting <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>. An effect on hip BMD in females not observed with the inclusion of <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK> was found (SMD 0.29, 95% CI 0.08 to 0.50, P = 0.006) but there were still no sex differences in effect size (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>). Results of analyses for hip BMD by serum vitamin D level and allocation concealment were similar to those of the analyses including <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Benefits after supplementation ceases</HEADING>
<P>The only study (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>) which provided follow-up data after supplementation ceased reported that there were no significant differences in total body BMC between the calcium supplemented milk group and the calcium-vitamin D supplemented milk group by three years after cessation of supplementation (percentage change since baseline 71.9 (SD 1.5) and 70.8 (SD 1.5) respectively).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse events</HEADING>
<P>There was limited reporting of adverse events (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and data were insufficient for meta-analysis, but published reasons for drop-outs and withdrawals suggest that supplementation was well-tolerated (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). One study reported that no children developed hypercalcaemia (<LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>). In one study, four children dropped out through disease onset unrelated to the trial, but otherwise not described (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>). In another, one child withdrew due to skin allergy, but the intervention arm to which the child belonged and potential relationship to vitamin D was not reported (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>). One study reported that treatment was very well-tolerated (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>) with two children in the placebo group having elevated serum calcium levels at the end of one year, and one girl receiving 1400 IU vitamin D<SUB>3 </SUB>per week developing post-streptococcal glomerulonephritis. In boys, three children in the placebo group and 1 in each vitamin dose group had elevated serum calcium levels at 1 year (<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>). The final study reported that 16 children dropped out for reasons not related to the study protocol, but gave no further details (<LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>).  </P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Summary of main results</HEADING>
<P>This review, the first systematic review examining the effectiveness of vitamin D supplementation for improving bone density in children known to the authors, failed to demonstrate statistically significant effects of vitamin D supplementation when applied to healthy children generally. However, subgroup analyses suggest that this may be explained in part by the lack of targeting of at-risk children, i.e. those with known low serum vitamin D levels. Compliance and pubertal status may also affect the effectiveness of supplementation. However, the making of a definitive recommendation regarding these aspects of vitamin supplementation is hampered by the paucity of evidence available. This was a significant limitation, particularly for subgroup analyses of possible important sources of clinical heterogeneity.</P>
<P>While it is difficult to extrapolate bone density outcomes to fracture risk reduction, particularly bone density in childhood to fractures in adulthood, the review results suggest that it is possible that vitamin D supplementation can deliver clinically significant improvements in bone health in children with low serum vitamin D. For example, the magnitude of the standardised mean difference (SMD) of effects in children with low baseline serum vitamin D levels were total body bone mineral content (BMC) 0.21, lumbar spine bone mineral density (BMD) 0.31 and hip BMD 0.25, all which were at least 0.2 SMD higher than in the high baseline vitamin D groups. This is approximately equivalent to a 2.6% percentage point greater change in total body BMC from baseline in the vitamin D than the control group. Equivalent estimates were 1% for hip BMD and 1.7% for lumbar spine BMD. Effects at the forearm were neither statistically nor clinically significant. The available studies do not allow us to ascertain whether the effects of supplementation accumulate while supplementation continues or if the effect plateaus over time. However, if 10% increase in peak bone mass can, as postulated, reduce the risk of an osteoporotic fracture in adult life by 50% (<LINK REF="REF-Cummings-1993" TYPE="REFERENCE">Cummings 1993</LINK>), it is certainly possible that an effect on fracture risk in later life of both clinical and public health significance is achievable. This is particularly so if effects do accumulate with ongoing supplementation. In addition, in a case-control study of fractures in children, children with wrist and forearm fractures had BMD at the total body, femoral neck and lumbar spine (<LINK REF="REF-Ma-2003" TYPE="REFERENCE">Ma 2003</LINK>) ranging from 1% to 5% lower than controls, depending on site. Similar magnitude differences have been observed in other studies (<LINK REF="REF-Goulding-1998" TYPE="REFERENCE">Goulding 1998</LINK>;<LINK REF="REF-Goulding-2001" TYPE="REFERENCE">Goulding 2001</LINK>). From <LINK REF="REF-Ma-2003" TYPE="REFERENCE">Ma 2003</LINK>, we estimate that a 5% increase in total body BMD and in femoral neck or lumbar spine BMD could decrease the relative risk of upper limb fracture in childhood by approximately 17% and 9% respectively. Thus, there is potential for vitamin D supplementation to have a substantial effect on adult fracture rates, as well as an effect in childhood. The cut-off of 35 nmol/L to define low serum vitamin D in this subgroup analysis was arbitrarily chosen based on the availability of adequate data - a lower cut-off would not have enabled the subgroup analysis to be performed at all. However, this means that the only study contributing data to the low baseline vitamin D subgroups for forearm and hip, and the only study of any size for lumbar spine, includes around 20% children with baseline vitamin D above 50 nmol/L. Thus, it is possible that the effect sizes observed in this review underestimate the possible benefits of supplementation in deficient children at these three sites.</P>
<P>Other potential modifiers of the effect of vitamin D supplementation include pubertal status and compliance. Unfortunately, subgroups studies by pre-pubertal versus mixed pubertal stage and low and high compliance were identical and the prepubertal/low compliance subgroup consisted only of one study (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>) making it difficult to separate these effects and making it necessary to interpret the results of the analysis with caution. The study <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK> was identified prior to any analysis as having a low standard deviation compared to the other included studies. Pre-specified analyses to explore heterogeneity identified that this study may be a major contributor to the heterogeneity observed in the hip and forearm analyses. Potential causes for this include the narrow age range in the study, the fact that it is the only study with only prepubertal participants and the only study with low compliance in the subjects analysed. Other factors could include the use of vBMD measures at the forearm compared to DXA in other studies, and the fact that percentage change figures extracted from Cheng were based on models adjusted for baseline value and Tanner stage (1 and 2). However, when study participants were divided within studies into pre and post pubertal groups, there were no differences in effects between subgroups, nor were there any effects of supplementation at any site within the subgroups. Moreover, there was persistent heterogeneity at the hip and forearm in the prepubertal subgroups, which included the study <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>. This suggests that compliance, rather than pubertal stage, may be the factor more likely to modify the effects of supplementation. The direction of effect was inconsistent at the forearm compared to other sites in the analysis by pubertal status/compliance subgroups. For forearm BMD there was an overall effect of 0.67 favouring the control group in the prepubertal/low compliance study (<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>) but the direction of effects favoured vitamin D supplementation at the hip, lumbar spine and total body BMC. This could reflect clinical and methodological differences between studies at the different sites. It could also reflect genuine differences in the response of cortical bone (predominates at distal 1/3 radius) compared to trabecular bone (predominates at lumbar spine, femoral neck and total body BMC). It is, however, unclear why the control group would demonstrate an effect at site. The available data do not allow this to be adequately addressed, and this adds further to the need to be cautious in interpreting this analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Overall completeness and applicability of the evidence</HEADING>
<P>The numbers of studies identified in this review were small (seven) and only five of these contributed a significant amount of data to the meta-analysis (<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>; <LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>; <LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>; <LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>; <LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>). Overall, the data available for this review were not adequate to address important clinical factors that might influence the review results. For example, compliance is a factor that potentially affect the results of studies, but the available data did not allow us to separate clearly the effects of compliance from those of pubertal stage, nor examine the potential interplay between compliance, the dose of supplement given and baseline vitamin D levels. Other major gaps in the evidence are the very limited amounts of data in males, in different ethnic groups and describing whether or not the benefits of supplementation persist after supplementation ceases.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Quality of the evidence</HEADING>
<P>The quality of the evidence from this review is assessed as gold.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-10-16 00:00:30 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2009-10-16 00:00:25 -0400" MODIFIED_BY="[Empty name]">
<P>The available evidence does not support the use of vitamin D supplementation to improve bone health in healthy children with normal vitamin D levels, but does suggest that supplementation given to vitamin D deficient children may have clinically useful benefits for peak bone mass. However, this remains to be clearly demonstrated.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-10-16 00:00:30 -0400" MODIFIED_BY="[Empty name]">
<P>Further randomised controlled trials in children with vitamin D deficiency are needed to determine definitively what benefits can be obtained, whether benefits continue to be accrued with increasing duration of supplementation, below what level of serum vitamin D can benefits on bone from supplementation be seen and whether any such benefits persist after supplementation ceases. On the current evidence, it may be that females with vitamin D deficiency are the subgroup likely to have the greatest response to supplementation, but the paucity of data in males means that this is by no means certain.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-09-30 01:05:12 -0400" MODIFIED_BY="[Empty name]">
<P>Thank you to Louise Falzon for undertaking the electronic searches for this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-09-30 01:08:05 -0400" MODIFIED_BY="[Empty name]">
<P>Tania Winzenberg - wrote review protocol, performed data extraction and quality assessment of articles, performed analyses and wrote the discussion of review results with the input of other authors. She will also be responsible for regularly updating and improving the review, as per Cochrane requirements.</P>
<P>Kelly Shaw - reviewed articles to decide on inclusion, had input into writing of the protocol and was involved in the writing of discussion of review results.</P>
<P>Sandi Powell - had input into writing of the protocol, reviewed initial search for articles to decide on inclusion, performed data extraction and quality assessment of articles, and was involved in the writing of discussion of review results. She also has content knowledge in the field of vitamin D.</P>
<P>Graeme Jones - is the content expert in paediatric bone health for the review. He provided input into design of the protocol, and assisted with the analysis and with writing the discussion of review results.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="METHODS" TYPE="SECTION">Methods</LINK>. We did not perform meta-regression due to the low number of studies included.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-09-06 02:31:59 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2010-08-31 23:46:09 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2010-08-31 23:46:09 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Ala_x002d_houlala-1988" MODIFIED="2010-01-24 18:05:28 -0500" MODIFIED_BY="[Empty name]" NAME="Ala-houlala 1988" YEAR="1984">
<REFERENCE MODIFIED="2010-01-24 18:05:28 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ala-Houhala M, Koskinen T, Koskinen M, Visakorpi JK</AU>
<TI>Double blind study on the need for vitamin D supplementation in prepubertal children</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1988</YR>
<VL>77</VL>
<NO>1</NO>
<PG>89-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Andersen-2008" MODIFIED="2010-08-31 21:04:47 -0400" MODIFIED_BY="[Empty name]" NAME="Andersen 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-01-24 18:05:23 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andersen R, Molgaard C, Skovgaard LT, Brot C, Cashman KD, Jakobsen J, et al</AU>
<TI>Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study</TI>
<SO>British Journal of Nutrition</SO>
<YR>2008</YR>
<VL>100</VL>
<PG>197-207</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-2005" MODIFIED="2010-08-26 06:51:02 -0400" MODIFIED_BY="[Empty name]" NAME="Cheng 2005" YEAR="unknw">
<REFERENCE MODIFIED="2010-08-26 06:51:02 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheng S, Lyytikainen A, Kroger H, Lamberg-Allardt C, Alen M, Koistinen A, et al</AU>
<TI>Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12 year old girls: a 2 year randomized trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>82</VL>
<NO>5</NO>
<PG>1115-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Du-2004" MODIFIED="2010-01-24 18:07:39 -0500" MODIFIED_BY="[Empty name]" NAME="Du 2004" YEAR="1999">
<REFERENCE MODIFIED="2010-01-24 18:06:19 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Du X, Zhu K, Trube A, Zhang Q, Ma G, Hu X, et al</AU>
<TI>School-milk intervention trial enhances growth and bone mineral accretion in Chinese girls aged 10-12 years in Beijing</TI>
<SO>British Journal of Nutrition</SO>
<YR>2004</YR>
<VL>92</VL>
<NO>1</NO>
<PG>159-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-24 18:06:31 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu K, Du X, Cowell CT, Greenfield H, Blades B, Dobbins TA, et al</AU>
<TI>Effects of school milk intervention on cortical bone accretion and indicators relevant to bone metabolism in Chinese girls aged 10-12 years in Beijing</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005 May</YR>
<VL>81</VL>
<NO>5</NO>
<PG>1168-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-24 18:07:09 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu K, Greenfield H, Du X, Zhang Q, Ma G, Hu X, et al</AU>
<TI>Effects of two years' milk supplementation on size-corrected bone mineral density of Chinese girls</TI>
<SO>Asia Pacific Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>17</VL>
<PG>147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-24 18:07:39 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu K, Zhang Q, Foo LH, Trube A, Ma G, Hu X, et al</AU>
<TI>Growth, bone mass, and vitamin D status of Chinese adolescent girls three years after withdrawal of milk supplementation</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>83</VL>
<PG>714-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-El-Hajj-Fuleihan-2006a" MODIFIED="2010-01-24 18:09:19 -0500" MODIFIED_BY="[Empty name]" NAME="El Hajj Fuleihan 2006a" YEAR="2006">
<REFERENCE MODIFIED="2010-01-24 18:08:11 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>El-Hajj Fuleihan G, Vieth R</AU>
<TI>Vitamin D insufficiency and musculoskeletal health in children and adolescents</TI>
<SO>Nutritional Aspects of Osteoporosis 2006, Proceedings of the International Symposium on Nutritional Aspects of Osteoporosis, 4-6 May 2006, Lausanne, Switzerland</SO>
<YR>2007</YR>
<ED>Burckhardt P, Heaney R, Dawson-Hughes B</ED>
<PB>Elsevier</PB>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-El_x002d_Hajj-Fuleihan-2006b" MODIFIED="2010-08-31 23:46:09 -0400" MODIFIED_BY="[Empty name]" NAME="El-Hajj Fuleihan 2006b" YEAR="2006">
<REFERENCE MODIFIED="2010-08-31 23:46:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, Choucair M, et al</AU>
<TI>Impact of vitamin D supplementation on musculoskeletal parameters in adolescents: a randomised trial</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>2004</YR>
<VL>19</VL>
<NO>Supplement 1</NO>
<PG>S13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-24 18:10:12 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, Khalife H, et al</AU>
<TI>Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>2006</YR>
<VL>91</VL>
<NO>2</NO>
<PG>405-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Viljakainen-2006" MODIFIED="2010-08-26 07:49:20 -0400" MODIFIED_BY="[Empty name]" NAME="Viljakainen 2006" YEAR="2001">
<REFERENCE MODIFIED="2010-08-26 07:49:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Viljakainen HT, Natri AM, Karkkainen M, Huttunen MM, Palssa A, Jakobsen J, et al</AU>
<TI>A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1 year intervention</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>June 2006</YR>
<VL>21</VL>
<NO>6</NO>
<PG>836-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-01-27 00:38:59 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Calvo-2000" MODIFIED="2010-01-27 00:38:06 -0500" MODIFIED_BY="[Empty name]" NAME="Calvo 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-01-27 00:38:06 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Calvo MS</AU>
<TI>Dietary considerations to prevent loss of bone and renal function</TI>
<SO>Nutrition</SO>
<YR>2000</YR>
<VL>16</VL>
<NO>7-8</NO>
<PG>564-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clutterbuck-2005" MODIFIED="2010-01-24 18:13:32 -0500" MODIFIED_BY="[Empty name]" NAME="Clutterbuck 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-01-24 18:13:32 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clutterbuck J</AU>
<TI>The prevention and treatment of osteoporosis - part (i) of (ii)</TI>
<SO>International Journal of Alternative and Complementary Medicine</SO>
<YR>1995</YR>
<VL>13</VL>
<NO>1</NO>
<PG>19-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Compston-1998" MODIFIED="2010-01-24 18:13:44 -0500" MODIFIED_BY="[Empty name]" NAME="Compston 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-01-24 18:13:44 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Compston J</AU>
<TI>Vitamin D helps stem bone loss</TI>
<SO>Nursing Times</SO>
<YR>1998</YR>
<VL>94</VL>
<NO>49</NO>
<PG>47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duhamel-2000" MODIFIED="2010-01-24 18:14:04 -0500" MODIFIED_BY="[Empty name]" NAME="Duhamel 2000" YEAR="1996">
<REFERENCE MODIFIED="2010-01-24 18:14:04 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duhamel JF, Zeghoud F, Sempe M, Boudailliez B, Odievre M, Laurans M, et al</AU>
<TI>[Prevention of vitamin D deficiency in adolescents and pre-adolescents. An interventional multicenter study on the biological effect of repeated doses of 100,000 IU of vitamin D3]</TI>
<TO>Prophylaxie de la carence en vitamine D chez l'adolescent et le preadolescent. Etude interventionelle mulitcentrique sur les effets biologiques d'un apport repete de 100 000 UI de vitamine D3</TO>
<SO>Archives de Pediatrie</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>2</NO>
<PG>148-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fehily-1992" MODIFIED="2010-01-24 18:14:29 -0500" MODIFIED_BY="[Empty name]" NAME="Fehily 1992" YEAR="1976">
<REFERENCE MODIFIED="2010-01-24 18:14:29 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fehily AM, Coles RJ, Evans WD, Elwood PC</AU>
<TI>Factors affecting bone density in young adults</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1992</YR>
<VL>56</VL>
<NO>3</NO>
<PG>579-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feliciano-1994" MODIFIED="2010-01-24 18:14:41 -0500" MODIFIED_BY="[Empty name]" NAME="Feliciano 1994" YEAR="1986">
<REFERENCE MODIFIED="2010-01-24 18:14:41 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feliciano ES, Ho ML, Specker BL, Falciglia G, Shui QM, Yin TA, et al</AU>
<TI>Seasonal and geographical variations in the growth rate of infants in China receiving increasing dosages of vitamin D supplements</TI>
<SO>Journal of Tropical Pediatrics</SO>
<YR>1994</YR>
<VL>40</VL>
<NO>3</NO>
<PG>162-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flynn-2003" MODIFIED="2010-01-24 18:14:54 -0500" MODIFIED_BY="[Empty name]" NAME="Flynn 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-01-24 18:14:54 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flynn A</AU>
<TI>The role of dietary calcium in bone health</TI>
<SO>Proceedings of the Nutrition Society</SO>
<YR>2003</YR>
<VL>62</VL>
<NO>4</NO>
<PG>851-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guillemant-2001" MODIFIED="2010-01-24 18:15:17 -0500" MODIFIED_BY="[Empty name]" NAME="Guillemant 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-01-24 18:15:17 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guillemant J, Le HT, Maria A, Allemandou A, Peres G, Guillemant S</AU>
<TI>Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements</TI>
<SO>Osteoporosis International</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>10</NO>
<PG>875-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ho-1985" MODIFIED="2010-01-24 18:15:39 -0500" MODIFIED_BY="[Empty name]" NAME="Ho 1985" YEAR="1983">
<REFERENCE MODIFIED="2010-01-24 18:15:39 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ho ML, Yen HC, Tsang RC</AU>
<TI>Randomized study of sunshine exposure and serum 25-OHD in breast-fed infants in Beijing, China</TI>
<SO>Journal of Pediatrics</SO>
<YR>1985</YR>
<VL>107</VL>
<NO>6</NO>
<PG>928-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matsumoto-2008" MODIFIED="2010-01-24 18:15:56 -0500" MODIFIED_BY="[Empty name]" NAME="Matsumoto 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-01-24 18:15:56 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matsumoto T, Kubodera N</AU>
<TI>ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects</TI>
<SO>Journal of Steroid Biochemistry and Molecular Biology</SO>
<YR>2007</YR>
<VL>103</VL>
<PG>584-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Venkataraman-1992" MODIFIED="2010-01-27 00:38:59 -0500" MODIFIED_BY="[Empty name]" NAME="Venkataraman 1992" YEAR="1986">
<REFERENCE MODIFIED="2010-01-24 18:16:09 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Venkataraman PS, Luhar H, Neylan MJ</AU>
<TI>Bone mineral metabolism in full-term infants fed human milk, cow milk-based, and soy-based formulas</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1992</YR>
<VL>146</VL>
<NO>11</NO>
<PG>1302-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-01-27 00:38:59 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-09-06 02:31:59 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2010-09-06 02:31:59 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Access-2001" MODIFIED="2010-01-24 18:16:58 -0500" MODIFIED_BY="[Empty name]" NAME="Access 2001" TYPE="BOOK">
<AU>Access Economics</AU>
<SO>The burden of brittle bones: costing osteoporosis in Australia</SO>
<YR>2001</YR>
<PB>Access Economics</PB>
<CY>Canberra</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ala_x002d_Houhala-1988" NAME="Ala-Houhala 1988" TYPE="JOURNAL_ARTICLE">
<AU>Ala-Houhala M, Koskinen T, Koskinen M, Visakorpi JK</AU>
<TI>Double blind study on the need for vitamin D supplementation in prepubertal children</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1988</YR>
<VL>77</VL>
<PG>89-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Alderson-2002" MODIFIED="2010-08-31 23:46:55 -0400" MODIFIED_BY="[Empty name]" NAME="Alderson 2002" TYPE="BOOK_SECTION">
<AU>Alderson P, Green S</AU>
<TI>Additional Module 1: Meta-analysis of Continuous Data</TI>
<SO>Cochrane Collaboration: open learning material for reviewers 2002 [accessed 20 September 2005]; http://www.cochrane-net.org/openlearning/HTML/modA1.htm</SO>
<YR>2002</YR>
<PB>Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ANZBMS-2005" NAME="ANZBMS 2005" TYPE="JOURNAL_ARTICLE">
<AU>Working Group of the Australian and New Zealand Bone and Mineral Society. Endocrine Society of Australia. Osteoporosis Australia</AU>
<TI>Vitamin D and adult bone health in Australia and New Zealand: a position statement</TI>
<SO>Medical Journal of Australia</SO>
<YR>2005</YR>
<VL>182</VL>
<PG>281-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bailey-1999" MODIFIED="2010-01-24 18:24:23 -0500" MODIFIED_BY="[Empty name]" NAME="Bailey 1999" TYPE="JOURNAL_ARTICLE">
<AU>Bailey DA, McKay HA, Mirwald RL, Crocker PR, Faulkner RA</AU>
<TI>A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>1999</YR>
<VL>14</VL>
<PG>1672-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burge-2007" NAME="Burge 2007" TYPE="JOURNAL_ARTICLE">
<AU>Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A</AU>
<TI>Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>2007</YR>
<VL>22</VL>
<PG>465-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cheng-2003" NAME="Cheng 2003" TYPE="JOURNAL_ARTICLE">
<AU>Cheng S, Tylavsky F, Kroger H, Karkkainen M, Lyytikainen A, Koistinen A, et al</AU>
<TI>Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>78</VL>
<PG>485-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cummings-1993" NAME="Cummings 1993" TYPE="JOURNAL_ARTICLE">
<AU>Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al</AU>
<TI>Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group</TI>
<SO>Lancet</SO>
<YR>1993</YR>
<VL>341</VL>
<PG>72-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Du-2005" MODIFIED="2010-08-31 23:44:46 -0400" MODIFIED_BY="[Empty name]" NAME="Du 2005" TYPE="JOURNAL_ARTICLE">
<AU>Du X, Zhu K, Trube A, Fraser DR, Greenfield H, Zhang Q, et al</AU>
<TI>Effects of school-milk intervention on growth and bone mineral accretion in Chinese girls aged 10-12 years: accounting for cluster randomisation</TI>
<SO>British Journal of Nutrition</SO>
<YR>2005</YR>
<VL>94</VL>
<PG>1038-9</PG>
<IDENTIFIERS MODIFIED="2010-01-27 00:34:10 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-El_x002d_Hajj-2001" MODIFIED="2010-01-24 18:23:30 -0500" MODIFIED_BY="[Empty name]" NAME="El-Hajj 2001" TYPE="JOURNAL_ARTICLE">
<AU>El-Hajj Fuleihan G, Nabulsi M, Choucair M, Salamoun M, Hajj Shahine C, Kizirian A, et al</AU>
<TI>Hypovitaminosis D in healthy schoolchildren</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<PG>E53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-El_x002d_Hajj-2004" NAME="El-Hajj 2004" TYPE="JOURNAL_ARTICLE">
<AU>El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, Choucair M, et al</AU>
<TI>Impact of vitamin D supplementation on musculoskeletal parameters in adolescents: a randomised trial</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>2004</YR>
<VL>19</VL>
<PG>S13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-El_x002d_Hajj-2006" NAME="El-Hajj 2006" TYPE="JOURNAL_ARTICLE">
<AU>El-Hajj Fuleihan G, Nabulsi M, Tamim H, Maalouf J, Salamoun M, Khalife H, et al</AU>
<TI>Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>2006</YR>
<VL>91</VL>
<PG>405-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Finnern-2003" NAME="Finnern 2003" TYPE="JOURNAL_ARTICLE">
<AU>Finnern HW, Sykes DP</AU>
<TI>The hospital cost of vertebral fractures in the EU: estimates using national datasets</TI>
<SO>Osteoporosis International</SO>
<YR>2003</YR>
<VL>14</VL>
<PG>429-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-French-2005" NAME="French 2005" TYPE="JOURNAL_ARTICLE">
<AU>French SA, Story M, Fulkerson JA, Himes JH, Hannan P, Neumark-Sztainer D, et al</AU>
<TI>Increasing weight-bearing physical activity and calcium-rich foods to promote bone mass gains among 9-11 year old girls: outcomes of the Cal-Girls study</TI>
<SO>International Journal of Behavioral Nutrition and Physical Activity</SO>
<YR>2005</YR>
<VL>2</VL>
<PG>8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gilsanz-1998" MODIFIED="2010-01-24 18:23:55 -0500" MODIFIED_BY="[Empty name]" NAME="Gilsanz 1998" TYPE="JOURNAL_ARTICLE">
<AU>Gilsanz V</AU>
<TI>Bone density in children: a review of the available techniques and indications</TI>
<SO>European Journal of Radiology</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>2</NO>
<PG>177-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goulding-1998" MODIFIED="2010-01-24 18:24:37 -0500" MODIFIED_BY="[Empty name]" NAME="Goulding 1998" TYPE="JOURNAL_ARTICLE">
<AU>Goulding A, Cannan R, Williams SM, Gold EJ, Taylor RW, Lewis-Barned NJ</AU>
<TI>Bone mineral density in girls with forearm fractures</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>1998</YR>
<VL>13</VL>
<PG>143-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goulding-2001" MODIFIED="2010-01-24 18:24:53 -0500" MODIFIED_BY="[Empty name]" NAME="Goulding 2001" TYPE="JOURNAL_ARTICLE">
<AU>Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ</AU>
<TI>Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study</TI>
<SO>Journal of Pediatrics</SO>
<YR>2001</YR>
<VL>139</VL>
<PG>509-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hansen-1991" MODIFIED="2010-01-24 18:25:10 -0500" MODIFIED_BY="[Empty name]" NAME="Hansen 1991" TYPE="JOURNAL_ARTICLE">
<AU>Hansen MA, Overgaard K, Riis BJ, Christiansen C</AU>
<TI>Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12-year study</TI>
<SO>BMJ</SO>
<YR>1991</YR>
<VL>303</VL>
<PG>961-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2009" MODIFIED="2010-09-06 02:31:59 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2009" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hind-2007" NAME="Hind 2007" TYPE="JOURNAL_ARTICLE">
<AU>Hind K, Burrows M</AU>
<TI>Weight-bearing exercise and bone mineral accrual in children and adolescents: a review of controlled trials</TI>
<SO>Bone</SO>
<YR>2007</YR>
<VL>40</VL>
<PG>14-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holick-2007" MODIFIED="2010-01-24 18:25:58 -0500" MODIFIED_BY="[Empty name]" NAME="Holick 2007" TYPE="JOURNAL_ARTICLE">
<AU>Holick MF</AU>
<TI>Vitamin D deficiency</TI>
<SO>New England Journal of Medicine</SO>
<YR>2007</YR>
<VL>357</VL>
<PG>266-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Javaid-2002" MODIFIED="2010-01-24 18:25:24 -0500" MODIFIED_BY="[Empty name]" NAME="Javaid 2002" TYPE="JOURNAL_ARTICLE">
<AU>Javaid MK, Cooper C</AU>
<TI>Prenatal and childhood influences on osteoporosis</TI>
<SO>Best Practice and Research in Clinical Endocrinology and Metabolism</SO>
<YR>2002</YR>
<VL>16</VL>
<PG>349-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnell-2006" MODIFIED="2010-01-24 18:29:29 -0500" MODIFIED_BY="[Empty name]" NAME="Johnell 2006" TYPE="JOURNAL_ARTICLE">
<AU>Johnell O, Kanis JA</AU>
<TI>An estimate of the worldwide prevalence and disability associated with osteoporotic fractures</TI>
<SO>Osteoporosis International</SO>
<YR>Dec 2006</YR>
<VL>17</VL>
<PG>1726-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-1994" MODIFIED="2010-01-24 18:25:33 -0500" MODIFIED_BY="[Empty name]" NAME="Jones 1994" TYPE="JOURNAL_ARTICLE">
<AU>Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA</AU>
<TI>Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)</TI>
<SO>Osteoporosis International</SO>
<YR>1994</YR>
<VL>4</VL>
<PG>277-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-1998" NAME="Jones 1998" TYPE="JOURNAL_ARTICLE">
<AU>Jones G, Dwyer T</AU>
<TI>Bone mass in prepubertal children: gender differences and the role of physical activity and sunlight exposure</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1998</YR>
<VL>83</VL>
<PG>4274-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-1999" NAME="Jones 1999" TYPE="JOURNAL_ARTICLE">
<AU>Jones G, Blizzard C, Riley MD, Parameswaran V, Greenaway TM, Dwyer T</AU>
<TI>Vitamin D levels in prepubertal children in southern Tasmania: prevalence and determinants</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>53</VL>
<PG>824-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-2005" NAME="Jones 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jones G, Dwyer T, Hynes KL, Parameswaran V, Greenaway TM</AU>
<TI>Vitamin D insufficiency in adolescent males in southern Tasmania: prevalence, determinants, and relationship to bone turnover markers</TI>
<SO>Osteoporosis International</SO>
<YR>2005</YR>
<VL>16</VL>
<PG>636-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lanou-2005" NAME="Lanou 2005" TYPE="JOURNAL_ARTICLE">
<AU>Lanou AJ</AU>
<TI>Bone health in children</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>33</VL>
<PG>763-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lehtonen-2002" NAME="Lehtonen 2002" TYPE="JOURNAL_ARTICLE">
<AU>Lehtonen-Veromaa MK, Mottonen TT, Nuotio IO, Irjala KM, Leino AE, Viikari JS</AU>
<TI>Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-year prospective study</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<PG>1446-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Looker-2002" NAME="Looker 2002" TYPE="JOURNAL_ARTICLE">
<AU>Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR</AU>
<TI>Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III</TI>
<SO>Bone</SO>
<YR>2002</YR>
<VL>30</VL>
<PG>771-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ma-2003" MODIFIED="2010-01-24 18:30:41 -0500" MODIFIED_BY="[Empty name]" NAME="Ma 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ma D, Jones G</AU>
<TI>The association between bone mineral density, metacarpal morphometry, and upper limb fractures in children: a population-based case-control study</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>2003</YR>
<VL>88</VL>
<PG>1486-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marshall-1996" MODIFIED="2010-01-24 18:30:47 -0500" MODIFIED_BY="[Empty name]" NAME="Marshall 1996" TYPE="JOURNAL_ARTICLE">
<AU>Marshall D, Johnell O, Wedel H</AU>
<TI>Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<PG>1254-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Munns-2006" NAME="Munns 2006" TYPE="JOURNAL_ARTICLE">
<AU>Munns C, Zacharin MR, Rodda CP, Batch JA, Morley R, Cranswick NE, et al</AU>
<TI>Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement</TI>
<SO>Medical Journal of Australia</SO>
<YR>2006</YR>
<VL>185</VL>
<PG>268-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NIH-1993" MODIFIED="2010-01-24 18:36:33 -0500" MODIFIED_BY="[Empty name]" NAME="NIH 1993" TYPE="JOURNAL_ARTICLE">
<AU>National Institutes of Health</AU>
<TI>Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis</TI>
<SO>American Journal of Medicine</SO>
<YR>1993</YR>
<VL>94</VL>
<PG>646-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NIH-2000" MODIFIED="2010-08-31 23:48:42 -0400" MODIFIED_BY="[Empty name]" NAME="NIH 2000" TYPE="OTHER">
<TI>Osteoporosis Prevention, Diagnosis and Therapy. 2000 March 2000;17:1-45</TI>
<SO>NIH Consensus Statement 2000 Mar 27-29</SO>
<YR>2000</YR>
<VL>17</VL>
<NO>1</NO>
<PG>1-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Outila-2001" NAME="Outila 2001" TYPE="JOURNAL_ARTICLE">
<AU>Outila TA, Karkkainen MU, Lamberg-Allardt CJ</AU>
<TI>Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2001</YR>
<VL>74</VL>
<PG>206-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Riis-1996" MODIFIED="2010-01-24 18:36:47 -0500" MODIFIED_BY="[Empty name]" NAME="Riis 1996" TYPE="JOURNAL_ARTICLE">
<AU>Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C</AU>
<TI>Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study</TI>
<SO>Bone</SO>
<YR>1996</YR>
<VL>19</VL>
<PG>9-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ritenbaugh-2003" NAME="Ritenbaugh 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ritenbaugh C, DeBar L, Aickin M, Elmer PJ, Elliott D, Orwoll E</AU>
<TI>The effects of a lifestyle intervention for teen girls on bone mineral density</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>2003</YR>
<VL>18</VL>
<PG>S33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rockell-2005" NAME="Rockell 2005" TYPE="JOURNAL_ARTICLE">
<AU>Rockell JE, Green TJ, Skeaff CM, Whiting SJ, Taylor RW, Williams SM, et al</AU>
<TI>Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5-14 years</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<PG>2602-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rockell-2006" NAME="Rockell 2006" TYPE="JOURNAL_ARTICLE">
<AU>Rockell JE, Skeaff CM, Williams SM, Green TJ</AU>
<TI>Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older</TI>
<SO>Osteoporosis International</SO>
<YR>2006</YR>
<VL>17</VL>
<PG>1382-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Timperio-2004" NAME="Timperio 2004" TYPE="JOURNAL_ARTICLE">
<AU>Timperio A, Salmon J, Ball K</AU>
<TI>Evidence-based strategies to promote physical activity among children, adolescents and young adults: review and update</TI>
<SO>Journal of Sports Science and Medicine</SO>
<YR>2004</YR>
<VL>7</VL>
<PG>20-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tylavsky-2006" NAME="Tylavsky 2006" TYPE="JOURNAL_ARTICLE">
<AU>Tylavsky FA, Cheng S, Lyytikainen A, Viljakainen H, Lamberg-Allardt C</AU>
<TI>Strategies to improve vitamin D status in northern European children: exploring the merits of vitamin D fortification and supplementation</TI>
<SO>Journal of Nutrition</SO>
<YR>2006</YR>
<VL>136</VL>
<PG>1130-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Winzenberg-2006a" NAME="Winzenberg 2006a" TYPE="COCHRANE_REVIEW">
<AU>Winzenberg TM, Shaw K, Fryer J, Jones G</AU>
<TI>Calcium supplementation for improving bone mineral density in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>2</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD005119.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Winzenberg-2006b" NAME="Winzenberg 2006b" TYPE="JOURNAL_ARTICLE">
<AU>Winzenberg T, Shaw K, Fryer J, Jones G</AU>
<TI>Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>333</VL>
<PG>775</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zamora-1999" NAME="Zamora 1999" TYPE="JOURNAL_ARTICLE">
<AU>Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP</AU>
<TI>Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1999</YR>
<VL>84</VL>
<PG>4541-4</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2008-11-04 17:38:32 -0500" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ala_x002d_houlala-1988">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: school children, Tampere, Finland; latitude 61 degrees north</P>
<P>DURATION OF SUPPLEMENTATION:  13 months</P>
<P>DURATION OF FOLLOW-UP: 13 months</P>
<P>TYPE OF ANALYSIS: per protocol</P>
<P>COMPLIANCE: 4/30 (13%) of vitamin D supplement group excluded as had taken &lt; 5 capsules per week, else not stated</P>
<P>CONFOUNDERS MEASURED: none noted</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: unknown</P>
<P>N RANDOMISED: 60</P>
<P>N COMPLETED: 57 but further 6 excluded (compliance poor = 4, pubertal stage advanced = 1, multivitamin use = 1)</P>
<P>M = 45% at completion, after exclusions</P>
<P>F = 55% at completion, after exclusions</P>
<P>ETHNICITY: not stated</P>
<P>MEAN BASELINE AGE (yrs): not stated</P>
<P>BASELINE AGE RANGE (yrs): 8 to 10</P>
<P>INCLUSION CRITERIA: 8 to 10 years old, prepubertal</P>
<P>EXCLUSION CRITERIA: history of malabsorption, hepatic, renal or endocrine diseases, use of vitamin pills</P>
<P>BASELINE SERUM 25 hydroxy vitamin D (nmol/L): 49 nmol/L in supplement group, 46 nmol/L in placebo group</P>
<P>CALCIUM INTAKE: not stated</P>
<P>PUBERTAL STATUS: prepubertal</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>1. 400 IU vitamin D2 daily</P>
<P>2. Placebo</P>
<P>CO-INTERVENTIONS: nil</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: nil</P>
<P>BONE MINERAL CONTENT: 1/3 from distal end of diaphysis of non-dominant radius</P>
<P>BONE AREA: nil</P>
<P>METHOD OF MEASUREMENT: single photon absorptiometry</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 8/12, 13/12</P>
<P>OTHER OUTCOMES MEASURED: weight, height, serum vitamin D metabolites, calcium, albumin, inorganic phosphorus, alkaline phosphatase, parathyroid hormone</P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>BONE MINERAL CONTENT: 1/3 from distal end of diaphysis of non-dominant radius</P>
<P>SUB-GROUPS IDENTIFIED: Nil</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-26 06:32:27 -0400" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andersen-2008">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: community setting, Copenhagen area, Denmark</P>
<P>DURATION OF SUPPLEMENTATION: 1 year</P>
<P>DURATION OF FOLLOW UP: 1 year</P>
<P>TYPE OF ANALYSIS: available data analysis (intention to treat stated but no indication of imputation of missing data)</P>
<P>COMPLIANCE: 85%</P>
<P>CONFOUNDERS MEASURED: age, BMI, dietary calcium intake, dietary vitamin D intake, height, weight</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: not specified</P>
<P>N RANDOMISED: 26 in total; 8 to placebo, 9 each to 5 and 10 microgram groups</P>
<P>N COMPLETED: 7 in each group</P>
<P>M = 0%</P>
<P>F = 100%</P>
<P>ETHNICITY: Pakistani</P>
<P>MEDIAN BASELINE AGE (yrs): 12.2</P>
<P>BASELINE AGE RANGE (yrs): 10.1 to 14.7</P>
<P>INCLUSION CRITERIA: Pakistani origin (immigrants or descendants with Pakistani parents)</P>
<P>EXCLUSION CRITERIA: serious illness, medication known to affect bone metabolism or 25(OH)D concentrations, pregnancy, breastfeeding, planning pregnancy within 1 year, serum ionised calcium concentrations &gt; 1.5 mmol/L</P>
<P>BASELINE SERUM Vitamin D (nmol/L): 7.3, 16.9 and 8.8 nmol/L for placebo, 5 and 10 microgram groups respectively</P>
<P>CALCIUM INTAKE: 510 to 656 mg/day (median)</P>
<P>PUBERTAL STATUS: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>1. 400 IU vitamin D3</P>
<P>2. 200 IU vitamin D3</P>
<P>3. Placebo</P>
<P>CO-INTERVENTIONS: nil</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: whole body and L2-4 vertebrae</P>
<P>BONE MINERAL CONTENT: whole body and L2-4 vertebrae</P>
<P>BONE AREA: whole body and L2-4 vertebrae</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 0.5 and 1 year (bone measures 0 and 1 year)</P>
<P>OTHER OUTCOMES MEASURED: weight, height, serum 25 hydroxy D, intact parathyroid hormone, osteocalcin, urinary pyridinoline and deoxy pyridinoline, serum ionised calcium</P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>AREAL BONE MINERAL DENSITY: whole body and L2-4 vertebrae</P>
<P>BONE MINERAL CONTENT: whole body and L2-4 vertebrae</P>
<P>BONE AREA: whole body and L2-4 vertebrae</P>
<P>SUB-GROUPS IDENTIFIED: nil</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-26 06:33:57 -0400" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-2005">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: schools, Jyvaskyla, Finland</P>
<P>DURATION OF SUPPLEMENTATION: 2 years</P>
<P>DURATION OF FOLLOW UP: 2 years</P>
<P>TYPE OF ANALYSIS: available data and per protocol analyses</P>
<P>COMPLIANCE: 70% for calcium plus vitamin D, 68% for calcium alone</P>
<P>CONFOUNDERS MEASURED: age, BMI, physical activity, Tanner stage, calcium intake, dietary vitamin D intake</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: 1367</P>
<P>N RANDOMISED: 195 to all 4 study arms; 49 to calcium + vit D, 49 to Calcium</P>
<P>N COMPLETED: Ca+D= 46; Ca =41</P>
<P>M = 0%</P>
<P>F = 100%</P>
<P>ETHNICITY: white</P>
<P>MEAN BASELINE AGE (yrs): 11.1</P>
<P>BASELINE AGE RANGE (yrs): 10 to 12</P>
<P>INCLUSION CRITERIA: no history of serious medical conditions, history of medication known to affect bone metabolism, age 10 to 12, Tanner stage I-II, dietary calcium intake &lt; 900 mg/day</P>
<P>EXCLUSION CRITERIA: Tanner stage &gt; II, dietary calcium intake &gt; 900 mg/day, race other than white</P>
<P>BASELINE SERUM Vitamin D (nmol/L): 49.5 nmol/L</P>
<P>CALCIUM INTAKE: 666 mg/day baseline; 1623 mg/day in trial</P>
<P>PUBERTAL STATUS: prepubertal (Tanner stage I-II)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>1. 1000 mg calcium carbonate plus 200 IU vitamin D3</P>
<P>2. 1000 mg calcium carbonate plus vitamin D3 placebo</P>
<P>CO-INTERVENTIONS: the 2 other study arms not included in this review were:</P>
<P>3. 1000mg calcium daily from supplemented dairy products and</P>
<P>4. Calcium placebo with vitamin D3 placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: whole body, femoral neck, total femur and L2-4 vertebrae</P>
<P>BONE MINERAL CONTENT: whole body, femoral neck, total femur and L2-4 vertebrae</P>
<P>BONE AREA: whole body, femoral neck, total femur and L2-4 vertebrae</P>
<P>VOLUMETRIC BMD: distal radius, left tibial shaft</P>
<P>METHOD OF MEASUREMENT: DXA and pQCT</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 0.5, 1, 1.5 and 2 years (bone measures 0, 1 and 2 years)</P>
<P>OTHER OUTCOMES MEASURED: weight, height, lean tissue mass, fat mass, cross-sectional area and moment of inertia of distal radius, left tibial shaft, cortical thickness of left tibial shaft, serum 25 hydroxy D, intact parathyroid hormone, leptin, bone resorption and formation markers, urinary calcium excretion </P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>AREAL BONE MINERAL DENSITY: whole body, femoral neck, and L2-4 vertebrae</P>
<P>BONE MINERAL CONTENT: whole body, femoral neck, and L2-4 vertebrae</P>
<P>BONE AREA: whole body, femoral neck, and L2-4 vertebrae</P>
<P>VOLUMETRIC BMD: distal radius, left tibial shaft</P>
<P>SUB-GROUPS IDENTIFIED: nil</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-26 06:35:59 -0400" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Du-2004">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: schools, China</P>
<P>DURATION OF SUPPLEMENTATION: 2 years</P>
<P>DURATION OF FOLLOW UP: 5 years</P>
<P>TYPE OF ANALYSIS: per protocol with available data</P>
<P>COMPLIANCE: 33/757 excluded from analysis for failure to drink milk for ? 4 days. Remainder close to 100% compliance and average dose vitamin D received 3.33 microgram/day</P>
<P>CONFOUNDERS MEASURED: calcium intake, physical activity, dietary vitamin D intake, pubertal status, UV exposure</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: not stated</P>
<P>N RANDOMISED: 757 in total, 498 to treatment arms included in review</P>
<P>N COMPLETED: 698 in total, 451 in treatment arms included in review</P>
<P>M = 0%</P>
<P>F = 100%</P>
<P>ETHNICITY: Chinese</P>
<P>MEAN BASELINE AGE (yrs): 10.1</P>
<P>BASELINE AGE RANGE (yrs): not stated</P>
<P>INCLUSION CRITERIA: 10 years old</P>
<P>EXCLUSION CRITERIA: any disease that might affect bone development</P>
<P>BASELINE SERUM Vitamin D (nmol/L): 17.7 nmol/L (calcium group); 20.6 nmol/L (calcium plus vitamin D)</P>
<P>CALCIUM INTAKE: 418 mg/day (baseline); 649 to 660 mg/day during trial</P>
<P>PUBERTAL STATUS: Tanner I 40.6% to 42%; Tanner II 49.3% to 49.8%, Tanner III-IV 8.3% to 9.6%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>1. 330 ml calcium fortified milk (calcium dose 560 mg) daily on school days (245 mg/day average) </P>
<P>2. 330 ml calcium fortified milk (calcium dose 560 mg) with 5 or 8 microgram vitamin D3 on school days (average 245 mg calcium and 3.33 microgram vitamin D3 daily)</P>
<P>3. Control group with normal diet (not included in review)</P>
<P>CO-INTERVENTIONS: 330 ml calcium fortified milk (calcium dose 560 mg) daily on school days (245 mg/day average)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: distal and proximal forearm of non-dominant arm, whole body</P>
<P>BONE MINERAL CONTENT: distal and proximal forearm of non-dominant arm, whole body</P>
<P>BONE AREA: distal and proximal forearm of non-dominant arm, whole body</P>
<P>METHOD OF MEASUREMENT: DXA</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 1, 2</P>
<P>OTHER OUTCOMES MEASURED: weight, height, serum 25 hydroxy vitamin D, serum intact parathyroid hormone, serum total calcium (uncorrected for albumin, urinary calcium:creatinine ratio (mmol/mmol), bone age</P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>AREAL BONE MINERAL DENSITY: distal radial metaphysis, diaphysis of radius, femoral neck, femoral trochanter, femoral diaphysis and L2-4 vertebrae, mean of the 6 sites</P>
<P>BONE MINERAL CONTENT: L2-4 vertebrae, mean of all 6 sites</P>
<P>BONE AREA: femoral diaphysis and L2-4 vertebrae, mean of the 6 sites</P>
<P>SUB-GROUPS IDENTIFIED: pre and post menarche</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Cluster-randomised by school. In first reference (Du, <I>British Journal of Nutrition</I> 2004) data was not analysed taking into account clustering, corrected in letter to editor (Du, <I>British Journal of Nutrition</I> 2005).</P>
<P>Whole body measures performed on a random selection of half the participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: Beirut, schools</P>
<P>DURATION OF SUPPLEMENTATION: 1 year</P>
<P>DURATION OF FOLLOW UP: 1 year</P>
<P>TYPE OF ANALYSIS: available data</P>
<P>COMPLIANCE: 97% to 98% of dose taken</P>
<P>CONFOUNDERS MEASURED: calcium intake, sun exposure, exercise (hours per week), age, height, weight, Tanner stage, baseline vitamin D levels</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: not known</P>
<P>N RANDOMISED: 184</P>
<P>N COMPLETED: 172</P>
<P>M = 100%</P>
<P>F = 0%</P>
<P>ETHNICITY: Not stated</P>
<P>MEAN BASELINE AGE (yrs): 13.0 years</P>
<P>BASELINE AGE RANGE (yrs): 10 to 17 years</P>
<P>INCLUSION CRITERIA: healthy</P>
<P>EXCLUSION CRITERIA: any disorders or medications known to affect bone metabolism</P>
<P>BASELINE SERUM Vitamin D (nmol/L): 40</P>
<P>CALCIUM INTAKE: mg/day (baseline); 775</P>
<P>PUBERTAL STATUS: Tanner stage 1-2 = 92, Tanner 3-4 = 80</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-08-26 06:39:34 -0400" MODIFIED_BY="[Empty name]">
<P>1. 1400 IU vitamin D3 per week</P>
<P>2. 14,000 IU vitamin D3 per week</P>
<P>3. Placebo</P>
<P>CO-INTERVENTIONS: nil</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE MINERAL CONTENT: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE AREA: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>METHOD OF MEASUREMENT: DXA</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 1</P>
<P>OTHER OUTCOMES MEASURED: weight, height, grip strength, sick days, fractures, serum calcium, phosphorus and alkaline phosphatase and 25 hydroxy D, subtotal fat mass and lean mass (non-fat soft tissue mass)</P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>AREAL BONE MINERAL DENSITY: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE MINERAL CONTENT: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE AREA: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>SUB-GROUPS IDENTIFIED: Tanner I-II versus III-IV boys</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Risk of bias assessment based on methods given in references to El Hajj Fuleihan (F) 2006</P>
<P>Data provided are unpublished</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: Beirut schools, Lebanon</P>
<P>DURATION OF SUPPLEMENTATION: 1 year</P>
<P>DURATION OF FOLLOW UP: 1 year</P>
<P>TYPE OF ANALYSIS: available data</P>
<P>COMPLIANCE: 97% to 98% in the 168 girls completing the study and included in the analysis</P>
<P>CONFOUNDERS MEASURED: Calcium intake, sun exposure, exercise (hours per week), age, height, weight, Tanner stage, baseline vitamin D levels</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: 219</P>
<P>N RANDOMISED: 179</P>
<P>N COMPLETED: 168</P>
<P>M = 0%</P>
<P>F = 100%</P>
<P>ETHNICITY: not stated</P>
<P>MEAN BASELINE AGE (yrs): 13.2 (girls)</P>
<P>BASELINE AGE RANGE (yrs): 10 to 17</P>
<P>INCLUSION CRITERIA: healthy</P>
<P>EXCLUSION CRITERIA: any disorders or medications known to affect bone metabolism</P>
<P>BASELINE SERUM Vitamin D (nmol/L): 34.9 nmol/L</P>
<P>CALCIUM INTAKE: 677 mg/day (girls, baseline); 798 mg/day (boys, baseline)</P>
<P>PUBERTAL STATUS: 34 premenarcheal, 134 post menarcheal (of 168 girls completing study)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-20 01:11:35 -0400" MODIFIED_BY="[Empty name]">
<P>1. 1400 IU vitamin D3 per week</P>
<P>2. 14,000 IU vitamin D3 per week</P>
<P>3. Placebo</P>
<P>CO-INTERVENTIONS: nil</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE MINERAL CONTENT: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE AREA: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>METHOD OF MEASUREMENT: DXA</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 1</P>
<P>OTHER OUTCOMES MEASURED: weight, height, grip strength, sick days, fractures, serum calcium, phosphorus and alkaline phosphatase and 25 hydroxy D, subtotal fat mass and lean mass (non-fat soft tissue mass).</P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>AREAL BONE MINERAL DENSITY: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE MINERAL CONTENT: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>BONE AREA: lumbar spine, total hip, femoral neck, trochanter and one-third radius and subtotal (whole body excluding head)</P>
<P>SUB-GROUPS IDENTIFIED: males and females; pre and post menarcheal girls, Tanner I-II versus III-IV boys</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>Unpublished and published data used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Viljakainen-2006">
<CHAR_METHODS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>STUDY DESIGN: randomised controlled trial</P>
<P>LOCATION AND SETTING: schools, Finland, 60 degrees north latitude</P>
<P>DURATION OF SUPPLEMENTATION: 1 year</P>
<P>DURATION OF FOLLOW UP: 1 year</P>
<P>TYPE OF ANALYSIS: available data and per protocol</P>
<P>COMPLIANCE: 90% of participants completing had compliance &gt; 80%</P>
<P>CONFOUNDERS MEASURED: pubertal stage, dietary vitamin D and calcium intake, physical activity, time spent outdoors</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>N SCREENED: not stated</P>
<P>N RANDOMISED: 228</P>
<P>N COMPLETED: 212</P>
<P>M = 0%</P>
<P>F = 100%</P>
<P>ETHNICITY: white</P>
<P>MEAN BASELINE AGE (yrs): 11.4</P>
<P>BASELINE AGE RANGE (yrs): 11 to 12</P>
<P>INCLUSION CRITERIA: healthy</P>
<P>EXCLUSION CRITERIA: use of medicines known to affect calcium metabolism</P>
<P>BASELINE SERUM Vitamin D (nmol/L): 47 nmol/L</P>
<P>CALCIUM INTAKE: 1198 mg/day baseline</P>
<P>PUBERTAL STATUS: mixed (n = 10/112/71/7/12 for Tanner I-V respectively)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-20 01:12:20 -0400" MODIFIED_BY="[Empty name]">
<P>1. 400 IU vitamin D3</P>
<P>2. 200 IU vitamin D3</P>
<P>3. Placebo</P>
<P>CO-INTERVENTIONS: nil</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<P>BONE MEASURES: SITES</P>
<P>AREAL BONE MINERAL DENSITY: total hip and L2-4 vertebrae</P>
<P>BONE MINERAL CONTENT: total hip and L2-4 vertebrae</P>
<P>BONE AREA: total hip and L2-4 vertebrae</P>
<P>SIZE ADJUSTED BMC: total hip and L2-4 vertebrae</P>
<P>METHOD OF MEASUREMENT: DXA</P>
<P>FOLLOW-UP ASSESSMENT POINTS (yrs): 0, 1</P>
<P>OTHER OUTCOMES MEASURED: weight, height, serum osteocalcin, urinary pyridinoline, deoxypyridinoline, serum 25 hydroxy vitamin D, serum intact parathyroid hormone, serum and urinary calcium, phosphate and creatinine</P>
<P>BONE MEASURES INCLUDED IN STUDY ANALYSES:</P>
<P>AREAL BONE MINERAL DENSITY: total hip and L2-4 vertebrae.</P>
<P>BONE MINERAL CONTENT: total hip and L2-4 vertebrae</P>
<P>BONE AREA: total hip and L2-4 vertebrae</P>
<P>SIZE ADJUSTED BMC: total hip and L2-4 vertebrae</P>
<P> SUB-GROUPS IDENTIFIED: Tanner I-II versus Tanner III-V</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-03 23:42:55 -0400" MODIFIED_BY="[Empty name]">
<P>Published and unpublished data used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BMC = bone mineral content<BR/>BMD = bone mineral density<BR/>BMI = body mass index<BR/>Ca = calcium</P>
<P>DXA = dual x-ray absorptiometry</P>
<P>pQCT = peripheral quantitative computerised tomography</P>
<P>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-09-24 02:27:30 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:26:44 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Calvo-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:26:44 -0400" MODIFIED_BY="[Empty name]">
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:26:58 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clutterbuck-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:26:58 -0400" MODIFIED_BY="[Empty name]">
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:27:00 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Compston-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:27:00 -0400" MODIFIED_BY="[Empty name]">
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-24 02:27:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Duhamel-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-24 02:27:30 -0400" MODIFIED_BY="[Empty name]">
<P>No primary outcomes were measured</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:28:05 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fehily-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:28:05 -0400" MODIFIED_BY="[Empty name]">
<P>All participants aged &lt; 1 month</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:28:26 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feliciano-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:28:26 -0400" MODIFIED_BY="[Empty name]">
<P>Not a vitamin D intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:28:37 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flynn-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:28:37 -0400" MODIFIED_BY="[Empty name]">
<P>Not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:29:22 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guillemant-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:29:22 -0400" MODIFIED_BY="[Empty name]">
<P>No placebo in control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:29:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ho-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:29:33 -0400" MODIFIED_BY="[Empty name]">
<P>No bone density outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-24 00:42:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Matsumoto-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-24 00:42:18 -0400" MODIFIED_BY="[Empty name]">
<P>Participants aged &gt; 18 years</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 00:30:15 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Venkataraman-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 00:30:15 -0400" MODIFIED_BY="[Empty name]">
<P>All participants aged &lt; 1 month</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-06-01 23:36:06 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2009-06-01 23:36:06 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-19 18:46:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ala_x002d_houlala-1988">
<DESCRIPTION>
<P>Not described but described as "randomised controlled trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-24 02:03:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2008">
<DESCRIPTION>
<P>Stated randomisation but no description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-19 18:57:13 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2005">
<DESCRIPTION>
<P>"assignments were generated by a computer program in blocks of randomly varying size"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-20 01:05:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2004">
<DESCRIPTION>
<P>Stated randomisation but no description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<DESCRIPTION>
<P>"The randomisation sequence, stratified by socioeconomic status, was generated by a computer at Merck headquarters, mailed to the study centre and administered by a senior pharmacist"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<DESCRIPTION>
<P>"The randomisation sequence, stratified by socioeconomic status, was generated by a computer at Merck headquarters, mailed to the study centre and administered by a senior pharmacist"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Viljakainen-2006">
<DESCRIPTION>
<P>"stratified randomisation process". "Stratification factor was pubertal development"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-19 18:42:17 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ala_x002d_houlala-1988">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-24 02:03:00 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2008">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-01 23:36:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2005">
<DESCRIPTION>
<P>"Study group assignments were placed in double sealed envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-20 01:06:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2004">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<DESCRIPTION>
<P>"The randomisation sequence, stratified by socioeconomic status, was generated by a computer at Merck headquarters, mailed to the study centre and administered by a senior pharmacist"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<DESCRIPTION>
<P>"The randomisation sequence, stratified by socioeconomic status, was generated by a computer at Merck headquarters, mailed to the study centre and administered by a senior pharmacist"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Viljakainen-2006">
<DESCRIPTION>
<P>"The randomisation was done by a person not involved in the project" but allocation was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ala_x002d_houlala-1988">
<DESCRIPTION>
<P>Described as "double blind", placebo used and bone density outcomes not likely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2008">
<DESCRIPTION>
<P>Stated study was double-blind and used a placebo but inadequate description. Bone density outcomes unlikely to be influenced by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-10-19 18:59:35 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2005">
<DESCRIPTION>
<P>"The investigators were unblinded at the conclusion of the trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-09-30 01:08:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Du-2004">
<DESCRIPTION>
<P>"the identity of the supplement being unknown to both subjects and investigators during the course of the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<DESCRIPTION>
<P>"The subjects were randomly assigned in a double blind manner" "All students received identical bottles of an oily solution". Bone density outcomes not likely to be influenced by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<DESCRIPTION>
<P>"The subjects were randomly assigned in a double blind manner". "All students received identical bottles of an oily solution". Bone density outcomes not likely to be influenced by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Viljakainen-2006">
<DESCRIPTION>
<P>Stated study was double-blind and used a placebo but inadequate description. Bone density outcomes unlikely to be influenced by lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Bone density outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-10-19 18:50:10 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ala_x002d_houlala-1988">
<DESCRIPTION>
<P>"At the end of the study, after control counting of the remaining capsules, we also had to exclude 4 children in the vitamin D supplemented group who had consumed less than 5 capsules weekly."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2008">
<DESCRIPTION>
<P>19% (5/26) drop-outs, no description given and no method of imputing missing data described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-10-19 19:01:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2005">
<DESCRIPTION>
<P>Reasons for withdrawals stated and unlikely to be related to true outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Du-2004">
<DESCRIPTION>
<P>Participants (n = 33) who were noncompliant were excluded from analysis, and then only full data sets on 681 of the 698 completing the study were included in analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-03 23:37:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<DESCRIPTION>
<P>93% of subjects included in analysis; no data on distribution of loss to follow up across groups and reasons for loss to follow up not published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<DESCRIPTION>
<P>94% of subjects included in analysis; loss to follow up even across groups and reasons for loss to follow up not likely to be related to true outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-09-24 02:04:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Viljakainen-2006">
<DESCRIPTION>
<P>7% dropped out but for reasons not related to true outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-19 18:52:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ala_x002d_houlala-1988">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-24 02:06:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2008">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2005">
<DESCRIPTION>
<P>Outcomes reported on all bone density measures given in the methods; a priori power calculations reported for BMC outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Du-2004">
<DESCRIPTION>
<P>BMC, bone area and BMD were measured at the distal and proximal forearm of the non-dominant arm, but results were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-03 23:38:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<DESCRIPTION>
<P>Study protocol not available. A priori power calculations for lumbar spine bone density outcomes described, but not for total body outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-20 20:53:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<DESCRIPTION>
<P>Study protocol not available. A priori power calculations for lumbar spine bone density outcomes described, but not for total body outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Viljakainen-2006">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ala_x002d_houlala-1988">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-24 02:06:45 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2008">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-19 19:05:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheng-2005">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Du-2004">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El-Hajj-Fuleihan-2006a">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-31 22:23:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Viljakainen-2006">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2010-07-15 01:00:51 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2010-07-15 01:00:51 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2010-07-15 01:00:46 -0400" MODIFIED_BY="Grade Profiler">Vitamin D supplementation for improving bone mineral density in children</TITLE>
<TABLE COLS="7" ROWS="7">
<TR>
<TD COLSPAN="7">
<P>
<B>Vitamin D supplementation for improving bone mineral density in children</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with improving bone mineral density in children<BR/>
<B>Settings:</B> <BR/>
<B>Intervention:</B> Vitamin D supplementation<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Vitamin D supplementation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>% Change total body bone mineral content from baseline</B>
<BR/>Follow-up: 1-2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean % Change total body bone mineral content from baseline in the intervention groups was<BR/>
<B>0.1 standard deviations higher</B>
<BR/>(0.06 lower to 0.26 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>672<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.1 (-0.06 to 0.26) Not statistically significant</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>% Change hip bone mineral density from baseline</B>
<BR/>Follow-up: 1-2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean % Change hip bone mineral density from baseline in the intervention groups was<BR/>
<B>0.06 standard deviations higher</B>
<BR/>(0.18 lower to 0.29 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>639<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.06 (-0.18 to 0.29) Not statistically significant</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>% Change lumbar spine bone mineral density from baseline</B>
<BR/>Follow-up: 1-2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean % Change lumbar spine bone mineral density from baseline in the intervention groups was<BR/>
<B>0.15 standard deviations higher</B>
<BR/>(0.01 lower to 0.31 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>660<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.15 (-0.01 to 0.31) Not statistically significant</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>% Change forearm bone mineral density from baseline</B>
<BR/>Follow-up: 1-2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean % Change forearm bone mineral density from baseline in the intervention groups was<BR/>
<B>0.04 standard deviations higher</B>
<BR/>(0.36 lower to 0.45 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>427<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD 0.04 (-0.36 to 0.45) Not statistically significant</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Adverse events</B>
<SUP>3</SUP> - not reported</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> There was substantial heterogeneity in results not adequately explained by subgroup analyses.<BR/>
<SUP>2</SUP> There was substantial heterogeneity in results not adequately explained by subgroup analyses.<BR/>
<SUP>3</SUP> Adverse events were not well reported and data did allow pooling of results</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2010-08-31 23:13:02 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2010-08-31 23:13:02 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-09-30 00:46:07 -0400" MODIFIED_BY="[Empty name]">Adverse events</TITLE>
<TABLE COLS="2" ROWS="8">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P> Study</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Adverse events</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ala_x002d_houlala-1988" TYPE="STUDY">Ala-houlala 1988</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Andersen-2008" TYPE="STUDY">Andersen 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No hypercalcaemia, otherwise not reported</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cheng-2005" TYPE="STUDY">Cheng 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No drop-outs due to adverse events, otherwise not reported</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Du-2004" TYPE="STUDY">Du 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 withdrawal due to skin allergy - intervention arm not reported, otherwise not reported</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-El-Hajj-Fuleihan-2006a" TYPE="STUDY">El Hajj Fuleihan 2006a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 boys in placebo and 1 in each vitamin D dosage arm had hypercalcaemia at 1 year, otherwise not reported</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-El_x002d_Hajj-Fuleihan-2006b" TYPE="STUDY">El-Hajj Fuleihan 2006b</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 subjects in placebo arm with hypercalcaemia; 11 withdrawals evenly distributed across 3 treatment arms with reasons for withdrawal unrelated to adverse events in 10 cases; 1 girl developed poststreptococcal glomerulonephritis</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Viljakainen-2006" TYPE="STUDY">Viljakainen 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 drop-outs for reasons unrelated to study protocol, otherwise not reported</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-08-26 07:03:28 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-10-04 19:33:50 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Vitamin D supplementation vs placebo combining dosage groups, all data</NAME>
<CONT_OUTCOME CHI2="4.054677346532506" CI_END="0.2576287104628855" CI_START="-0.055793915799368876" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10091739733175831" ESTIMABLE="YES" I2="1.3485005552726617" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2009-10-04 19:33:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39865688865306736" P_Q="1.0" P_Z="0.20689190208932817" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="99.99999999999999" Z="1.2621581698971638">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" MODIFIED="2009-09-28 19:36:44 -0400" MODIFIED_BY="[Empty name]" ORDER="341" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.9601040136805756"/>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="21" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="299" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.69156569900406"/>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" MODIFIED="2009-08-21 00:26:13 -0400" MODIFIED_BY="[Empty name]" ORDER="300" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="301" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="23.43246016042895"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.088795604896442" CI_END="0.29236145839972394" CI_START="-0.18102404321268345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.05566870759352023" ESTIMABLE="YES" I2="50.72917216029583" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2009-09-28 00:13:00 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1073692072084167" P_Q="1.0" P_Z="0.6448189037780425" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.029368938657370898" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="0.4609717094315478">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="28" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.18163563243661"/>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" MODIFIED="2009-06-01 18:43:13 -0400" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.106850509681415"/>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" MODIFIED="2009-06-01 18:43:27 -0400" MODIFIED_BY="[Empty name]" ORDER="26" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.767632347525737"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" MODIFIED="2009-06-01 18:42:43 -0400" MODIFIED_BY="[Empty name]" ORDER="25" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.943881510356235"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.02272172362773" CI_END="0.3124307124361121" CI_START="-0.00980056116149089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1513150756373106" ESTIMABLE="YES" I2="20.36190296620803" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2009-09-28 19:37:33 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.28497411353566005" P_Q="1.0" P_Z="0.06565957700789123" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="232" UNITS="" WEIGHT="100.00000000000001" Z="1.8407406286544195">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" MODIFIED="2009-09-28 19:37:33 -0400" MODIFIED_BY="[Empty name]" ORDER="342" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.103380206365845"/>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="29" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008"/>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" MODIFIED="2009-06-01 18:45:54 -0400" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" MODIFIED="2009-06-01 18:47:45 -0400" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="24.74076996412259"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" MODIFIED="2009-06-01 18:44:45 -0400" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="32.05467153606467"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.817202856077749" CI_END="0.44648748856920334" CI_START="-0.3607366613109035" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04287541362914991" ESTIMABLE="YES" I2="74.41540104789487" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2009-09-28 00:14:16 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.020068584986071336" P_Q="1.0" P_Z="0.8350684899448644" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.09414146513491982" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.2082055313827586">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="33" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866"/>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" MODIFIED="2009-06-01 18:48:10 -0400" MODIFIED_BY="[Empty name]" ORDER="34" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="35.10411253162387"/>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" MODIFIED="2009-06-01 18:48:58 -0400" MODIFIED_BY="[Empty name]" ORDER="35" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="34.99332328586747"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2010-08-26 06:53:20 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Sensitivity analysis - vitamin D supplementation vs placebo combining dosage groups, all data, correcting Du 2004 for clustering</NAME>
<CONT_OUTCOME CHI2="3.963521328473924" CI_END="0.26224488920843914" CI_START="-0.08254691215732911" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.08984898852555502" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2009-09-28 20:58:19 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4109653988229083" P_Q="1.0" P_Z="0.3070221033289664" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="347" TOTAL_2="216" UNITS="" WEIGHT="100.0" Z="1.0214905392754745">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="346" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.5822850601215874"/>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="340" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="16.665993259147193"/>
<CONT_DATA CI_END="0.5186441386272965" CI_START="-0.21355394015054407" EFFECT_SIZE="0.15254509923837622" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" MODIFIED="2009-09-27 22:41:17 -0400" MODIFIED_BY="[Empty name]" ORDER="338" SD_1="8.5" SD_2="8.43" SE="0.18678865646341605" STUDY_ID="STD-Du-2004" TOTAL_1="58" TOTAL_2="57" WEIGHT="22.174645765293143"/>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" ORDER="337" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="29.219372413585027"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="339" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="28.357703501853052"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2010-08-26 06:55:18 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Vitamin D supplementation - high dose vs low dose</NAME>
<CONT_OUTCOME CHI2="6.10330146562565" CI_END="0.25882672464868184" CI_START="-0.05487195963400024" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10197738250734081" ESTIMABLE="YES" I2="1.692550600809306" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2010-08-26 06:54:06 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4117184791459739" P_Q="0.7706877058529049" P_Z="0.20255967111718798" Q="0.08495795605706125" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="100.0" Z="1.2742928610560764">
<NAME>% change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.767717757942659" CI_END="0.3660552711121712" CI_START="-0.23905199022364876" DF="2" EFFECT_SIZE="0.0635016404442612" ESTIMABLE="YES" I2="27.73829649860434" ID="CMP-003.01.01" MODIFIED="2010-08-26 06:53:59 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2506098652366441" P_Z="0.6808026034875491" STUDIES="3" TAU2="0.0" TOTAL_1="129" TOTAL_2="63" WEIGHT="26.875754498669387" Z="0.4113681529955768">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="353" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.965320741875704"/>
<CONT_DATA CI_END="0.23172606291873393" CI_START="-0.6678421665303125" EFFECT_SIZE="-0.2180580518057893" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="15.8" MODIFIED="2009-08-21 00:36:44 -0400" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="7.4" SD_2="8.4" SE="0.2294859080433941" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="12.160660854857559"/>
<CONT_DATA CI_END="0.7679778381569521" CI_START="-0.1471841240956958" EFFECT_SIZE="0.31039685703062814" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="8.7" MODIFIED="2009-06-01 19:46:23 -0400" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="11.3" SD_2="8.8" SE="0.23346397420343656" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="28" WEIGHT="11.749772901936124"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.25062575162593" CI_END="0.2995408268136044" CI_START="-0.06730366132416812" DF="3" EFFECT_SIZE="0.11611858274471815" ESTIMABLE="YES" I2="7.710077098250064" ID="CMP-003.01.02" MODIFIED="2010-08-26 06:54:06 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3545740073243412" P_Z="0.2146838559452262" STUDIES="4" TAU2="0.0" TOTAL_1="273" TOTAL_2="207" WEIGHT="73.12424550133062" Z="1.2407886582720493">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="73" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.795668034757808"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="74" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.75446659581369"/>
<CONT_DATA CI_END="0.710139231062215" CI_START="-0.2005743330742225" EFFECT_SIZE="0.2547824489939962" ESTIMABLE="YES" MEAN_1="18.1" MEAN_2="15.8" MODIFIED="2009-06-01 19:49:28 -0400" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="9.2" SD_2="8.4" SE="0.23232915791311212" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="11.864837222762679"/>
<CONT_DATA CI_END="0.7179208994905963" CI_START="-0.1988223471797958" EFFECT_SIZE="0.2595492761554003" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="8.7" MODIFIED="2009-06-01 19:50:19 -0400" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="10.4" SD_2="8.8" SE="0.23386737049801576" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="11.709273647996442"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.7328688806218056" CI_END="0.27550855025553433" CI_START="-0.09691497524579908" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.08929678750486762" ESTIMABLE="YES" I2="22.409133109243466" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2010-08-26 06:54:22 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2583346773184123" P_Q="0.7805445864889796" P_Z="0.3472742361889267" Q="0.07762321220228952" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.014151805896019332" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.00000000000001" Z="0.9398895368334632">
<NAME>% change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.5163132258741636" CI_END="0.4431074042469179" CI_START="-0.22264441103598748" DF="2" EFFECT_SIZE="0.11023149660546523" ESTIMABLE="YES" I2="43.12224561556812" ID="CMP-003.02.01" MODIFIED="2009-06-01 20:07:48 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1723623500756969" P_Z="0.5163125565836068" STUDIES="3" TAU2="0.03734150009678745" TOTAL_1="189" TOTAL_2="92" WEIGHT="42.846526291701664" Z="0.6490399525740764">
<NAME>High dose (&gt; 200 iu daily)</NAME>
<CONT_DATA CI_END="0.21296455940757414" CI_START="-0.6870423892972939" EFFECT_SIZE="-0.2370389149448599" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="4.3" MODIFIED="2009-06-01 20:07:48 -0400" MODIFIED_BY="[Empty name]" ORDER="79" SD_1="4.6" SD_2="4.6" SE="0.2295978282774602" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="13.499149444802974"/>
<CONT_DATA CI_END="0.6878940342652908" CI_START="-0.22499391758383774" EFFECT_SIZE="0.23145005834072652" ESTIMABLE="YES" MEAN_1="4.3" MEAN_2="3.2" MODIFIED="2009-06-01 20:04:07 -0400" MODIFIED_BY="[Empty name]" ORDER="78" SD_1="4.9" SD_2="4.3" SE="0.23288385884890542" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="28" WEIGHT="13.199163495786541"/>
<CONT_DATA CI_END="0.7109717307417056" CI_START="-0.08994011689966308" EFFECT_SIZE="0.31051580692102126" ESTIMABLE="YES" MEAN_1="8.31" MEAN_2="6.71" MODIFIED="2009-06-01 20:04:38 -0400" MODIFIED_BY="[Empty name]" ORDER="77" SD_1="4.37" SD_2="6.4" SE="0.2043180012385072" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="74" TOTAL_2="36" WEIGHT="16.148213351112148"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.138932442545352" CI_END="0.32614701847335414" CI_START="-0.1837475190505268" DF="3" EFFECT_SIZE="0.07119974971141366" ESTIMABLE="YES" I2="27.517541258656877" ID="CMP-003.02.02" MODIFIED="2009-06-01 20:11:05 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.24684758413348706" P_Z="0.5841287166198936" STUDIES="4" TAU2="0.018632593061027217" TOTAL_1="225" TOTAL_2="133" WEIGHT="57.15347370829835" Z="0.5473639542023966">
<NAME>Low dose (&#8804; 200 iu daily)</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="84" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.842897183814348"/>
<CONT_DATA CI_END="0.566545695935091" CI_START="-0.34141121397884827" EFFECT_SIZE="0.11256724097812136" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.3" MODIFIED="2009-06-01 20:08:24 -0400" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="4.3" SD_2="4.6" SE="0.23162591687290876" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="13.312914959352195"/>
<CONT_DATA CI_END="0.6990508944758236" CI_START="-0.2172102684969396" EFFECT_SIZE="0.24092031298944197" ESTIMABLE="YES" MEAN_1="4.4" MEAN_2="3.2" MODIFIED="2009-06-01 20:08:29 -0400" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="5.2" SD_2="4.3" SE="0.2337443877030686" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="13.122114205501013"/>
<CONT_DATA CI_END="0.6452631487212848" CI_START="-0.1648058760918747" EFFECT_SIZE="0.24022863631470504" ESTIMABLE="YES" MEAN_1="8.21" MEAN_2="6.71" MODIFIED="2009-06-01 20:11:05 -0400" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="6.08" SD_2="6.4" SE="0.20665405874875267" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="65" TOTAL_2="37" WEIGHT="15.875547359630788"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.831825355862513" CI_END="0.2750109737793446" CI_START="-0.04760163036540632" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.11370467170696913" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2010-08-26 06:54:54 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6804777956783288" P_Q="0.4608985504434089" P_Z="0.16710164958230195" Q="0.5437118789234221" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="231" UNITS="" WEIGHT="100.0" Z="1.3815769040419619">
<NAME>% change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.4129232920928487" CI_END="0.4233833285064663" CI_START="-0.06036323399404328" DF="3" EFFECT_SIZE="0.18151004725621153" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.01" MODIFIED="2010-08-26 06:54:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7025084882775392" P_Z="0.14133857650879686" STUDIES="4" TAU2="0.0" TOTAL_1="203" TOTAL_2="98" WEIGHT="44.47611840676868" Z="1.4708245309917343">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="362" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.1107296724094726"/>
<CONT_DATA CI_END="0.4037833526918432" CI_START="-0.4934684929503115" EFFECT_SIZE="-0.04484257012923415" ESTIMABLE="YES" MEAN_1="9.3" MEAN_2="9.6" MODIFIED="2009-06-01 20:12:49 -0400" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="6.6" SD_2="6.7" SE="0.22889498294855484" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="12.928077322926814"/>
<CONT_DATA CI_END="0.7111875947628868" CI_START="-0.21324988086748306" EFFECT_SIZE="0.2489688569477019" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="6.5" MODIFIED="2009-06-01 20:12:51 -0400" MODIFIED_BY="[Empty name]" ORDER="87" SD_1="7.4" SD_2="5.2" SE="0.23583022007603577" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="27" WEIGHT="12.178886292610716"/>
<CONT_DATA CI_END="0.6800274331775852" CI_START="-0.12006855588032483" EFFECT_SIZE="0.2799794386486302" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" MODIFIED="2009-06-01 20:13:18 -0400" MODIFIED_BY="[Empty name]" ORDER="88" SD_1="6.19" SD_2="7.76" SE="0.20410987022439317" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="74" TOTAL_2="36" WEIGHT="16.258425118821677"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.8751901848462422" CI_END="0.2758675801190636" CI_START="-0.15708608565980486" DF="3" EFFECT_SIZE="0.05939074722962935" ESTIMABLE="YES" I2="0.0" ID="CMP-003.03.02" MODIFIED="2010-08-26 06:54:54 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.41127149733481494" P_Z="0.5907710001542836" STUDIES="4" TAU2="0.0" TOTAL_1="225" TOTAL_2="133" WEIGHT="55.52388159323132" Z="0.5377190899889452">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="89" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.615272189143196"/>
<CONT_DATA CI_END="0.5262663809223392" CI_START="-0.3812984583745008" EFFECT_SIZE="0.07248396127391919" ESTIMABLE="YES" MEAN_1="10.1" MEAN_2="9.6" MODIFIED="2009-06-01 20:26:40 -0400" MODIFIED_BY="[Empty name]" ORDER="124" SD_1="6.9" SD_2="6.7" SE="0.23152589702045437" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="12.635933663924195"/>
<CONT_DATA CI_END="0.8101628071317526" CI_START="-0.10943919845178923" EFFECT_SIZE="0.35036180433998165" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="6.5" MODIFIED="2009-06-01 20:26:19 -0400" MODIFIED_BY="[Empty name]" ORDER="125" SD_1="7.4" SD_2="5.2" SE="0.23459665913181185" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="12.307301562468306"/>
<CONT_DATA CI_END="0.4559115207836127" CI_START="-0.3514941216492015" EFFECT_SIZE="0.05220869956720557" ESTIMABLE="YES" MEAN_1="10.08" MEAN_2="9.71" MODIFIED="2009-06-01 20:26:49 -0400" MODIFIED_BY="[Empty name]" ORDER="126" SD_1="6.59" SD_2="7.76" SE="0.20597461198305858" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="65" TOTAL_2="37" WEIGHT="15.965374177695622"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.974797038263021" CI_END="0.34224567198170086" CI_START="-0.14808990575642625" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09707788311263732" ESTIMABLE="YES" I2="33.052119186916" I2_Q="33.66212100101491" ID="CMP-003.04" MODIFIED="2010-08-26 06:55:18 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.20103848586445228" P_Q="0.21953138102647884" P_Z="0.4377033549782382" Q="1.5074343875469687" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02585514147451569" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.7760772957730392">
<NAME>% change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.4032460216118097" CI_END="0.32383944378250185" CI_START="-0.4347600396604254" DF="1" EFFECT_SIZE="-0.0554602979389618" ESTIMABLE="YES" I2="28.736658818289715" ID="CMP-003.04.01" MODIFIED="2010-08-26 06:55:13 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.23618105668094036" P_Z="0.7744329884853165" STUDIES="2" TAU2="0.02152616280215222" TOTAL_1="115" TOTAL_2="56" WEIGHT="39.49651676697539" Z="0.2865812300290187">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.20278569809737038" CI_START="-0.6974746825628064" EFFECT_SIZE="-0.247344492232718" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" MODIFIED="2009-06-01 20:28:33 -0400" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="3.3" SD_2="4.2" SE="0.2296624804744668" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="19.90710523269175"/>
<CONT_DATA CI_END="0.5952541362371502" CI_START="-0.3158197697596179" EFFECT_SIZE="0.13971718323876614" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="3.7" MODIFIED="2009-06-01 20:28:38 -0400" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="3.9" SD_2="2.7" SE="0.2324210835462291" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="28" WEIGHT="19.58941153428364"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.0641166291042428" CI_END="0.5150030211658034" CI_START="-0.12219387816511465" DF="2" EFFECT_SIZE="0.19640457150034438" ESTIMABLE="YES" I2="34.728333086176434" ID="CMP-003.04.02" MODIFIED="2010-08-26 06:55:18 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2160905125937277" P_Z="0.22695196989206612" STUDIES="3" TAU2="0.027539376699535333" TOTAL_1="160" TOTAL_2="96" WEIGHT="60.50348323302461" Z="1.2082478334213658">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="96" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="21.279967553005157"/>
<CONT_DATA CI_END="0.4765128712759419" CI_START="-0.4308017802303755" EFFECT_SIZE="0.022855545522783162" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="3.9" MODIFIED="2009-06-01 20:30:13 -0400" MODIFIED_BY="[Empty name]" ORDER="127" SD_1="4.4" SD_2="4.2" SE="0.2314620724317129" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="19.699127539687446"/>
<CONT_DATA CI_END="0.49071756164177127" CI_START="-0.4225968206205756" EFFECT_SIZE="0.03406037051059786" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="3.7" MODIFIED="2009-06-01 20:29:29 -0400" MODIFIED_BY="[Empty name]" ORDER="128" SD_1="3.0" SD_2="2.7" SE="0.2329926441165384" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="19.524388140332004"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2010-08-26 06:57:36 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Vitamin D supplementation - high dose vs low dose; sensitivity - omit Cheng 2005</NAME>
<CONT_OUTCOME CHI2="3.503307393846316" CI_END="0.3225329492553468" CI_START="-0.01533589937524546" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.15359852494005066" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2010-08-26 06:56:52 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.622887364615575" P_Q="0.481720065031097" P_Z="0.07474302228580122" Q="0.49496688806612577" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="356" TOTAL_2="229" UNITS="" WEIGHT="100.0" Z="1.7820380788648909">
<NAME>% change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.767717757942659" CI_END="0.3660552711121712" CI_START="-0.23905199022364876" DF="2" EFFECT_SIZE="0.0635016404442612" ESTIMABLE="YES" I2="27.73829649860434" ID="CMP-004.01.01" MODIFIED="2010-08-26 06:56:41 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2506098652366441" P_Z="0.6808026034875491" STUDIES="3" TAU2="0.0" TOTAL_1="129" TOTAL_2="63" WEIGHT="31.176802703494946" Z="0.4113681529955768">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="354" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.439874394098117"/>
<CONT_DATA CI_END="0.23172606291873393" CI_START="-0.6678421665303125" EFFECT_SIZE="-0.2180580518057893" ESTIMABLE="YES" MEAN_1="14.1" MEAN_2="15.8" MODIFIED="2009-08-21 00:37:35 -0400" MODIFIED_BY="[Empty name]" ORDER="99" SD_1="7.4" SD_2="8.4" SE="0.2294859080433941" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="14.106786257285503"/>
<CONT_DATA CI_END="0.7679778381569521" CI_START="-0.1471841240956958" EFFECT_SIZE="0.31039685703062814" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="8.7" ORDER="100" SD_1="11.3" SD_2="8.8" SE="0.23346397420343656" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="28" WEIGHT="13.63014205211133"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.24062274783753113" CI_END="0.39804648235954476" CI_START="-0.009221931797563865" DF="2" EFFECT_SIZE="0.19441227528099045" ESTIMABLE="YES" I2="0.0" ID="CMP-004.01.02" MODIFIED="2010-08-26 06:56:52 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8866443196156777" P_Z="0.06131686847996978" STUDIES="3" TAU2="0.0" TOTAL_1="227" TOTAL_2="166" WEIGHT="68.82319729650506" Z="1.8712035820005273">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="103" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="41.47641514144554"/>
<CONT_DATA CI_END="0.710139231062215" CI_START="-0.2005743330742225" EFFECT_SIZE="0.2547824489939962" ESTIMABLE="YES" MEAN_1="18.1" MEAN_2="15.8" ORDER="102" SD_1="9.2" SD_2="8.4" SE="0.23232915791311212" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="13.76362063515162"/>
<CONT_DATA CI_END="0.7179208994905963" CI_START="-0.1988223471797958" EFFECT_SIZE="0.2595492761554003" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="8.7" ORDER="104" SD_1="10.4" SD_2="8.8" SE="0.23386737049801576" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="13.583161519907899"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.93958589158222" CI_END="0.3365557449899821" CI_START="-0.018744979892716285" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1589053825486329" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2010-08-26 06:57:02 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5581466169425009" P_Q="0.6449662361885959" P_Z="0.07957520631330041" Q="0.21230566025323627" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="368" TOTAL_2="184" UNITS="" WEIGHT="100.0" Z="1.753156157211355">
<NAME>% change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.5163132258741636" CI_END="0.4431074042469179" CI_START="-0.22264441103598748" DF="2" EFFECT_SIZE="0.11023149660546523" ESTIMABLE="YES" I2="43.12224561556812" ID="CMP-004.02.01" MODIFIED="2010-08-26 06:56:58 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1723623500756969" P_Z="0.5163125565836068" STUDIES="3" TAU2="0.03734150009678745" TOTAL_1="189" TOTAL_2="92" WEIGHT="50.41273380191021" Z="0.6490399525740764">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.21296455940757414" CI_START="-0.6870423892972939" EFFECT_SIZE="-0.2370389149448599" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="4.3" ORDER="129" SD_1="4.6" SD_2="4.6" SE="0.2295978282774602" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="15.58477232135143"/>
<CONT_DATA CI_END="0.6878940342652908" CI_START="-0.22499391758383774" EFFECT_SIZE="0.23145005834072652" ESTIMABLE="YES" MEAN_1="4.3" MEAN_2="3.2" ORDER="130" SD_1="4.9" SD_2="4.3" SE="0.23288385884890542" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="28" WEIGHT="15.148067662690362"/>
<CONT_DATA CI_END="0.7109717307417056" CI_START="-0.08994011689966308" EFFECT_SIZE="0.31051580692102126" ESTIMABLE="YES" MEAN_1="8.31" MEAN_2="6.71" ORDER="131" SD_1="4.37" SD_2="6.4" SE="0.2043180012385072" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="74" TOTAL_2="36" WEIGHT="19.679893817868415"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.21096700545482014" CI_END="0.45329419630026424" CI_START="-0.05126370393532251" DF="2" EFFECT_SIZE="0.20101524618247088" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.02" MODIFIED="2010-08-26 06:57:02 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8998893201917305" P_Z="0.11835998070506422" STUDIES="3" TAU2="0.0" TOTAL_1="179" TOTAL_2="92" WEIGHT="49.5872661980898" Z="1.5616944762023874">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.566545695935091" CI_START="-0.34141121397884827" EFFECT_SIZE="0.11256724097812136" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="4.3" ORDER="132" SD_1="4.3" SD_2="4.6" SE="0.23162591687290876" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="15.313050360499942"/>
<CONT_DATA CI_END="0.6990508944758236" CI_START="-0.2172102684969396" EFFECT_SIZE="0.24092031298944197" ESTIMABLE="YES" MEAN_1="4.4" MEAN_2="3.2" ORDER="133" SD_1="5.2" SD_2="4.3" SE="0.2337443877030686" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="15.036737892182435"/>
<CONT_DATA CI_END="0.6452631487212848" CI_START="-0.1648058760918747" EFFECT_SIZE="0.24022863631470504" ESTIMABLE="YES" MEAN_1="8.21" MEAN_2="6.71" ORDER="134" SD_1="6.08" SD_2="6.4" SE="0.20665405874875267" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="65" TOTAL_2="37" WEIGHT="19.237477945407424"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.514628459777152" CI_END="0.34010331699852747" CI_START="-0.009029949467151688" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1655366837656879" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2010-08-26 06:57:14 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8668270274743144" P_Q="0.8516614681805009" P_Z="0.06308678752232823" Q="0.03496863017993368" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="382" TOTAL_2="190" UNITS="" WEIGHT="100.0" Z="1.85857934183902">
<NAME>% change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.4129232920928487" CI_END="0.42338332850646637" CI_START="-0.06036323399404325" DF="3" EFFECT_SIZE="0.18151004725621156" ESTIMABLE="YES" I2="0.0" ID="CMP-004.03.01" MODIFIED="2010-08-26 06:57:09 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7025084882775392" P_Z="0.1413385765087968" STUDIES="4" TAU2="0.0" TOTAL_1="203" TOTAL_2="98" WEIGHT="52.089079097718304" Z="1.4708245309917345">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="363" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.6431921166280725"/>
<CONT_DATA CI_END="0.4037833526918432" CI_START="-0.4934684929503115" EFFECT_SIZE="-0.04484257012923415" ESTIMABLE="YES" MEAN_1="9.3" MEAN_2="9.6" ORDER="147" SD_1="6.6" SD_2="6.7" SE="0.22889498294855484" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="15.140971523110002"/>
<CONT_DATA CI_END="0.7111875947628868" CI_START="-0.21324988086748306" EFFECT_SIZE="0.2489688569477019" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="6.5" ORDER="148" SD_1="7.4" SD_2="5.2" SE="0.23583022007603577" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="27" WEIGHT="14.263541742018825"/>
<CONT_DATA CI_END="0.6800274331775852" CI_START="-0.12006855588032483" EFFECT_SIZE="0.2799794386486302" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="149" SD_1="6.19" SD_2="7.76" SE="0.20410987022439317" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="74" TOTAL_2="36" WEIGHT="19.041373715961406"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0667365375043694" CI_END="0.4003696923397936" CI_START="-0.10402902368563213" DF="2" EFFECT_SIZE="0.14817033432708074" ESTIMABLE="YES" I2="0.0" ID="CMP-004.03.02" MODIFIED="2010-08-26 06:57:14 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5866258263927806" P_Z="0.24952505282837034" STUDIES="3" TAU2="0.0" TOTAL_1="179" TOTAL_2="92" WEIGHT="47.91092090228169" Z="1.151503799005302">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.5262663809223392" CI_START="-0.3812984583745008" EFFECT_SIZE="0.07248396127391919" ESTIMABLE="YES" MEAN_1="10.1" MEAN_2="9.6" ORDER="150" SD_1="6.9" SD_2="6.7" SE="0.23152589702045437" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="14.798821742355564"/>
<CONT_DATA CI_END="0.8101628071317526" CI_START="-0.10943919845178923" EFFECT_SIZE="0.35036180433998165" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="6.5" ORDER="151" SD_1="7.4" SD_2="5.2" SE="0.23459665913181185" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="14.41393780598714"/>
<CONT_DATA CI_END="0.4559115207836127" CI_START="-0.3514941216492015" EFFECT_SIZE="0.05220869956720557" ESTIMABLE="YES" MEAN_1="10.08" MEAN_2="9.71" ORDER="152" SD_1="6.59" SD_2="7.76" SE="0.20597461198305858" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="65" TOTAL_2="37" WEIGHT="18.69816135393899"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5376393583967587" CI_END="0.21291797206365598" CI_START="-0.2410571070143087" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.014069567475326355" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2010-08-26 06:57:36 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6736108615130814" P_Q="0.7151070518392808" P_Z="0.9033059728173373" Q="0.1332293483122886" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="229" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="0.12148616433176491">
<NAME>% change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.4032460216118097" CI_END="0.32383944378250185" CI_START="-0.4347600396604254" DF="1" EFFECT_SIZE="-0.0554602979389618" ESTIMABLE="YES" I2="28.736658818289715" ID="CMP-004.04.01" MODIFIED="2010-08-26 06:57:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.23618105668094036" P_Z="0.7744329884853165" STUDIES="2" TAU2="0.02152616280215222" TOTAL_1="115" TOTAL_2="56" WEIGHT="50.257772029970454" Z="0.2865812300290187">
<NAME>High dose (&gt; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.20278569809737038" CI_START="-0.6974746825628064" EFFECT_SIZE="-0.247344492232718" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="153" SD_1="3.3" SD_2="4.2" SE="0.2296624804744668" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="60" TOTAL_2="28" WEIGHT="25.428910326824283"/>
<CONT_DATA CI_END="0.5952541362371502" CI_START="-0.3158197697596179" EFFECT_SIZE="0.13971718323876614" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="3.7" ORDER="154" SD_1="3.9" SD_2="2.7" SE="0.2324210835462291" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="55" TOTAL_2="28" WEIGHT="24.82886170314617"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0011639884726604489" CI_END="0.35026057509762737" CI_START="-0.2934185073900703" DF="1" EFFECT_SIZE="0.02842103385377855" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.02" MODIFIED="2010-08-26 06:57:36 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9727836352790216" P_Z="0.8625880204605818" STUDIES="2" TAU2="0.0" TOTAL_1="114" TOTAL_2="55" WEIGHT="49.742227970029546" Z="0.17308066790523435">
<NAME>Low dose (&#8804; 200 IU daily)</NAME>
<CONT_DATA CI_END="0.4765128712759419" CI_START="-0.4308017802303755" EFFECT_SIZE="0.022855545522783162" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="3.9" ORDER="155" SD_1="4.4" SD_2="4.2" SE="0.2314620724317129" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="56" TOTAL_2="28" WEIGHT="25.035033558160002"/>
<CONT_DATA CI_END="0.49071756164177127" CI_START="-0.4225968206205756" EFFECT_SIZE="0.03406037051059786" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="3.7" ORDER="156" SD_1="3.0" SD_2="2.7" SE="0.2329926441165384" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="58" TOTAL_2="27" WEIGHT="24.70719441186954"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2010-07-14 00:49:35 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Vitamin D supplementation - females vs males; all data</NAME>
<CONT_OUTCOME CHI2="4.054677346532506" CI_END="0.2576287104628855" CI_START="-0.05579391579936889" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1009173973317583" ESTIMABLE="YES" I2="1.3485005552726617" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2009-09-28 21:12:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39865688865306736" P_Q="0.5187430218124995" P_Z="0.20689190208932828" Q="0.41639174772725296" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="99.99999999999999" Z="1.2621581698971636">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.6382855988052527" CI_END="0.3099571180528842" CI_START="-0.04990549382346629" DF="3" EFFECT_SIZE="0.13002581211470896" ESTIMABLE="YES" I2="17.543581488348636" ID="CMP-005.01.01" MODIFIED="2009-09-28 21:12:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3032650279133061" P_Z="0.15667272417624578" STUDIES="4" TAU2="0.0" TOTAL_1="286" TOTAL_2="214" WEIGHT="75.8555279361981" Z="1.4163511317645134">
<NAME>Females</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="355" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.9601040136805756"/>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="172" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="174" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.69156569900406"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="173" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="23.43246016042895"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3283936285286469" CI_START="-0.30946067283777906" DF="0" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" I2="0.0" ID="CMP-005.01.02" MODIFIED="2009-08-21 00:38:16 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9536083133847185" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885" Z="0.058176155895633457">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" MODIFIED="2009-08-21 00:38:16 -0400" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.088795604896442" CI_END="0.29236145839972394" CI_START="-0.18102404321268345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.055668707593520245" ESTIMABLE="YES" I2="50.72917216029583" I2_Q="12.884508034241593" ID="CMP-005.02" MODIFIED="2010-07-14 00:49:23 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1073692072084167" P_Q="0.2839889245659556" P_Z="0.6448189037780425" Q="1.1479014552234403" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02936893865737089" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.00000000000001" Z="0.4609717094315479">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.940894149673001" CI_END="0.4017144547546603" CI_START="-0.2135519347517274" DF="2" EFFECT_SIZE="0.09408126000146642" ESTIMABLE="YES" I2="59.52149672883876" ID="CMP-005.02.01" MODIFIED="2009-10-15 23:37:52 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.08454711115535885" P_Z="0.548905000583506" STUDIES="3" TAU2="0.04374639670450928" TOTAL_1="298" TOTAL_2="169" WEIGHT="73.89314949031859" Z="0.5994017692757734">
<NAME>Females</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="188" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.18163563243661"/>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="189" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.76763234752574"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="190" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.943881510356235"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.24664236497006012" CI_START="-0.3913964189195416" DF="0" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.02" MODIFIED="2009-10-15 23:37:52 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6565627551716673" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.10685050968142" Z="0.44466377204781604">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="187" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.10685050968142"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.02272172362773" CI_END="0.3124307124361121" CI_START="-0.00980056116149089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1513150756373106" ESTIMABLE="YES" I2="20.36190296620803" I2_Q="0.0" ID="CMP-005.03" MODIFIED="2009-09-28 21:19:20 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.28497411353566005" P_Q="0.32582506729810334" P_Z="0.06565957700789123" Q="0.9654208397397372" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="232" UNITS="" WEIGHT="100.00000000000001" Z="1.8407406286544195">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.057300883887993" CI_END="0.38528380767189085" CI_START="0.011905462809053774" DF="3" EFFECT_SIZE="0.1985946352404723" ESTIMABLE="YES" I2="26.059218040413416" ID="CMP-005.03.01" MODIFIED="2009-09-28 21:19:20 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.25534286986737975" P_Z="0.03707347830269539" STUDIES="4" TAU2="0.0" TOTAL_1="312" TOTAL_2="176" WEIGHT="74.47956358995319" Z="2.084953977377472">
<NAME>Females</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="364" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.103380206365845"/>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="183" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="180" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="24.74076996412259"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="181" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="32.05467153606467"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1364999111106466E-34" CI_END="0.3322618015925394" CI_START="-0.3055956588787111" DF="0" EFFECT_SIZE="0.013333071356914134" ESTIMABLE="YES" I2="100.0" ID="CMP-005.03.02" MODIFIED="2009-06-01 20:41:27 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.9346961226984113" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823" Z="0.08193786631749252">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="192" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.817202856077749" CI_END="0.44648748856920323" CI_START="-0.3607366613109035" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04287541362914987" ESTIMABLE="YES" I2="74.41540104789487" I2_Q="71.38528767100382" ID="CMP-005.04" MODIFIED="2010-07-14 00:49:35 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.020068584986071336" P_Q="0.061565472855259595" P_Z="0.8350684899448645" Q="3.494705760108827" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.09414146513491978" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.20820553138275846">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.322497095968922" CI_END="0.7600397644106205" CI_START="-0.3515314941987304" DF="1" EFFECT_SIZE="0.20425413510594506" ESTIMABLE="YES" I2="76.86522448025285" ID="CMP-005.04.01" MODIFIED="2009-06-01 20:42:14 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.03761188294314877" P_Z="0.4713421268344401" STUDIES="2" TAU2="0.1241235495529878" TOTAL_1="159" TOTAL_2="96" WEIGHT="64.89588746837613" Z="0.720297048705399">
<NAME>Females</NAME>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="185" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866"/>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" ORDER="186" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="34.993323285867476"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.8895594519015997E-32" CI_END="0.07221437560016652" CI_START="-0.5678335700529755" DF="0" EFFECT_SIZE="-0.2478095972264045" ESTIMABLE="YES" I2="100.0" ID="CMP-005.04.02" MODIFIED="2009-06-01 20:42:14 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.12909201272135762" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="35.10411253162387" Z="1.5176921944230146">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="193" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="35.10411253162387"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2010-08-26 06:57:49 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Vitamin D supplementation - females vs males; all data; sensitivity omit Cheng 2005</NAME>
<CONT_OUTCOME CHI2="1.4724700726429616" CI_END="0.32102593894861053" CI_START="-0.016498071752878457" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.15226393359786605" ESTIMABLE="YES" I2="0.0" I2_Q="6.5078561797486465" ID="CMP-006.01" MODIFIED="2009-09-28 21:12:57 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6886386666857276" P_Q="0.30103428049110137" P_Z="0.07700089140712112" Q="1.0696085886345776" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="356" TOTAL_2="229" UNITS="" WEIGHT="100.0" Z="1.7683590887414116">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.402861484008384" CI_END="0.40668643133587046" CI_START="0.008909085136514755" DF="2" EFFECT_SIZE="0.20779775823619262" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.01" MODIFIED="2009-09-28 21:12:57 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8175602762665108" P_Z="0.04058359398476936" STUDIES="3" TAU2="0.0" TOTAL_1="240" TOTAL_2="173" WEIGHT="71.9994624504455" Z="2.0477592608151327">
<NAME>Females</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="356" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.432856322831462"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="194" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="41.39179448266583"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="195" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="27.174811644948218"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3283936285286469" CI_START="-0.30946067283777906" DF="0" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.02" MODIFIED="2009-08-21 00:38:38 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9536083133847185" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="28.000537549554487" Z="0.058176155895633457">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" MODIFIED="2009-08-21 00:38:38 -0400" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="28.000537549554487"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.552075578083953" CI_END="0.342404047325068" CI_START="-0.059211173728214966" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1415964367984265" ESTIMABLE="YES" I2="21.632414918465706" I2_Q="60.5922413131666" ID="CMP-006.02" MODIFIED="2010-07-14 00:49:53 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2791412424128611" P_Q="0.11116598074420003" P_Z="0.16695977670851778" Q="2.5375713649355855" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.006834499000631027" TOTALS="YES" TOTAL_1="368" TOTAL_2="184" UNITS="" WEIGHT="100.0" Z="1.3820388367566299">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.014504213148367575" CI_END="0.4530623137783288" CI_START="0.026135775671244144" DF="1" EFFECT_SIZE="0.23959904472478646" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.01" MODIFIED="2009-10-15 23:37:33 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9041398067200381" P_Z="0.027811446691537036" STUDIES="2" TAU2="0.0" TOTAL_1="252" TOTAL_2="128" WEIGHT="68.50395735129305" Z="2.1999358506638136">
<NAME>Females</NAME>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="200" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="30.816067741577758"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="199" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.68788960971529"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.24664236497006012" CI_START="-0.3913964189195416" DF="0" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.02" MODIFIED="2009-10-15 23:37:33 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6565627551716673" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="31.496042648706947" Z="0.44466377204781604">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="201" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="31.496042648706947"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.0953503126070117" CI_END="0.38374872621320777" CI_START="0.035098629316040714" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.20942367776462426" ESTIMABLE="YES" I2="0.0" I2_Q="51.711911890971145" ID="CMP-006.03" MODIFIED="2009-09-28 21:19:28 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5528540522250918" P_Q="0.1501325450365033" P_Z="0.018543481817625083" Q="2.070904107327913" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="382" TOTAL_2="191" UNITS="" WEIGHT="100.0" Z="2.3545834037134923">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.024446205279098646" CI_END="0.5011448496462034" CI_START="0.0847948696010446" DF="2" EFFECT_SIZE="0.292969859623624" ESTIMABLE="YES" I2="0.0" ID="CMP-006.03.01" MODIFIED="2009-09-28 21:19:28 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9878512969644475" P_Z="0.00581017388310287" STUDIES="3" TAU2="0.0" TOTAL_1="266" TOTAL_2="135" WEIGHT="70.12332233650328" Z="2.7583062372467393">
<NAME>Females</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="365" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.633115382633779"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="204" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="28.96392512605375"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="202" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.52628182781575"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1364999111106466E-34" CI_END="0.3322618015925394" CI_START="-0.3055956588787111" DF="0" EFFECT_SIZE="0.013333071356914134" ESTIMABLE="YES" I2="100.0" ID="CMP-006.03.02" MODIFIED="2009-06-01 20:43:05 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.9346961226984113" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="29.876677663496725" Z="0.08193786631749252">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="205" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="29.876677663496725"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6446581581643751" CI_END="0.07165614511902518" CI_START="-0.3825348160541718" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1554393354675733" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.04" MODIFIED="2010-07-14 00:50:14 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.4220292845522483" P_Q="0.4220292845522483" P_Z="0.1797482944551126" Q="0.6446581581643751" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="229" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="1.3415304369349113">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.26056729147560076" CI_START="-0.3840552314749456" DF="0" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" I2="0.0" ID="CMP-006.04.01" MODIFIED="2009-06-01 20:43:29 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7073161496387549" STUDIES="1" TAU2="0.0" TOTAL_1="113" TOTAL_2="55" WEIGHT="49.643914964622965" Z="0.37546301332435306">
<NAME>Females</NAME>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" ORDER="206" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="49.643914964622965"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.8895594519015997E-32" CI_END="0.07221437560016652" CI_START="-0.5678335700529755" DF="0" EFFECT_SIZE="-0.2478095972264045" ESTIMABLE="YES" I2="100.0" ID="CMP-006.04.02" MODIFIED="2009-06-01 20:43:05 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.12909201272135762" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="50.35608503537704" Z="1.5176921944230146">
<NAME>Males</NAME>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="208" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="50.35608503537704"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2010-08-26 06:58:50 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Vitamin D supplementation - by baseline serum vitamin D levels; all data</NAME>
<CONT_OUTCOME CHI2="4.054677346532506" CI_END="0.2576287104628855" CI_START="-0.055793915799368876" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10091739733175831" ESTIMABLE="YES" I2="1.3485005552726617" I2_Q="65.82180506763923" ID="CMP-007.01" MODIFIED="2010-08-26 06:58:08 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39865688865306736" P_Q="0.087171887942749" P_Z="0.20689190208932817" Q="2.9258420521593287" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="99.99999999999997" Z="1.2621581698971638">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.7259738103647928" CI_END="0.1804107669579521" CI_START="-0.32859163513271605" DF="1" EFFECT_SIZE="-0.07409043408738199" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.01" MODIFIED="2010-08-26 06:58:02 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3941913803655722" P_Z="0.5682809526220367" STUDIES="2" TAU2="0.0" TOTAL_1="162" TOTAL_2="97" WEIGHT="37.9158701268864" Z="0.5705850574133068">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="243" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513"/>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" MODIFIED="2009-08-21 00:40:50 -0400" MODIFIED_BY="[Empty name]" ORDER="246" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.402861484008384" CI_END="0.40668643133587046" CI_START="0.008909085136514755" DF="2" EFFECT_SIZE="0.20779775823619262" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.02" MODIFIED="2010-08-26 06:58:08 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8175602762665108" P_Z="0.04058359398476936" STUDIES="3" TAU2="0.0" TOTAL_1="240" TOTAL_2="173" WEIGHT="62.08412987311358" Z="2.0477592608151327">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="357" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.9601040136805756"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="274" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.69156569900406"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="275" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="23.43246016042895"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.0887956048964424" CI_END="0.29236145839972394" CI_START="-0.18102404321268345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.05566870759352023" ESTIMABLE="YES" I2="50.72917216029583" I2_Q="35.48055953665582" ID="CMP-007.02" MODIFIED="2010-08-26 06:58:27 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1073692072084168" P_Q="0.21314766665863927" P_Z="0.6448189037780425" Q="1.5499204469513899" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.029368938657370898" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="0.4609717094315478">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.538875157945053" CI_END="0.2761042258529184" CI_START="-0.3103871259706955" DF="2" EFFECT_SIZE="-0.017141450058888553" ESTIMABLE="YES" I2="55.936219208428554" ID="CMP-007.02.01" MODIFIED="2010-08-26 06:58:22 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10337043541665636" P_Z="0.9087873985680688" STUDIES="3" TAU2="0.03739028815287574" TOTAL_1="301" TOTAL_2="170" WEIGHT="74.23236765247427" Z="0.11456818469274778">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="249" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.18163563243661"/>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="284" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.106850509681415"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="250" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.943881510356235"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5779451668712492" CI_START="-0.06888829729301077" DF="0" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" I2="0.0" ID="CMP-007.02.02" MODIFIED="2010-08-26 06:58:27 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.12295494891893462" STUDIES="1" TAU2="0.0" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.767632347525737" Z="1.5424884235777292">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="276" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.767632347525737"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.022721723627729" CI_END="0.3124307124361121" CI_START="-0.00980056116149089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1513150756373106" ESTIMABLE="YES" I2="20.361902966208017" I2_Q="28.926731164800458" ID="CMP-007.03" MODIFIED="2010-08-26 06:58:39 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.28497411353566027" P_Q="0.23555548367189827" P_Z="0.06565957700789123" Q="1.4069987442377814" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="232" UNITS="" WEIGHT="100.0" Z="1.8407406286544195">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.609327471713922" CI_END="0.2804150982430707" CI_START="-0.09892776230668333" DF="2" EFFECT_SIZE="0.09074366796819368" ESTIMABLE="YES" I2="44.58801492317122" ID="CMP-007.03.01" MODIFIED="2010-08-26 06:58:35 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16452983796818088" P_Z="0.3484001846349417" STUDIES="3" TAU2="0.0" TOTAL_1="301" TOTAL_2="170" WEIGHT="72.15584982951157" Z="0.9376969466881186">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="254" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008"/>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="282" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="252" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="32.05467153606467"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.006395507676025739" CI_END="0.6136118159502182" CI_START="0.002950085366983324" DF="1" EFFECT_SIZE="0.3082809506586007" ESTIMABLE="YES" I2="0.0" ID="CMP-007.03.02" MODIFIED="2010-08-26 06:58:39 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9362595907277655" P_Z="0.04782715154006381" STUDIES="2" TAU2="0.0" TOTAL_1="127" TOTAL_2="62" WEIGHT="27.844150170488437" Z="1.97890101884572">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="366" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.103380206365845"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="277" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="24.74076996412259"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.817202856077749" CI_END="0.44648748856920334" CI_START="-0.3607366613109035" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04287541362914991" ESTIMABLE="YES" I2="74.41540104789487" I2_Q="0.0" ID="CMP-007.04" MODIFIED="2010-08-26 06:58:50 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.020068584986071336" P_Q="0.6875718976831597" P_Z="0.8350684899448644" Q="0.16172676126127072" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.09414146513491982" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.2082055313827586">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.655476094816478" CI_END="0.8542048282081737" CI_START="-0.6233149454902301" DF="1" EFFECT_SIZE="0.11544494135897172" ESTIMABLE="YES" I2="86.93745512866144" ID="CMP-007.04.01" MODIFIED="2010-08-26 06:58:46 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0056600845496956875" P_Z="0.7593909002161439" STUDIES="2" TAU2="0.24736595919735233" TOTAL_1="162" TOTAL_2="97" WEIGHT="65.00667671413252" Z="0.3062807432952971">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="256" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866"/>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="286" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="35.10411253162387"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.26056729147560076" CI_START="-0.3840552314749456" DF="0" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" I2="0.0" ID="CMP-007.04.02" MODIFIED="2010-08-26 06:58:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7073161496387549" STUDIES="1" TAU2="0.0" TOTAL_1="113" TOTAL_2="55" WEIGHT="34.99332328586747" Z="0.37546301332435306">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" ORDER="278" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="34.99332328586747"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2010-08-26 06:59:47 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Vitamin D supplementation - by baseline serum vitamin D levels; sensitivity omit Cheng 2005</NAME>
<CONT_OUTCOME CHI2="1.4724700726429616" CI_END="0.32102593894861053" CI_START="-0.016498071752878457" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.15226393359786605" ESTIMABLE="YES" I2="0.0" I2_Q="6.5078561797486465" ID="CMP-008.01" MODIFIED="2010-08-26 06:59:12 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6886386666857276" P_Q="0.30103428049110137" P_Z="0.07700089140712112" Q="1.0696085886345776" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="356" TOTAL_2="229" UNITS="" WEIGHT="100.0" Z="1.7683590887414116">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3283936285286469" CI_START="-0.30946067283777906" DF="0" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.01" MODIFIED="2010-08-26 06:59:07 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9536083133847185" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="28.000537549554487" Z="0.058176155895633457">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" MODIFIED="2009-08-21 00:41:10 -0400" MODIFIED_BY="[Empty name]" ORDER="288" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="28.000537549554487"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.40286148400838406" CI_END="0.40668643133587046" CI_START="0.008909085136514755" DF="2" EFFECT_SIZE="0.20779775823619262" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.02" MODIFIED="2010-08-26 06:59:12 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8175602762665107" P_Z="0.04058359398476936" STUDIES="3" TAU2="0.0" TOTAL_1="240" TOTAL_2="173" WEIGHT="71.99946245044552" Z="2.0477592608151327">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="358" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.432856322831462"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="289" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="41.39179448266583"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="290" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="27.174811644948218"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.552075578083953" CI_END="0.342404047325068" CI_START="-0.059211173728214966" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1415964367984265" ESTIMABLE="YES" I2="21.632414918465706" I2_Q="0.0" ID="CMP-008.02" MODIFIED="2010-08-26 06:59:25 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2791412424128611" P_Q="0.4193718094523101" P_Z="0.16695977670851778" Q="0.6520757165078774" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.006834499000631027" TOTALS="YES" TOTAL_1="368" TOTAL_2="184" UNITS="" WEIGHT="99.99999999999999" Z="1.3820388367566299">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.8999998615760756" CI_END="0.38085668301618936" CI_START="-0.2069343190585149" DF="1" EFFECT_SIZE="0.08696118197883725" ESTIMABLE="YES" I2="47.36841721817356" ID="CMP-008.02.01" MODIFIED="2010-08-26 06:59:20 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16807856482259054" P_Z="0.561957313672143" STUDIES="2" TAU2="0.02138008173283245" TOTAL_1="255" TOTAL_2="129" WEIGHT="69.18393225842223" Z="0.5799366922254885">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="291" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="31.496042648706947"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="292" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.68788960971529"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5779451668712492" CI_START="-0.06888829729301077" DF="0" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" I2="0.0" ID="CMP-008.02.02" MODIFIED="2010-08-26 06:59:25 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.12295494891893462" STUDIES="1" TAU2="0.0" TOTAL_1="113" TOTAL_2="55" WEIGHT="30.816067741577758" Z="1.5424884235777292">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="294" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="30.816067741577758"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.0953503126070117" CI_END="0.38374872621320777" CI_START="0.035098629316040714" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.20942367776462426" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.03" MODIFIED="2010-08-26 06:59:36 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5528540522250918" P_Q="0.43955726865916656" P_Z="0.018543481817625083" Q="0.5974382866432293" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="382" TOTAL_2="191" UNITS="" WEIGHT="100.0" Z="2.3545834037134923">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.4915165182877566" CI_END="0.3739492556936801" CI_START="-0.050719497772105465" DF="1" EFFECT_SIZE="0.16161487896078733" ESTIMABLE="YES" I2="32.95414514429996" ID="CMP-008.03.01" MODIFIED="2010-08-26 06:59:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2219816687792303" P_Z="0.13575291908393985" STUDIES="2" TAU2="0.0" TOTAL_1="255" TOTAL_2="129" WEIGHT="67.40295949131247" Z="1.4917949085908613">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="297" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="29.876677663496725"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="296" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.52628182781575"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.006395507676025739" CI_END="0.6136118159502182" CI_START="0.002950085366983324" DF="1" EFFECT_SIZE="0.3082809506586007" ESTIMABLE="YES" I2="0.0" ID="CMP-008.03.02" MODIFIED="2010-08-26 06:59:36 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9362595907277655" P_Z="0.04782715154006381" STUDIES="2" TAU2="0.0" TOTAL_1="127" TOTAL_2="62" WEIGHT="32.59704050868753" Z="1.97890101884572">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="367" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.633115382633779"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="298" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="28.96392512605375"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6446581581643751" CI_END="0.07165614511902518" CI_START="-0.3825348160541718" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1554393354675733" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.04" MODIFIED="2010-08-26 06:59:47 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.4220292845522483" P_Q="0.4220292845522483" P_Z="0.1797482944551126" Q="0.6446581581643751" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="229" TOTAL_2="111" UNITS="" WEIGHT="100.0" Z="1.3415304369349113">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.8895594519015997E-32" CI_END="0.07221437560016652" CI_START="-0.5678335700529755" DF="0" EFFECT_SIZE="-0.2478095972264045" ESTIMABLE="YES" I2="100.0" ID="CMP-008.04.01" MODIFIED="2010-08-26 06:59:43 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.12909201272135762" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="56" WEIGHT="50.35608503537704" Z="1.5176921944230146">
<NAME>High (&gt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="221" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="50.35608503537704"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.26056729147560076" CI_START="-0.3840552314749456" DF="0" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" I2="0.0" ID="CMP-008.04.02" MODIFIED="2010-08-26 06:59:47 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7073161496387549" STUDIES="1" TAU2="0.0" TOTAL_1="113" TOTAL_2="55" WEIGHT="49.643914964622965" Z="0.37546301332435306">
<NAME>Low (&lt; 35 nmol/L)</NAME>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" ORDER="222" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="49.643914964622965"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2010-08-26 07:00:43 -0400" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Vitamin D supplementation vs placebo by pubertal stage of entire study</NAME>
<CONT_OUTCOME CHI2="4.054677346532506" CI_END="0.2576287104628855" CI_START="-0.05579391579936886" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10091739733175832" ESTIMABLE="YES" I2="1.3485005552726617" I2_Q="61.2734419071745" ID="CMP-009.01" MODIFIED="2010-08-26 07:00:07 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39865688865306736" P_Q="0.10807124826888659" P_Z="0.20689190208932795" Q="2.5822072738895443" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="99.99999999999999" Z="1.262158169897164">
<NAME>% change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.6594875225542467E-32" CI_END="0.2017053369381233" CI_START="-0.6428757064921775" DF="0" EFFECT_SIZE="-0.22058518477702713" ESTIMABLE="YES" I2="100.0" ID="CMP-009.01.01" MODIFIED="2010-08-26 07:00:04 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.3059320227643031" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513" Z="1.0237952202434557">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="379" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4724700726429616" CI_END="0.32102593894861053" CI_START="-0.016498071752878457" DF="3" EFFECT_SIZE="0.15226393359786605" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.02" MODIFIED="2010-08-26 07:00:07 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6886386666857276" P_Z="0.07700089140712112" STUDIES="4" TAU2="0.0" TOTAL_1="356" TOTAL_2="229" WEIGHT="86.22860193691547" Z="1.7683590887414116">
<NAME>Mixed</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="380" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.9601040136805756"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="381" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.69156569900406"/>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" ORDER="382" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="383" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="23.43246016042895"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.088795604896442" CI_END="0.29236145839972394" CI_START="-0.18102404321268345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.055668707593520245" ESTIMABLE="YES" I2="50.72917216029583" I2_Q="71.7252145372315" ID="CMP-009.02" MODIFIED="2010-08-26 07:00:18 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1073692072084167" P_Q="0.0600241899364391" P_Z="0.6448189037780425" Q="3.5367200268124885" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02936893865737089" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="0.4609717094315479">
<NAME>% change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.12603251596685705" CI_START="-0.7207227814535841" DF="0" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" I2="0.0" ID="CMP-009.02.01" MODIFIED="2010-08-26 07:00:15 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.16866219760294054" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.18163563243661" Z="1.3765151583478135">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="384" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.18163563243661"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.552075578083953" CI_END="0.342404047325068" CI_START="-0.059211173728214966" DF="2" EFFECT_SIZE="0.1415964367984265" ESTIMABLE="YES" I2="21.632414918465706" ID="CMP-009.02.02" MODIFIED="2010-08-26 07:00:18 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2791412424128611" P_Z="0.16695977670851778" STUDIES="3" TAU2="0.006834499000631027" TOTAL_1="368" TOTAL_2="184" WEIGHT="80.81836436756339" Z="1.3820388367566299">
<NAME>Mixed</NAME>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="385" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.10685050968142"/>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="386" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.76763234752574"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="387" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.943881510356235"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.022721723627729" CI_END="0.3124307124361121" CI_START="-0.00980056116149089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1513150756373106" ESTIMABLE="YES" I2="20.361902966208017" I2_Q="65.8396609246341" ID="CMP-009.03" MODIFIED="2010-08-26 07:00:31 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.28497411353566027" P_Q="0.08708933577738276" P_Z="0.06565957700789123" Q="2.9273714110207174" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="232" UNITS="" WEIGHT="100.0" Z="1.8407406286544195">
<NAME>% change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.6622674340550408E-32" CI_END="0.2328311360570779" CI_START="-0.6110433895929803" DF="0" EFFECT_SIZE="-0.18910612676795124" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-009.03.01" MODIFIED="2010-08-26 07:00:28 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.3797119004427144" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008" Z="0.8784272695885349">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="388" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.0953503126070117" CI_END="0.3837487262132078" CI_START="0.03509862931604074" DF="3" EFFECT_SIZE="0.20942367776462428" ESTIMABLE="YES" I2="0.0" ID="CMP-009.03.02" MODIFIED="2010-08-26 07:00:31 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5528540522250918" P_Z="0.018543481817625055" STUDIES="4" TAU2="0.0" TOTAL_1="382" TOTAL_2="191" WEIGHT="85.41925811659992" Z="2.3545834037134927">
<NAME>Mixed</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="389" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.103380206365845"/>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="390" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="391" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="24.74076996412259"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="392" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="32.05467153606467"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.817202856077749" CI_END="0.44648748856920334" CI_START="-0.3607366613109035" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04287541362914991" ESTIMABLE="YES" I2="74.41540104789487" I2_Q="86.05794676621647" ID="CMP-009.04" MODIFIED="2010-08-26 07:00:43 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.020068584986071336" P_Q="0.007402791620339633" P_Z="0.8350684899448644" Q="7.172544697913374" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.09414146513491982" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.2082055313827586">
<NAME>% change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9345014113906318" CI_START="0.0786093011935986" DF="0" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" I2="0.0" ID="CMP-009.04.01" MODIFIED="2010-08-26 07:00:39 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.02034145798098645" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866" Z="2.3199892665907234">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="393" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6446581581643751" CI_END="0.07165614511902518" CI_START="-0.3825348160541718" DF="1" EFFECT_SIZE="-0.1554393354675733" ESTIMABLE="YES" I2="0.0" ID="CMP-009.04.02" MODIFIED="2010-08-26 07:00:43 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4220292845522483" P_Z="0.1797482944551126" STUDIES="2" TAU2="0.0" TOTAL_1="229" TOTAL_2="111" WEIGHT="70.09743581749134" Z="1.3415304369349113">
<NAME>Mixed</NAME>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="394" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="35.10411253162387"/>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" ORDER="395" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="34.99332328586747"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2010-08-26 07:01:20 -0400" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Vitamin D supplementation - by pubertal status (pre- vs post-pubertal); all data</NAME>
<CONT_OUTCOME CHI2="5.749139784802631" CI_END="0.24461195091000754" CI_START="-0.07631315487297764" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.08414939801851494" ESTIMABLE="YES" I2="0.0" I2_Q="21.577693326047697" ID="CMP-010.01" MODIFIED="2010-08-26 07:00:58 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4518702268302729" P_Q="0.2588033522549845" P_Z="0.3040252314498849" Q="1.2751473941688412" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="381" TOTAL_2="262" UNITS="" WEIGHT="100.0" Z="1.0278397449437549">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.551752406103277" CI_END="0.218942437452754" CI_START="-0.23825684640937927" DF="3" EFFECT_SIZE="-0.009657204478312644" ESTIMABLE="YES" I2="15.534652842218222" ID="CMP-010.01.01" MODIFIED="2009-08-21 00:43:48 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.31411192587560033" P_Z="0.9340115339727205" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="130" WEIGHT="49.271558902080294" Z="0.08279878659888411">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="364" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.4385880980646"/>
<CONT_DATA CI_END="0.39445705816578513" CI_START="-0.370676264259893" EFFECT_SIZE="0.011890396952946065" ESTIMABLE="YES" MEAN_1="36.3" MEAN_2="36.2" MODIFIED="2009-06-01 23:28:13 -0400" MODIFIED_BY="[Empty name]" ORDER="366" SD_1="8.74" SD_2="7.93" SE="0.19519065872152552" STUDY_ID="STD-Du-2004" TOTAL_1="53" TOTAL_2="52" WEIGHT="17.592726586953436"/>
<CONT_DATA CI_END="0.4346109581848081" CI_START="-0.44502584317547045" EFFECT_SIZE="-0.005207442495331164" ESTIMABLE="YES" MEAN_1="17.56" MEAN_2="17.6" MODIFIED="2009-08-21 00:43:48 -0400" MODIFIED_BY="[Empty name]" ORDER="367" SD_1="7.88" SD_2="7.0" SE="0.22440126663008642" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="63" TOTAL_2="29" WEIGHT="13.310691095233297"/>
<CONT_DATA CI_END="1.4632983418772674" CI_START="-0.15564671817276587" EFFECT_SIZE="0.6538258118522507" ESTIMABLE="YES" MEAN_1="20.92" MEAN_2="15.4" MODIFIED="2009-06-01 22:18:41 -0400" MODIFIED_BY="[Empty name]" ORDER="365" SD_1="8.31" SD_2="8.0" SE="0.41300377782960945" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="26" TOTAL_2="8" WEIGHT="3.929553121828965"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9222399845305137" CI_END="0.40055507134482415" CI_START="-0.050031178683801525" DF="2" EFFECT_SIZE="0.17526194633051131" ESTIMABLE="YES" I2="0.0" ID="CMP-010.01.02" MODIFIED="2010-08-26 07:00:58 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6305770421804195" P_Z="0.12733097896945064" STUDIES="3" TAU2="0.0" TOTAL_1="193" TOTAL_2="132" WEIGHT="50.728441097919706" Z="1.5247118732379035">
<NAME>Post pubertal</NAME>
<CONT_DATA CI_END="0.6860131011357459" CI_START="-0.06352112892933104" EFFECT_SIZE="0.3112459861032074" ESTIMABLE="YES" MEAN_1="43.2" MEAN_2="40.5" MODIFIED="2009-06-01 23:28:43 -0400" MODIFIED_BY="[Empty name]" ORDER="441" SD_1="8.0" SD_2="9.14" SE="0.19121122530243087" STUDY_ID="STD-Du-2004" TOTAL_1="53" TOTAL_2="58" WEIGHT="18.332616083866473"/>
<CONT_DATA CI_END="0.4940179851204435" CI_START="-0.4328697394282883" EFFECT_SIZE="0.030574122846077575" ESTIMABLE="YES" MEAN_1="14.18" MEAN_2="13.9" MODIFIED="2009-08-21 01:03:50 -0400" MODIFIED_BY="[Empty name]" ORDER="439" SD_1="8.9" SD_2="9.4" SE="0.2364552950615174" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="53" TOTAL_2="27" WEIGHT="11.988176407543653"/>
<CONT_DATA CI_END="0.4933028883118182" CI_START="-0.21710407418916516" EFFECT_SIZE="0.1380994070613265" ESTIMABLE="YES" MEAN_1="8.91" MEAN_2="7.6" MODIFIED="2009-08-21 01:05:26 -0400" MODIFIED_BY="[Empty name]" ORDER="440" SD_1="9.94" SD_2="8.4" SE="0.18122959608048483" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="87" TOTAL_2="47" WEIGHT="20.407648606509582"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.985051007158582" CI_END="0.27432634415586316" CI_START="-0.1352742543886371" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.06952604488361301" ESTIMABLE="YES" I2="33.22241581912365" I2_Q="27.067243250567245" ID="CMP-010.02" MODIFIED="2010-08-26 07:01:04 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.17442060434338325" P_Q="0.24161869704330652" P_Z="0.5058120963930832" Q="1.3711260132886416" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02492336417489441" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="0.6653727774989673">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.940192009032199" CI_END="0.36605196819662034" CI_START="-0.35888161031143917" DF="3" EFFECT_SIZE="0.0035851789425906007" ESTIMABLE="YES" I2="56.773530241012075" ID="CMP-010.02.01" MODIFIED="2009-09-09 21:51:13 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.07382875851820814" P_Z="0.9845330897127962" STUDIES="4" TAU2="0.07492388745864374" TOTAL_1="214" TOTAL_2="121" WEIGHT="53.13338973951125" Z="0.019386111538854178">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="370" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="15.252574348340724"/>
<CONT_DATA CI_END="0.19734480695721815" CI_START="-0.6852369410050075" EFFECT_SIZE="-0.24394606702389468" ESTIMABLE="YES" MEAN_1="3.14" MEAN_2="4.2" MODIFIED="2009-06-01 22:22:14 -0400" MODIFIED_BY="[Empty name]" ORDER="368" SD_1="4.52" SD_2="3.8" SE="0.2251525423232054" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="63" TOTAL_2="29" WEIGHT="14.439274331805539"/>
<CONT_DATA CI_END="1.5531221780331923" CI_START="-0.07515826062810516" EFFECT_SIZE="0.7389819587025436" ESTIMABLE="YES" MEAN_1="6.18" MEAN_2="2.2" MODIFIED="2009-06-01 22:22:34 -0400" MODIFIED_BY="[Empty name]" ORDER="369" SD_1="5.58" SD_2="3.9" SE="0.41538529572608623" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="26" TOTAL_2="8" WEIGHT="5.529267316097087"/>
<CONT_DATA CI_END="0.5391665684662622" CI_START="-0.20492135094771532" EFFECT_SIZE="0.16712260875927346" ESTIMABLE="YES" MEAN_1="7.683" MEAN_2="6.6" MODIFIED="2009-09-09 21:51:13 -0400" MODIFIED_BY="[Empty name]" ORDER="371" SD_1="6.23" SD_2="6.812" SE="0.1898218348100394" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="79" TOTAL_2="43" WEIGHT="17.912273743267903"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.673732984837741" CI_END="0.40337462346983427" CI_START="-0.07161717920384647" DF="2" EFFECT_SIZE="0.1658787221329939" ESTIMABLE="YES" I2="0.0" ID="CMP-010.02.02" MODIFIED="2010-08-26 07:01:04 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7140042312970099" P_Z="0.1710197657827934" STUDIES="3" TAU2="0.0" TOTAL_1="200" TOTAL_2="104" WEIGHT="46.866610260488756" Z="1.3689344504564012">
<NAME>Post pubertal</NAME>
<CONT_DATA CI_END="0.5533962098844173" CI_START="-0.3738794959199725" EFFECT_SIZE="0.0897583569822224" ESTIMABLE="YES" MEAN_1="4.93" MEAN_2="4.5" MODIFIED="2009-08-21 01:14:28 -0400" MODIFIED_BY="[Empty name]" ORDER="445" SD_1="4.38" SD_2="5.4" SE="0.23655427169035304" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="53" TOTAL_2="27" WEIGHT="13.499476749560289"/>
<CONT_DATA CI_END="0.4650337024757157" CI_START="-0.245083128232437" EFFECT_SIZE="0.10997528712163934" ESTIMABLE="YES" MEAN_1="3.81" MEAN_2="3.3" MODIFIED="2009-08-21 01:14:31 -0400" MODIFIED_BY="[Empty name]" ORDER="446" SD_1="4.72" SD_2="4.4" SE="0.1811555815079929" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="87" TOTAL_2="47" WEIGHT="18.909623433648605"/>
<CONT_DATA CI_END="0.7617766214298729" CI_START="-0.11997446270293305" EFFECT_SIZE="0.32090107936346995" ESTIMABLE="YES" MEAN_1="9.031" MEAN_2="6.89" MODIFIED="2009-09-09 21:51:21 -0400" MODIFIED_BY="[Empty name]" ORDER="447" SD_1="6.96" SD_2="5.85" SE="0.22494063439123016" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="60" TOTAL_2="30" WEIGHT="14.457510077279862"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.220104727446665" CI_END="0.24692317158071916" CI_START="-0.08075739484312747" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.08308288836879585" ESTIMABLE="YES" I2="3.538601632789825" I2_Q="0.0" ID="CMP-010.03" MODIFIED="2010-08-26 07:01:11 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.3989912815026283" P_Q="0.36392896270148334" P_Z="0.32027569400326394" Q="0.8242898302173893" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="0.9938915249784624">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.43718612465746" CI_END="0.2370659060177242" CI_START="-0.21549555096321382" DF="3" EFFECT_SIZE="0.010785177527255189" ESTIMABLE="YES" I2="32.38958394535246" ID="CMP-010.03.01" MODIFIED="2009-09-09 21:53:42 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.21796230194561728" P_Z="0.9255719600637525" STUDIES="4" TAU2="0.0" TOTAL_1="214" TOTAL_2="121" WEIGHT="52.42594210121561" Z="0.09341740969859609">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="375" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="15.078065222884502"/>
<CONT_DATA CI_END="0.4413202743299684" CI_START="-0.4383152941662139" EFFECT_SIZE="0.0015024900818772365" ESTIMABLE="YES" MEAN_1="10.11" MEAN_2="10.1" MODIFIED="2009-06-01 22:24:10 -0400" MODIFIED_BY="[Empty name]" ORDER="374" SD_1="6.6" SD_2="6.6" SE="0.22440095211816016" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="63" TOTAL_2="29" WEIGHT="13.87700700256858"/>
<CONT_DATA CI_END="1.6172952379281682" CI_START="-0.01827727168213844" EFFECT_SIZE="0.7995089831230149" ESTIMABLE="YES" MEAN_1="13.59" MEAN_2="8.2" MODIFIED="2009-06-01 22:24:24 -0400" MODIFIED_BY="[Empty name]" ORDER="372" SD_1="7.14" SD_2="4.0" SE="0.4172455520896031" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="26" TOTAL_2="8" WEIGHT="4.013855803508202"/>
<CONT_DATA CI_END="0.3810361609906324" CI_START="-0.3618334438519232" EFFECT_SIZE="0.009601358569354604" ESTIMABLE="YES" MEAN_1="9.85" MEAN_2="9.77" MODIFIED="2009-09-09 21:53:42 -0400" MODIFIED_BY="[Empty name]" ORDER="373" SD_1="7.98" SD_2="8.81" SE="0.18951103456548596" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="79" TOTAL_2="43" WEIGHT="19.45701407225432"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.958628772571815" CI_END="0.40029331322624906" CI_START="-0.07478541727347526" DF="2" EFFECT_SIZE="0.1627539479763869" ESTIMABLE="YES" I2="0.0" ID="CMP-010.03.02" MODIFIED="2010-08-26 07:01:11 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6192078288299655" P_Z="0.17930399819937085" STUDIES="3" TAU2="0.0" TOTAL_1="200" TOTAL_2="104" WEIGHT="47.57405789878438" Z="1.3429011062645713">
<NAME>Post pubertal</NAME>
<CONT_DATA CI_END="0.48448938601094693" CI_START="-0.44237156750208995" EFFECT_SIZE="0.021058909254428465" ESTIMABLE="YES" MEAN_1="9.35" MEAN_2="9.2" MODIFIED="2009-08-21 01:22:59 -0400" MODIFIED_BY="[Empty name]" ORDER="442" SD_1="7.13" SD_2="6.9" SE="0.23644846559018373" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="53" TOTAL_2="27" WEIGHT="12.498911640707014"/>
<CONT_DATA CI_END="0.4903846624415027" CI_START="-0.21998932779750005" EFFECT_SIZE="0.1351976673220013" ESTIMABLE="YES" MEAN_1="7.06" MEAN_2="6.2" MODIFIED="2009-08-21 01:23:23 -0400" MODIFIED_BY="[Empty name]" ORDER="443" SD_1="6.81" SD_2="5.3" SE="0.18122118463460096" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="87" TOTAL_2="47" WEIGHT="21.27782672444025"/>
<CONT_DATA CI_END="0.7746972150834821" CI_START="-0.10747489726793508" EFFECT_SIZE="0.33361115890777354" ESTIMABLE="YES" MEAN_1="12.27" MEAN_2="9.61" MODIFIED="2009-09-09 21:55:04 -0400" MODIFIED_BY="[Empty name]" ORDER="444" SD_1="8.74" SD_2="5.85" SE="0.22504804152267038" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="60" TOTAL_2="30" WEIGHT="13.79731953363712"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.764259792844679" CI_END="0.38837551313203894" CI_START="-0.19253220207353844" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.09792165552925024" ESTIMABLE="YES" I2="48.48188872188066" I2_Q="0.0" ID="CMP-010.04" MODIFIED="2010-08-26 07:01:20 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.10060566509300639" P_Q="0.7571803207661172" P_Z="0.5087604413025002" Q="0.09559577374686068" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.05171270815381268" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.660769045134642">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="7.342193471399694" CI_END="0.7165262312217215" CI_START="-0.45472422331782175" DF="2" EFFECT_SIZE="0.13090100395194987" ESTIMABLE="YES" I2="72.76018389067693" ID="CMP-010.04.01" MODIFIED="2009-06-01 22:26:00 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0254486163705413" P_Z="0.6613152300038719" STUDIES="3" TAU2="0.18944408669200224" TOTAL_1="135" TOTAL_2="78" WEIGHT="53.63194025680002" Z="0.43809802129266984">
<NAME>Prepubertal</NAME>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="377" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="22.09681475251162"/>
<CONT_DATA CI_END="0.10584408278396457" CI_START="-0.7793982101160368" EFFECT_SIZE="-0.33677706366603616" ESTIMABLE="YES" MEAN_1="2.06" MEAN_2="3.2" MODIFIED="2009-06-01 22:25:51 -0400" MODIFIED_BY="[Empty name]" ORDER="376" SD_1="3.29" SD_2="3.5" SE="0.22583126523820837" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="63" TOTAL_2="29" WEIGHT="21.381341437585792"/>
<CONT_DATA CI_END="1.0537480592724688" CI_START="-0.5364782586714543" EFFECT_SIZE="0.2586349003005073" ESTIMABLE="YES" MEAN_1="5.02" MEAN_2="4.1" MODIFIED="2009-06-01 22:26:00 -0400" MODIFIED_BY="[Empty name]" ORDER="378" SD_1="3.7" SD_2="2.5" SE="0.4056774334853664" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="26" TOTAL_2="8" WEIGHT="10.153784066702617"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3264705476981234" CI_END="0.3383072758728744" CI_START="-0.22545770354871814" DF="1" EFFECT_SIZE="0.05642478616207815" ESTIMABLE="YES" I2="0.0" ID="CMP-010.04.02" MODIFIED="2010-08-26 07:01:20 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5677449273798655" P_Z="0.6948154715386627" STUDIES="2" TAU2="0.0" TOTAL_1="140" TOTAL_2="74" WEIGHT="46.36805974319997" Z="0.39232855090257673">
<NAME>Post pubertal</NAME>
<CONT_DATA CI_END="0.6280744672290113" CI_START="-0.30022544640646537" EFFECT_SIZE="0.16392451041127293" ESTIMABLE="YES" MEAN_1="5.3" MEAN_2="4.6" MODIFIED="2009-08-21 01:26:22 -0400" MODIFIED_BY="[Empty name]" ORDER="448" SD_1="3.85" SD_2="4.9" SE="0.2368155539994071" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="53" TOTAL_2="27" WEIGHT="20.37334124587552"/>
<CONT_DATA CI_END="0.34841551174195384" CI_START="-0.3611997893879557" EFFECT_SIZE="-0.006392138823000945" ESTIMABLE="YES" MEAN_1="3.68" MEAN_2="3.7" MODIFIED="2009-08-21 01:25:58 -0400" MODIFIED_BY="[Empty name]" ORDER="449" SD_1="3.31" SD_2="2.7" SE="0.1810276379380602" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="87" TOTAL_2="47" WEIGHT="25.994718497324452"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2010-08-26 07:02:13 -0400" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Vitamin D supplementation - by compliance (&lt; 80% versus more than 80%); all data</NAME>
<CONT_OUTCOME CHI2="4.054677346532506" CI_END="0.2576287104628855" CI_START="-0.05579391579936886" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10091739733175832" ESTIMABLE="YES" I2="1.3485005552726617" I2_Q="61.2734419071745" ID="CMP-011.01" MODIFIED="2010-08-26 07:01:49 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39865688865306736" P_Q="0.10807124826888659" P_Z="0.20689190208932795" Q="2.5822072738895443" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="99.99999999999999" Z="1.262158169897164">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.6594875225542467E-32" CI_END="0.2017053369381233" CI_START="-0.6428757064921775" DF="0" EFFECT_SIZE="-0.22058518477702713" ESTIMABLE="YES" I2="100.0" ID="CMP-011.01.01" MODIFIED="2009-09-23 01:53:55 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.3059320227643031" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513" Z="1.0237952202434557">
<NAME>Low compliance</NAME>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="895" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4724700726429616" CI_END="0.32102593894861053" CI_START="-0.016498071752878457" DF="3" EFFECT_SIZE="0.15226393359786605" ESTIMABLE="YES" I2="0.0" ID="CMP-011.01.02" MODIFIED="2009-09-28 21:16:13 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6886386666857276" P_Z="0.07700089140712112" STUDIES="4" TAU2="0.0" TOTAL_1="356" TOTAL_2="229" WEIGHT="86.22860193691547" Z="1.7683590887414116">
<NAME>High compliance</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="359" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.9601040136805756"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="896" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.69156569900406"/>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" ORDER="897" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="898" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="23.43246016042895"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.088795604896442" CI_END="0.29236145839972394" CI_START="-0.18102404321268345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.05566870759352023" ESTIMABLE="YES" I2="50.72917216029583" I2_Q="71.7252145372315" ID="CMP-011.02" MODIFIED="2010-08-26 07:02:04 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1073692072084167" P_Q="0.0600241899364391" P_Z="0.6448189037780425" Q="3.5367200268124885" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.02936893865737089" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="99.99999999999999" Z="0.4609717094315478">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.12603251596685705" CI_START="-0.7207227814535841" DF="0" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" I2="0.0" ID="CMP-011.02.01" MODIFIED="2009-09-23 01:54:21 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.16866219760294054" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.181635632436606" Z="1.3765151583478135">
<NAME>Low compliance</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="899" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.181635632436606"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.552075578083953" CI_END="0.342404047325068" CI_START="-0.059211173728214966" DF="2" EFFECT_SIZE="0.1415964367984265" ESTIMABLE="YES" I2="21.632414918465706" ID="CMP-011.02.02" MODIFIED="2009-09-23 01:54:35 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2791412424128611" P_Z="0.16695977670851778" STUDIES="3" TAU2="0.006834499000631027" TOTAL_1="368" TOTAL_2="184" WEIGHT="80.81836436756338" Z="1.3820388367566299">
<NAME>High compliance</NAME>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="900" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.106850509681415"/>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="901" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.767632347525737"/>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="902" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.94388151035623"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.022721723627729" CI_END="0.3124307124361121" CI_START="-0.00980056116149089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1513150756373106" ESTIMABLE="YES" I2="20.361902966208017" I2_Q="65.8396609246341" ID="CMP-011.03" MODIFIED="2010-08-26 07:02:09 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.28497411353566027" P_Q="0.08708933577738276" P_Z="0.06565957700789123" Q="2.9273714110207174" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="232" UNITS="" WEIGHT="100.0" Z="1.8407406286544195">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.6622674340550408E-32" CI_END="0.2328311360570779" CI_START="-0.6110433895929803" DF="0" EFFECT_SIZE="-0.18910612676795124" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-011.03.01" MODIFIED="2009-09-23 01:54:51 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.3797119004427144" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008" Z="0.8784272695885349">
<NAME>Low compliance</NAME>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="903" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.0953503126070117" CI_END="0.3837487262132078" CI_START="0.03509862931604074" DF="3" EFFECT_SIZE="0.20942367776462428" ESTIMABLE="YES" I2="0.0" ID="CMP-011.03.02" MODIFIED="2009-09-28 21:20:28 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5528540522250918" P_Z="0.018543481817625055" STUDIES="4" TAU2="0.0" TOTAL_1="382" TOTAL_2="191" WEIGHT="85.41925811659992" Z="2.3545834037134927">
<NAME>High compliance</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="368" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.103380206365845"/>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="904" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="905" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="24.74076996412259"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="906" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="32.05467153606467"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.817202856077749" CI_END="0.44648748856920334" CI_START="-0.3607366613109035" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.04287541362914991" ESTIMABLE="YES" I2="74.41540104789487" I2_Q="86.05794676621647" ID="CMP-011.04" MODIFIED="2010-08-26 07:02:13 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.020068584986071336" P_Q="0.007402791620339633" P_Z="0.8350684899448644" Q="7.172544697913374" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.09414146513491982" TOTALS="YES" TOTAL_1="275" TOTAL_2="152" UNITS="" WEIGHT="100.0" Z="0.2082055313827586">
<NAME>% Change forearm bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9345014113906318" CI_START="0.0786093011935986" DF="0" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" I2="0.0" ID="CMP-011.04.01" MODIFIED="2009-09-23 01:55:13 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.02034145798098645" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866" Z="2.3199892665907234">
<NAME>Low compliance</NAME>
<CONT_DATA CI_END="0.9345014113906318" CI_START="0.0786093011935986" EFFECT_SIZE="0.5065553562921152" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.61" ORDER="907" SD_1="1.4" SD_2="1.5" SE="0.2183438361490826" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="29.90256418250866"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6446581581643751" CI_END="0.07165614511902518" CI_START="-0.3825348160541718" DF="1" EFFECT_SIZE="-0.1554393354675733" ESTIMABLE="YES" I2="0.0" ID="CMP-011.04.02" MODIFIED="2009-09-23 01:55:19 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4220292845522483" P_Z="0.1797482944551126" STUDIES="2" TAU2="0.0" TOTAL_1="229" TOTAL_2="111" WEIGHT="70.09743581749134" Z="1.3415304369349113">
<NAME>High compliance</NAME>
<CONT_DATA CI_END="0.07221437560016655" CI_START="-0.5678335700529755" EFFECT_SIZE="-0.24780959722640447" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" ORDER="908" SD_1="3.3" SD_2="4.2" SE="0.1632805374746063" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="35.10411253162387"/>
<CONT_DATA CI_END="0.26056729147560076" CI_START="-0.3840552314749456" EFFECT_SIZE="-0.06174396999967242" ESTIMABLE="YES" MEAN_1="3.48" MEAN_2="3.7" ORDER="909" SD_1="3.89" SD_2="2.7" SE="0.16444754292304514" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="34.99332328586747"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2010-08-26 07:02:44 -0400" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Vitamin D supplementation - by study quality (adequate allocation concealment); all data</NAME>
<CONT_OUTCOME CHI2="4.054677346532506" CI_END="0.2576287104628855" CI_START="-0.055793915799368876" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10091739733175831" ESTIMABLE="YES" I2="1.3485005552726617" I2_Q="0.0" ID="CMP-012.01" MODIFIED="2010-08-26 07:02:28 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39865688865306736" P_Q="0.5595463510896529" P_Z="0.20689190208932817" Q="0.34049060267924824" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="270" UNITS="" WEIGHT="99.99999999999997" Z="1.2621581698971638">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours vitamin D</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.6819560442185972" CI_END="0.26396234301210353" CI_START="-0.13619332407571783" DF="2" EFFECT_SIZE="0.06388450946819284" ESTIMABLE="YES" I2="45.6810462704899" ID="CMP-012.01.01" MODIFIED="2010-08-26 07:02:28 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.15866225682125323" P_Z="0.5314375141472092" STUDIES="3" TAU2="0.0" TOTAL_1="275" TOTAL_2="152" WEIGHT="61.34833028731534" Z="0.6258131423648496">
<NAME>Adequate allocation concealment</NAME>
<CONT_DATA CI_END="0.20170533693812326" CI_START="-0.6428757064921775" EFFECT_SIZE="-0.22058518477702715" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="35.0" ORDER="948" SD_1="1.3" SD_2="1.4" SE="0.2154583069108025" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="13.771398063084513"/>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" ORDER="949" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="24.144472063801885"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="950" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="23.43246016042895"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.03223069963466036" CI_END="0.41176351219265583" CI_START="-0.09237075157138208" DF="1" EFFECT_SIZE="0.15969638031063688" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.02" MODIFIED="2009-09-28 21:17:09 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8575223109833578" P_Z="0.21433646395138684" STUDIES="2" TAU2="0.0" TOTAL_1="127" TOTAL_2="118" WEIGHT="38.65166971268464" Z="1.2417293422323712">
<NAME>Inadequate or unclear allocation concealment</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="361" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="2.9601040136805756"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="947" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="35.69156569900406"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.088795604896442" CI_END="0.29236145839972394" CI_START="-0.18102404321268345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.05566870759352023" ESTIMABLE="YES" I2="50.72917216029583" I2_Q="38.18091685714564" ID="CMP-012.02" MODIFIED="2010-08-26 07:02:36 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1073692072084167" P_Q="0.20342353561692195" P_Z="0.6448189037780425" Q="1.6176234734655548" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.029368938657370898" TOTALS="YES" TOTAL_1="414" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="0.4609717094315478">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.471172131430887" CI_END="0.28622257816368785" CI_START="-0.32147965905422055" DF="2" EFFECT_SIZE="-0.01762854044526635" ESTIMABLE="YES" I2="55.269000136661035" ID="CMP-012.02.01" MODIFIED="2010-08-26 07:02:36 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10692955586771069" P_Z="0.909466658010422" STUDIES="3" TAU2="0.0397340582458355" TOTAL_1="275" TOTAL_2="152" WEIGHT="71.05611848964377" Z="0.1137112956203925">
<NAME>Adequate allocation concealment</NAME>
<CONT_DATA CI_END="0.12603251596685705" CI_START="-0.7207227814535841" EFFECT_SIZE="-0.29734513274336355" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.5" ORDER="952" SD_1="1.0" SD_2="1.0" SE="0.21601297373307338" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="19.18163563243661"/>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="953" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="26.106850509681415"/>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="954" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="25.767632347525737"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5122217418035828" CI_START="-0.05607159868754963" DF="0" EFFECT_SIZE="0.2280750715580166" ESTIMABLE="YES" I2="0.0" ID="CMP-012.02.02" MODIFIED="2009-09-23 02:11:04 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.11567301682504595" STUDIES="1" TAU2="0.0" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.943881510356235" Z="1.5731978334948775">
<NAME>Inadequate or unclear allocation concealment</NAME>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="951" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="28.943881510356235"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.022721723627729" CI_END="0.3124307124361121" CI_START="-0.00980056116149089" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1513150756373106" ESTIMABLE="YES" I2="20.361902966208017" I2_Q="30.5781886663034" ID="CMP-012.03" MODIFIED="2010-08-26 07:02:44 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.28497411353566027" P_Q="0.2300636556703699" P_Z="0.06565957700789123" Q="1.4404694731936658" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="428" TOTAL_2="232" UNITS="" WEIGHT="100.00000000000001" Z="1.8407406286544195">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.565215381228094" CI_END="0.2787494417488774" CI_START="-0.12141607361359277" DF="2" EFFECT_SIZE="0.07866668406764232" ESTIMABLE="YES" I2="43.90240739646229" ID="CMP-012.03.01" MODIFIED="2010-08-26 07:02:44 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16819902076217141" P_Z="0.4409437876957405" STUDIES="3" TAU2="0.0" TOTAL_1="275" TOTAL_2="152" WEIGHT="64.8419482575695" Z="0.7706004722376439">
<NAME>Adequate allocation concealment</NAME>
<CONT_DATA CI_END="0.23283113605707786" CI_START="-0.6110433895929804" EFFECT_SIZE="-0.18910612676795127" ESTIMABLE="YES" MEAN_1="19.2" MEAN_2="19.4" ORDER="956" SD_1="1.0" SD_2="1.1" SE="0.21527806947128436" STUDY_ID="STD-Cheng-2005" TOTAL_1="46" TOTAL_2="41" WEIGHT="14.58074188340008"/>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="957" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="25.520436410046823"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="958" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="24.74076996412259"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.017036869205969276" CI_END="0.5570227140171757" CI_START="0.013578101938560794" DF="1" EFFECT_SIZE="0.28530040797786826" ESTIMABLE="YES" I2="0.0" ID="CMP-012.03.02" MODIFIED="2009-09-28 21:20:42 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8961507974660011" P_Z="0.03959931298011228" STUDIES="2" TAU2="0.0" TOTAL_1="153" TOTAL_2="80" WEIGHT="35.158051742430516" Z="2.057904382462862">
<NAME>Inadequate or unclear allocation concealment</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="370" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.103380206365845"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="955" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="32.05467153606467"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2010-08-26 07:03:28 -0400" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Vitamin D supplementation - by study quality (adequate allocation concealment); sensitivity analysis omit Cheng 2005</NAME>
<CONT_OUTCOME CHI2="1.4724700726429616" CI_END="0.32102593894861053" CI_START="-0.016498071752878457" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.15226393359786605" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.01" MODIFIED="2010-08-26 07:03:11 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6886386666857276" P_Q="0.9379855030585332" P_Z="0.07700089140712112" Q="0.0060531614885035445" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="356" TOTAL_2="229" UNITS="" WEIGHT="100.0" Z="1.7683590887414116">
<NAME>% Change total body bone mineral content from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours vitamin D</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.4341862115197976" CI_END="0.3734225465093821" CI_START="-0.08097097183899438" DF="1" EFFECT_SIZE="0.14622578733519387" ESTIMABLE="YES" I2="30.274047263339213" ID="CMP-013.01.01" MODIFIED="2010-08-26 07:03:11 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.23108272164606258" P_Z="0.2071469074254363" STUDIES="2" TAU2="0.0" TOTAL_1="229" TOTAL_2="111" WEIGHT="55.1753491945027" Z="1.26144966957149">
<NAME>Adequate allocation concealment</NAME>
<CONT_DATA CI_END="0.3283936285286469" CI_START="-0.30946067283777906" EFFECT_SIZE="0.009466477845433903" ESTIMABLE="YES" MEAN_1="15.88" MEAN_2="15.8" ORDER="398" SD_1="8.42" SD_2="8.4" SE="0.16272092405721209" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="28.000537549554487"/>
<CONT_DATA CI_END="0.6108769307160076" CI_START="-0.03659568004629882" EFFECT_SIZE="0.2871406253348544" ESTIMABLE="YES" MEAN_1="11.64" MEAN_2="8.7" ORDER="396" SD_1="10.8" SD_2="8.8" SE="0.1651746195005336" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="27.174811644948218"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.03223069963466036" CI_END="0.41176351219265583" CI_START="-0.09237075157138208" DF="1" EFFECT_SIZE="0.15969638031063688" ESTIMABLE="YES" I2="0.0" ID="CMP-013.01.02" MODIFIED="2009-09-29 01:57:03 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8575223109833578" P_Z="0.21433646395138684" STUDIES="2" TAU2="0.0" TOTAL_1="127" TOTAL_2="118" WEIGHT="44.82465080549729" Z="1.2417293422323712">
<NAME>Inadequate or unclear allocation concealment</NAME>
<CONT_DATA CI_END="1.1507201533535927" CI_START="-0.6709798514735601" EFFECT_SIZE="0.2398701509400163" ESTIMABLE="YES" MEAN_1="15.4" MEAN_2="12.7" ORDER="400" SD_1="12.0" SD_2="7.6" SE="0.46472792847126015" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.432856322831462"/>
<CONT_DATA CI_END="0.4153587469234582" CI_START="-0.10926451751447888" EFFECT_SIZE="0.15304711470448965" ESTIMABLE="YES" MEAN_1="39.7" MEAN_2="38.4" ORDER="399" SD_1="8.5" SD_2="8.43" SE="0.13383492466598834" STUDY_ID="STD-Du-2004" TOTAL_1="113" TOTAL_2="111" WEIGHT="41.39179448266583"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.552075578083953" CI_END="0.342404047325068" CI_START="-0.059211173728214966" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.1415964367984265" ESTIMABLE="YES" I2="21.632414918465706" I2_Q="0.0" ID="CMP-013.02" MODIFIED="2010-08-26 07:03:18 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2791412424128611" P_Q="0.4531257943702528" P_Z="0.16695977670851778" Q="0.5628214053143581" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.006834499000631027" TOTALS="YES" TOTAL_1="368" TOTAL_2="184" UNITS="" WEIGHT="100.0" Z="1.3820388367566299">
<NAME>% Change hip bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.989254172769595" CI_END="0.41030479373264006" CI_START="-0.2304029670176624" DF="1" EFFECT_SIZE="0.08995091335748881" ESTIMABLE="YES" I2="49.729903111992876" ID="CMP-013.02.01" MODIFIED="2010-08-26 07:03:18 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.15841922620537996" P_Z="0.582092626430879" STUDIES="2" TAU2="0.026572472767762773" TOTAL_1="229" TOTAL_2="111" WEIGHT="62.3121103902847" Z="0.5503306229682742">
<NAME>Adequate allocation concealment</NAME>
<CONT_DATA CI_END="0.24664236497006012" CI_START="-0.3913964189195416" EFFECT_SIZE="-0.07237702697474072" ESTIMABLE="YES" MEAN_1="3.97" MEAN_2="4.3" ORDER="403" SD_1="4.51" SD_2="4.6" SE="0.16276798679015791" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="31.496042648706947"/>
<CONT_DATA CI_END="0.5779451668712492" CI_START="-0.06888829729301077" EFFECT_SIZE="0.2545284347891192" ESTIMABLE="YES" MEAN_1="4.35" MEAN_2="3.2" ORDER="402" SD_1="4.59" SD_2="4.3" SE="0.16501156890289814" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="30.816067741577758"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5122217418035828" CI_START="-0.05607159868754963" DF="0" EFFECT_SIZE="0.2280750715580166" ESTIMABLE="YES" I2="0.0" ID="CMP-013.02.02" MODIFIED="2009-09-29 01:57:03 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.11567301682504595" STUDIES="1" TAU2="0.0" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.68788960971529" Z="1.5731978334948775">
<NAME>Inadequate or unclear allocation concealment</NAME>
<CONT_DATA CI_END="0.5122217418035828" CI_START="-0.056071598687549656" EFFECT_SIZE="0.22807507155801657" ESTIMABLE="YES" MEAN_1="8.19" MEAN_2="6.71" ORDER="404" SD_1="6.5" SD_2="6.4" SE="0.14497545489962005" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.68788960971529"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.095350312607012" CI_END="0.3837487262132078" CI_START="0.03509862931604074" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.20942367776462428" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.03" MODIFIED="2010-08-26 07:03:28 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5528540522250917" P_Q="0.47553761760754987" P_Z="0.018543481817625055" Q="0.509079607117356" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="382" TOTAL_2="191" UNITS="" WEIGHT="100.0" Z="2.3545834037134927">
<NAME>% Change lumbar spine bone mineral density from baseline</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5692338362836868" CI_END="0.3836064716337976" CI_START="-0.07091168184378546" DF="1" EFFECT_SIZE="0.15634739489500607" ESTIMABLE="YES" I2="36.274634354798636" ID="CMP-013.03.01" MODIFIED="2010-08-26 07:03:28 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.21031835755431583" P_Z="0.1775310031116956" STUDIES="2" TAU2="0.0" TOTAL_1="229" TOTAL_2="111" WEIGHT="58.84060278955047" Z="1.3483961453521434">
<NAME>Adequate allocation concealment</NAME>
<CONT_DATA CI_END="0.3322618015925394" CI_START="-0.3055956588787111" EFFECT_SIZE="0.013333071356914132" ESTIMABLE="YES" MEAN_1="9.69" MEAN_2="9.6" ORDER="405" SD_1="6.73" SD_2="6.7" SE="0.16272172996610873" STUDY_ID="STD-El-Hajj-Fuleihan-2006a" TOTAL_1="116" TOTAL_2="56" WEIGHT="29.876677663496725"/>
<CONT_DATA CI_END="0.6277836096561391" CI_START="-0.020046429926572462" EFFECT_SIZE="0.3038685898647833" ESTIMABLE="YES" MEAN_1="8.56" MEAN_2="6.5" ORDER="407" SD_1="7.38" SD_2="5.2" SE="0.16526580199756533" STUDY_ID="STD-El_x002d_Hajj-Fuleihan-2006b" TOTAL_1="113" TOTAL_2="55" WEIGHT="28.96392512605375"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.017036869205969276" CI_END="0.5570227140171757" CI_START="0.013578101938560794" DF="1" EFFECT_SIZE="0.28530040797786826" ESTIMABLE="YES" I2="0.0" ID="CMP-013.03.02" MODIFIED="2009-09-29 01:57:03 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8961507974660011" P_Z="0.03959931298011228" STUDIES="2" TAU2="0.0" TOTAL_1="153" TOTAL_2="80" WEIGHT="41.15939721044953" Z="2.057904382462862">
<NAME>Inadequate or unclear allocation concealment</NAME>
<CONT_DATA CI_END="1.2580340161638184" CI_START="-0.5711196629139639" EFFECT_SIZE="0.3434571766249273" ESTIMABLE="YES" MEAN_1="13.15" MEAN_2="9.6" ORDER="408" SD_1="10.86" SD_2="7.5" SE="0.4666294109243621" STUDY_ID="STD-Andersen-2008" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.633115382633779"/>
<CONT_DATA CI_END="0.5642418559825506" CI_START="-0.004901961199094529" EFFECT_SIZE="0.27966994739172807" ESTIMABLE="YES" MEAN_1="11.61" MEAN_2="9.71" ORDER="409" SD_1="6.19" SD_2="7.76" SE="0.14519241722577023" STUDY_ID="STD-Viljakainen-2006" TOTAL_1="139" TOTAL_2="73" WEIGHT="37.52628182781575"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2010-08-31 20:56:45 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.1 % Change total body bone mineral content from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-001.02" SETTINGS="SHOW_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.2 % Change hip bone mineral density from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.03" SETTINGS="SHOW_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.3 % Change lumbar spine bone mineral density from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.04" SETTINGS="SHOW_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.4 % Change forearm bone mineral density from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.1 % Change total body bone mineral content from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxkAAADACAMAAABf5F63AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.2 % Change hip bone mineral density from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxIAAACwCAMAAACsJqiBAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-001.03" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.3 % Change lumbar spine bone mineral density from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAx8AAADACAMAAABS+i7wAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2010-01-24 18:09:38 -0500" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-001.04" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Vitamin D supplementation vs placebo combining dosage groups, all data, outcome: 1.4 % Change forearm bone mineral density from baseline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxIAAACgCAMAAACv8KoaAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="PRISMA FLOW DIAGRAM.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2010-08-31 20:56:45 -0400" MODIFIED_BY="[Empty name]" NO="9" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA flow diagram</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAfgAAAI0CAYAAADx6jstAABUZ0lEQVR42u2dCZgUxdmATYCd3eFa
lvtekBtEBBVFucQDQQSJcsh9CiqIimJURI3GaDT6a6LxCokiXuABGo0xYKKJ5leDZ4wxisQkKmo8
UECT3++v6t1aa4vqmZ7d2dmZ2fd7nndndqbvqa63q7q6aq+LLrpoLwAAAMgvgj87d+4Uze7du9PG
l4pdu7+UL3ftkt1ffqk+2yVfqf93f1k+TfCZmm5X+ta5S61L89FHH13IjwsAAHVe8EaMtiTTwZdK
6rsUn+tXLfJdX8pXO8u/V5/pi4pdaVxnsDwEDwAAUCb4L774opIg04Ja5s5danlf7JTdO82yd6rP
dgWf6e+CC4o0rNNst37V+4LgAQAAwZcL3lTT6/f2/1UlWEa5dHfu1CL/XHbuVu+V3D/f+UWZ5PV0
u3amZ13WtiN4AABA8OWC13z++ecVkqw2n+8uW6YS+46PP5IXH31EPn7zDfn8Sy119b0S8o7PdwSv
aVtnOR988AGCBwAABG/E/tlnn8unn+6oeK0On+jXTz6RHTt2yB/vfUDW3HGHrP/Zann/L3+Tjz/9
RD79+FP5+LOy6VIhdH2ffFZxgYLgAQAAwesS/I4v5KvdX8jDj78nP/3F1jJ+rnnLw9Y9uOEXZZ/f
9PNt6vXt8s/V+19sk2svfEAWL71RZi++RqbMvFjOnHmpXPXjl+V/bn1Lrv3ZW3Ldz7bJdeXvDdeV
c62H627ZKj++9a1g+TeUr/+61W/L9be8KNu2/V3+/eF2ef/99xE8AAAg+M8//0z+89VO+fk9b8qK
770sZ3/vRVlxyUvBazRekrMufjl4XXHxC7JcLWPFJa/IeSuekKmTfyTjJv1IDh+3UoYdtVQOHnGK
LJ58uZx+wbNl03/vpeA1KssvKePsS17+5rNVW+S0s++Wm265WZ577nl555//RPAAAIDgP9cl+C+/
kNV3/FXOWPmnQL7LVj4nyy7w8fyerHpezaO+W/msnKb+X37Bn+Ssc5+RuZOulKOP/6EcMfZcGX6Y
kvuwRTJ42AIZduhcOWXWrXLaef8ryxSnr1TLOL9sncF769XltPPVazmn6+n0+s97VmYvuknmL1go
GzdulG3vbEPwAACA4PV9ci34m29/RU777jNyyjl/kFNXPJ0Cf1Q8I0vO/oOcol/1Z9N/JqO/c5mM
GrNKhoxYIoMPmSODD50n+x80Q/YbPF3GqvfzT9kgJy//XRXW9Ufrf7XOs38v0+f+RGbMmCH3379e
Cf4dBA8AAAj+008/lV27dshPf/6CLD7zD7Lg9Cdk0Zm/k5PO8PHbPViopl145mZZdMZTslAJe8mi
B+XYcRfJYUruh4w8TQ48ZIEMHDw7EPu++58o+w6cIr33nSiTRp0hc059XBYse8JZpn89vu8Wnq5Q
r1NnXSvTp8+QBx54ULZu3YrgAQAAwX/yySeye/cX8uNbnpd5Sx9XbEqR38i8JZtl7mmbZNHSX8vM
Yy6V4UdruS9TJfb5Su4zZMCgadJ/0BTpt98JSu7HSc9+x8mAfY6VGcddJXNOeVTmLvmNzNfLOXWT
zF7y6+D/RNjr1xcJk2ZcLdNn6hL8/QgeAAAQfEUJfvcOufamZ2W2ku3Mxb9SPFrOr0L+r8yMkx+T
mSf/SuadcL0MP2KlDBm5XAYdPF+V2GfJPgMnyz77TZa++35H+vQbL737TpAefUZL1z5HybABJ8jk
GXfIzAW/lBnl65m1+DH1Pnxde6x70aPynWlXIXgAAABb8P/+979l187P5JqfPiPTT3pYTlzwkMXD
5TwUyoyFG2Waep015145ZtQ5ctDIM2TQQYuU3KdLvwFa7MdLL1Vi76Xk3qPPOOnee4x06TlKunQ/
TDrvPUyOG7pUJs1ZJ1MWbJQT1fqnzXso6Tptps7fKBOnXCHTZkyX++67T958800EDwAACD4Q/K7P
5Mof/0GmzH1AJs99UAn3gchMVkyZ+5BMO3KVHDDiTBk4ZJH0HzhDeiux9+l/vPTse6yS+jjp1vto
2bvHkVLa63Dp3E3JvdtI6dB1uPTteqiMP/YKOX7mepk8+8FgeSfMjb7+42fdJ+NPuCwowSN4AACA
csF/+OGHsnvXDrni2idl0uz75DtKtN9wXznrw5l1v8yceL0MGXaG7H/IEuk7aJr07n+C9Oo/Ubr3
GS/deo2Vrj2Oli5K7l26j5KO3UZIaelw6dBlmLTvPETadBosw/pOlGOOv0UmTrtXjpt9b/J1Whw3
/V45ZuIlQQl+/bp1CB4AABC8EfzOnZ/I5dc8IRNn3CPjT7xbjpt2t3q9VyaceI9MmLZOcY/6TL2f
rr7T3yuplk13b/D/mKFny4AhS2Wf/edIn34nSM9+Wu6q1N7rGCX1oxSq5N5dldy7jJROXZXYS7Xc
D5F2HQ6S1h32l45tBsrYoctlzJQ1Mj5Y170yUa0jWK96nVj+md6m8dPuLNum6Xob1Tbp9R93UfCY
3LpA8G8geAAAQPAffrBddn7xqXz/yk1y7NS7ZNyktTJuyl1yzOQ7ZezktTJWvR876Y7gs2P1Z3oa
/Trldhk39R6ZeuSlst/Bi6X/AfOk5z6TpHvf8bJ3z3FK6qOV1LXYj5BOe4+Ujl1HSAcl9g6lQ6Vt
RyX29gdKmw4HSut2+0nLtgOkb4eDZcyYy1VJfo1a39pgHceo9R8TvC/7f9wktV3qImDcpPLvJiu5
n7BGxky8WGZMny3r198nb7zxOoIHAAAE/+EHugS/Q85dtV6GH3WhjDzqAvWqOOI8GX6kYvSFMmL0
KhlxlGalDDtypRw66jwZesT5MvqwM2XQPmWPve3dQ5XUu4yQtu0HS7uOB0j7TgdKu077S5v2A6Sk
ZR9p0qyHlLTqLS3b9JTWbdVrqx7SouXeUtyiu7Rs3lW9lspBPUbI0CPPllGjz5PDx6wsY+wFwesR
6vWwMecr1PaobRgx+gIZOXplsE1HjT1NZs6YKevX3asETwkeAAAQ/F4ffPCBfPjhdvno3ztk48OP
yNLTz5R5J18oi0++VE4+9RJZsPAUmT5zlsyZOVOmzZgrZ5x+vlxw0TWKq+Ss+afLkEOHyoEHDJb+
+w6QHj17ybz5J8kRR4yW7j16Sffu3aVPn36yfPkK+eEPfyRHH32MdOrUUTp27CTt23eQXr16yb4D
Bkrr1i0VHaR3m9bynbHHyqKTlbBnzZFZs+YGzJ49P/h/wYLFctJJy2TmzDkBs2bPlpmz58i06TPl
lJMXy4aNGxE8AAAg+DLBfygffLBdvvrPl/L21jflkUcekRUr18nta9fLT29aL+dfcLfcededsn79
/UqgD8rd9z4ud9zziKy96VZZc/uvZcU558rkyZNl4sSJctTRY+TOtevkzLPPkZEjRsjw4cPlBz/4
gZx11nIZNeowmTZtugwcOFAGDdo/eB13zHHyo2tvVRcC3aRX7z7qoqCHzD9mgtx5z+Nyzz13y/33
PSAbN2wM+ph/+OGNcuNN98n3r7hP7r9/neI+2bDhYcUGtW3r5T417QsvvCBbt9LIDgAAEPxe27e/
L9vf3y7/9/XX8t//7JZPP/lCrr3ht/KHPzwlDz10n6w4f5388uGH5cUXX5bPP9shz255U3775Bb5
4XnnyE2rN8h5510oJ06bJosX69L1Arnrrnvl/HMvUKX1o2XChAmBfC+55BI5VJX0DznkYBk2bJgc
dthhihGyUJXI193/Oxk3boIMUsLfd0B/OePs78u99zwhTz71e3nzzbeCMeWD8erV6/+qda+88D55
8vd/UBcjW2XH55/Lzp075aMPP5J33vm7vPfeu0rwDDYDZTQsikvDeFw4FgBQRwW/XYlRCf7/vhb5
+v9k15dfyQ+vflx+dttDcunld8mauzYpwW+QTb95XHbv2ikvvLxN7vrFQ3L11bfK9T9dI3PnzpFj
x42T+fPnKcEvlLV3rpczl68IJK5L9UuWLJWXXnpVlezvlQnHHS+jDjtCjjjiqOD7008/R5actlwu
WHWl9OzRU0aPGS8LTjpTvnfBj+XHN9wgzz+3Rb76z1ei41N1cfH66+/I/Ruekct/uEaee+5Z+fLL
L4Pvdu78IrjNoGsjtm3LrOBViE1BgwaixZJoGk28sKjSNLGC2B6fm88MhbFYxXd6OvN5rKDAKzH9
uZnG3SaN3lbzfbL9bBRvKA3q10+4D5p69epVfK/fp/q93kd7HUWFhaHbVhQrFN+xdY97ptKCb3v0
b+BeZOjfItPbBgB1UPDvv/+ubN/+LyX4/wSy3LX7P/Ljn26WRx/7rTzw4C/lBSXnjRs2yFOqRP3V
7q/khRe3yo0/WSs33fqoLD/jLJk8eYoqqR+nBD9f5s2bqwR/r5x19goZOXJkUII//vjjZfz48XLV
lVfJ+nUPyIgRI4Lq+uHDh8r5539PTXeYXHPNbXLQwUNkwYJlMmTIEFlx7rWyaOo0efTXj8uuXV8E
2/X4b1+VW2/7rVx59QOyYuUaeXjjQ/Lvjz5U3/yfKuHvUPvwnuID2ba1dgSvRWQL1ZauPY0tMFtw
Zl4jtEqCUEIw87nTG2G6EtFCTiZKV0RR9tPeR/fCwV6XLbuo35t90Rc2tgR9FxL2MdAXHvq9obYE
79se34VHcDGgjkHYfgEApKcE//778u6778l/v/5avlbs3LVbrvvpJlVi3yxrbr9dfvXYY/LE5k2q
ZLw1EO3vfvW8XHrZT+SclZepkv4vZMzYsTJjxnRZuHChzJ49R+6+64GgUd3QoUMDsWvJjxkzRoYN
Gy633nqb7L///oHEhw0bIatWXS4HHnCAzJq9WK64arVMmTpXevfuI99d+VM5aN+BsvqGm+TfH38s
u3Z+KY9vflk+/vgD2bRps5y38g752c/vlNdee0X++9//k51ffCHb33tfPti+XbZu21orgk/0WZRp
wgSfTCZhpUEjS708n+DNBUNVS5PuhYMRtl3LYEr8WmTJvo96nHzHIKyU75tXr8usV8+vL4RMqVr/
b0tXv7enMcctWY2Juz3mt9Drtae1j4W+QLMvEHzyN9/7LmbMhaD5vSv2K8lyzXwavZ16GnPRZpaV
7OIPALK2BP9+cO9al4RFvpbdX34l//OT38iTTz4pGzdukL+9+YZ8+vFH8p+v/ytff/aJ3HX7w3L5
FdfLpBOOV9PdJd89Z5VMmTIlqKKfPuNEWX/fBiX4swKJH3nkkXL99derkv284B79eeeeL/377RM0
sBsxfKRc9v0rZdD+A6Vvv95y3Q3rZb/9BkppaWdZfs6PZP/Bh8ic48bL395+Q/7wzOvywbsfyauv
viy/ffI38ovbHpWLL1srv//971QJ/3PZvXunvPve9qAEn+nBZqoieLt6PZngwwSWTPAmQw8TvD2P
K9pU9tuIxFeitwWR7PtMCN78b0rYbg1Boumruz3J0oS5vaPndS8ITG2M/twcs7BaIvc4J1pu2O2j
MMg0AXJM8P9SpXddTf/233fIq69/Iq/++d9yz32vyG13PCK3/nyj/PH5f8orf/lEXv/rp/LImkfk
ku/fJItOPU8OG3W0TDx+psxfuFyGH3a0jBs3WcYee4IsWrxcxo6bJPvud6AMGTpSjj9huqxc9X2Z
N/9UJfbB0qvXPtKnz74yYMBgOXrsROneo6907tRVBg0cIq1btZVWrdvK4INGSNeuvaRj81Zy0zW/
kI2Pvi5PPPU3uevuTfKr37wiT/3+73LVdRvkphvvkk1P/lVeeOk9+Zcqwb//3nsZ76o2rIrezuR9
maXOdJPJwb3n7ZbYTEZuJG8ybjOfLVF7uWZ6uwSZSibu24d0Cj6qXNwq8EQSDSuN2tOEzW8+M6J1
f7t0CD7R9Gbb3d/Pd3sk1QvSPS80YxW3SWrrVgcApEvw//qnfPTRe3L3g2/LxVe/IZcoVv7oVVl6
5gZZeOZ6WXn5S3LJj96QSy97XqZN+p6MPu48OejQmdJ33zEyYOCx6vVo6d57qPTa53DZR/3fq/9o
2bvHECnd+0Dp3vNQ6dbzEOnU5QBp076foo+069BX2rfvL+079JfWbfpIi1ZdpaRFqaKzFJd0kmbN
OkqTZu2laeM2Em/YXIb2GC7Lzt8sp523WU5Z/oicd+mf1Hb+RVZc+ITMPWWNnHbO7+T7V27WJXf5
xz/eqTXB2xK2q3TdDNJXek8mB3seU9q0BZ9IVD7BV7oXXo5bIk9F7ukSvF0tri8+7HYEiYSqpzUX
OmHSc49XIpHq5Zljbl51VbdplJjstklVBB/1YsWeLkpNRyoXQcnSC5kmQI4JXt9//+jD7bL6ztfl
rItflOWr/iRnXvi8nPzdp+TUFU/I6Rf8Sc6+9GU5Zeq1cti482Xo4Utl0EFTpP/A46TfgAmyz37j
gvHde/Q5Snr2O1q69TlcuvYYJh27DpbO3YZIp70Plg5dDpTWHQaUS34faduur7Rp2zfo1a5Fq73L
BV9aIfjGxR2kaZPW0qhRS2nctJVMHrNSFi1/XE5V23T6+c+q7XtBll3wnJxyzmZZcvaTcvqKe+Se
e+6RP/3p+Yx3VRsl8wvLzH0l8rDqZvd7V1huC273PmqyGoVELdvd+fz3h2Oh99jL7m8n/t63PiNX
e56qVtGb9evjFEW87gWTXZuSquC/aTxYIIm2zT6ulS48yn9bc/ET5QIiynIRPEDel+D/pQT/vtx8
+yuybOXzsuy8/5Wl5z8jS7/7R1l67h9V6fk5OeuUDTJm7Hky4ogz5cBD5qqS+gnSb7/jpM+AcdK7
31jppcTes68qufcZJXv3HCFdegwNxN5JleLbl+4vbTsNkjYdB0jb9vsGkm+lSu4tW/dQdJPmLbsq
sXcOaKrkXqzk3qRpO2ncuJXEGzWXho1ayH6dDpAZ8++RJWf9Xm3fs3Lauf8rp5z3jCxR23faOU/L
nJNukpNPPlnuv/9+ee2117Je8FEb2Zl7p/bjcr4q+rAqZV+Gneh+e6J9ce9fJ2q1roVkPy2Qyvem
RsG3z+m6B6/X76sV2aPtQ/nFgP1oX9jFhq8VvX1R4F44+QRvlu0+vuiWwt0GeskEH7ZcBA+Q54L/
5z91Ff37csPqLXLyOX+QU5RET17xezn1LPX+7LL/Z3/nChk+arkcOHSR7DNokiq5j5c++x4jPfqN
kZ69j5buqtS+d8/DlNgPk9JuQ6XL3odI5y4HSadSJfiOA6VdUHrvL63a9ZPWbZXcW+mSe7eger64
pDSQexNdcm+qSu5K7o2atJFGSvANVQm+YbxE4rG4jB92qsxd+qgsXv5ksF0nK/Q2nnzGU3LinOtk
6tSpctddd8mrr76aE4L/phQf85bi3BL5nvfsY3s8HmcycDtztquak22vEVKyR+rCqnvdR/Pc+93J
vnefgU8k07ASqrvNrljddg1u7YGv0WLUJw38z8HHvLc93G2z5ete/NhPILiPWiba12TL9c3nphcE
D5Drglcl+J/c8ic56fTfycKlm2XhsidkwbLfKTbLogXrZdSIJTJ42BIZMGiq9N5nghK7knvfo6Vb
zyOlW68jpGuPUUrsw4OhYDt3GSIdOw+WDqrU3ba9Ens7XWrfV1q366vE3ktatOwpJS10tXyXilJ7
U10l37S9EnxbVXJvLUUNW0ojVXKPFzWTwsJmEitqIl2ad5YpU26WOUt+I/PVdi0ItvG3wfZOnnl1
0JJ/7dq18vLLL9OTHeTXiZri0wUAABWC/+CDf8m1Nz4rc5b+Ruac+rjMPuXXMlcx77RNMuXwFXLA
sKUyYP8ZSu7jpbsSe/deR6nS+uGW2IdLxy6HKgarEvv+Qak9ELuiddt9pFXbvqq03kPRXZq33Fua
NS+Te3FxmdybNGmnaKtK7a2loZJ7QFFzicWaKsE3Vq+NpLAgLqMGTpKpc9fJ7FN/rbbxV+r1NzJr
8WNywvQrZeqJJwaCz3QJHqA2esjzdW4EAFD5Hvw/tODflWuuf1pmLn5U8SslzUdlumLB1J/JIUOX
yMCDF0if/t+RvXuPlm69j5K9exwhXbofJp33HqnkPlQ6lB4q7TsfJB06HijtOuxXLvb+0lKLvXUf
KVFyL2neXZXadZV8F1Vq7yxNik2VfHsl9zbfiF1RFJTciyVW2ETRWBoUNJR69Quli7oQGDP+Kpk6
70GZsejRgGkLfykTp1whU06cSgkeAACgogT/zj9kuyrBX3XdUzJt/kY5ce5GmaIEOm3ugzJu1AoZ
NPgk6TdgsnTvfYyUqlJ7l+6Hq1L7yKA6vn3nQ6RD54OlXcfBSuz7K7EPKBN7m36KvtK8dW9VYtdy
7ybFzbqqkntpUCXfOJB7e2mkS+2NWkvjxlrsLSQeb65Qco8puceaSIEquWu5N1Cl9wb1i6TeXvVl
eL/xcuy0NTJlzoMyZcFDals3yITJP5DJU6fIHXfcgeABAADB6z/vvPNOUIK/4n9+JyfMfUCOn3W/
HD/7ATnxhFvkoIGzpd+g6dKj7zjp0u0I6dx1ZFAdX1ZiHyLttNw7HBDIvXXb8lJ7635lgm/VR5q3
6CHNSropsXdVYi+Xuyq1N26iW8lruWtalYu9JCi1a7TYA7lr6selfr3CgL2+HZO2hSUy+qiLZMKM
O+WE2ffJd2beJ+OOvxTBAwAA2ILftm2bfLD9n3L51b+VibPWy3Ez1gWSnzjkNOmz/0zp2W+ilKpS
e+fSw6Rj6TDp2GWYtOukxN7pIGnTXjekGyit2uyr6C8tWvctK7m37BVUyRcruesqeX2/PRB7cXtp
qErtcd2JjaKosa6Obx40pNPV8jFVci8obBRUy9dXJff6Bbrf8DK51/92odSrX6BeG8gBvY6WsRNv
VpJfJxOm3SvHTLwkEPyaNbcjeAAAQPD6z9/f3ibvvf8PuezKTXLctHtkwonrZOqE62XAAfq++xTp
0n20KrmPkA6ddcldy/0QadvxIGndfn8ld11yHxCU2pu3VCX2lr2lWYueqsTePSi5N23WRZoU6/vt
HaRRk/ZlDekatQmq5fW99ni8RSD4oqISKShoIg0aNC4rvTcoq5I3Jfdvq5L7t+vFpN63C+Rbe9WX
zmreoaMulLGT18i4KXfJ0RMuDgR/+223y4svvojgAQAAwb/9922y/f1/yQXf+6WMGn+zjJ5wsxx5
8BnSu+9x0rX70dJOSV0LvV27A6VtO32ffZC00lJXpfZmrftLScuy++zNWnSTEkWT4tJA6mX32TtK
w8btVKm9vcQbtZWG8VZK7EruQZW8biWvSu76XnuBRlfLNyyXe1yV1ovKxV4g9erp1/rq/2/LXoqi
vfaSg3qOl6Gjr5TDj/2JHHnMd2XS5BNlzW26BI/gAQAAwe+17e2twXCx1934kEyfvUqOOfokObCX
7kt+kCqt645pukurNl1UKb2rolRatSyVli07SvPm7aWkpJ00L2kjxU3bSNOAltK4SXNVUlevjUqk
UcNmSubFAfGiphIraiyFCl0FHyvUY5wXKcmX0aBBLODb9RoEVfH11Ou3v10mdc23vvWtMvYq61Ws
T5NWMvDA8TLi8Lky5pjZMnnKVLn99jWy5cXnETwAACD4t9/+u/x929vy5pt/lbV3rpVpk78jo7rt
Ld06dpQW7doqubeWVq1aSktF85atFC1USb25ooU0a14iJYriZk2laXFTVXJXNGkiTRWNGzeSRo0a
qhK7pkiKimKKhkrwhUrosYAGsQaq5K5kXqBk3qBAvlVfCV13C1peUt9LCd199rexosVe35I+jeKy
z779ZeTIYXLUUUfKtGnTgkZ2VNEDAACCV3/eemerbN36tvztb1vlsV8+Jj/84eVywbnflTPnzpGF
o0fL9BEj5YQhQ2X8AQfKmAED5Ig+fWRkr55yqLoIGLx3qezTpVR6dC6VLp07S2nHDtKxfVvp0Lad
oq20a91a2rZqJW1atpRWzZtLy5LigObqgqCkuIm0VBcCbRs3kVL12rNxY+nVpJH0btpU+jQrlr7N
msm+ar6BbdrIgR06yMFq+UN6dJMBvXpJ/749Zb99B8mYMWNk+RlnyIUXrZIrr7xSfv3rx2hkBwAA
CD6ooldyf1uV4PVwq3/5y5/lhS0vyNPPPCMbNm6U1b+4TX568y1y7fU/kWuuuVZ+dM3VcsVVV8oP
1EXA939wmVx6yaVy+QUr5fvfPUcuW3GWfO+MM+V7y86QVUtOlZWnniznLlos55x0kpy9YIGcPX++
nDVvvpw5b46cOWe2nD5nlixTLJozV+bPnSuz586TmXPmyYxZs2T6zJkybeZ0xQyZrv6fMXu2Yo7M
UdMtOGmhLF2yVM4973y58cabZPPmTfLs88/Lli3Py19eey3jg80AAABkaRV9mdzNq+att96S119/
XV566SV5Tsnz6aeflieffFI2bdokjz32mDzyyCPy0EMPyYYNG2T9+vWybt06ufuee2Tt2jvljjvW
ypo71sgvbrtNVv/85/Kz1avllltvlZtvuUVuuvnmCm686aZA0DfeeKPcrP7X3KKmuVVNu1rNc/vt
twdV7noAmXXr1ssDDzwgv/zlL+Xxxx+Xp556Sp599ll55ZVX9PjvFdutQfAAAIDg1R9bjlrsrui1
QP/2t78Fr2+88Yb89a9/VSX9vwQXAPr1z3/+c8Crr75agb4wMLz44ot7YH//8ssvB2hZ63nN8pSo
g3Xo9Wn0+m3sbbTfI3gAAEDw+h58ucT1q8H932AkmgxXxonwzRe2XPuiI2w7GWwGAAAQvPrjlort
1zBMiT6KtFO5GIhykWB/79sOGtkBAACCdwQfVeCpopeX7mXapXgEDwAA4AgeAAAAEDwAAAAgeAAA
AEDwAAAAgOABAAAAwQMAACB4AAAAQPAAAACA4AEAAADBAwAAAIIHAABA8AAAAIDgAQAAAMEDAAAA
ggcAAAAEDwAAAAgeAAAAwQMAAACCBwAAAAQPAAAACB4AAAAQPAAAAIIHAAAABA8AAAAIHgAAABA8
AAAAIHgAAABA8AAAAAgeAAAAEDwAAAAgeAAAAMgCwato07i42Vs9+w/6uDo0bVrymlpWMT8AAABA
LQu+pGWbOze/+bE896GkhV/9+V1p3rrtpfwIAAAAtSR4XXLXQk6X3A1rn9giatmF/BAAAAC1IPjG
xcX3plvuhoKCwkv4IQAAAGqnBC81JfjikpIt/BAAAAAIHgAAABA8AAAAgkfwAAAACB7BAwAAIHgE
DwAAgOABAAAAwQMAAACCBwAAQPAIHgAAAMEjeAAAAATPDwEAAIDgAQAAAMEDAAAgeAT/DZs3bxaC
yIUYNGjQx5k6L7Zu3coBJ3IiWrRosQPBI3gETyB4BE8geASP4AkCwRMEgq+DgtfTuyB4gkDwBIHg
c1jwRuhFhYUVxAuLEDxBIHiCQPC5LPgG9esHUqeKniAQPEEg+DysoqcETxAIniAQfB4JPlZQwD14
gkDwBIHgaUWP4AkCwRMEgs8JwetqeVNyT1Q9j+AJAsETBILPEcHbcrdb1CP45FGvXr3geBU0aCAN
i+IZWadeX6Iw7Sjc0Ldiqhv2svVrrCAmhbFY0m1KZTv0cfRtf7ojU+upS4JPlg5835v0EJZuoyw3
ndtYkxHlHAzbvnRst70Mt91Vthw/BF8Dj8nZpXad8XEPPvXErmXfKN6w1jPR6mQuqaxP72+6tsNe
B4LPTcHrCz2NzkuqIvhMSSTbBZ/O7U40T1WPA4LPccFrSSH41BO7PnlNKb5hPF7plodb4jdytKfT
tQBGPOYiyyyvomYlVlixTv14o70sn7j0us28duZitsO9ojcNLs22mNK5+c4s272l417ouMsO247Q
dcQK91iGe1x8x873m9ifR1kPgq/eueAeS1/a9aUHk7bc9OAu06R7jbmg9qVdO33oecIE5TvfkqVh
vexE26K3IeG+WttmlhVWynaPnW/77H0wnyU6jva5YOcXYflW2HYg+BwQvJ0A7QSB4KNlavpY6RM6
TDL2CedW4/suEDS2tO1SkTkBddjrCxN8su3QmZKuZg+bNlHpOh3LDluHvW8mc3aPS9jFlU/wrugT
rQfBV7V0uudvHZZ2fekhLG256csVT5T0FZZufOkqShrWn0fZlrBtS5TWfPtqHzvf9oWl5SjbEuWc
9m0Hgs+hRna25PUPSiO71EotPvnYRKme1MswJ6tddRx2kuoT2ndbIOyEta/ibcx2Jyr5RhV8qsuO
UkXvy4jCjl3YuuxMKmx5mS7F55PgTRsUjT7WyUTt+42iCD6V5ZmLDl9NVaJbNWFp2E23qW6j77zS
xyqVmpCw7QtLy1URfLJ8C8HniOD1j6qvyOxqVzq6qV6jlailCN90+phr3JPVLaknO+HCMkqznLDS
QzoEH2XZvpqHqgjed+zC1uXLBBF8es8DI3hTVZwo7fp+oyiCd8+hRIK3pw1Lz750ECUNR92WZGlf
p1lzYeq7gPd97tu+dAred/GG4HNQ8KZ6mY5u0iN4uxSpT/7gAir4rPJ9N7u0H0wXK6x0H9s9WXUJ
3QjKvrI2y08meNPa3azTtLHQ0+n1Jirtm1KQuehLJvhEy3a3w63e9a0jkeB9x87+3F6X3WbArvJH
8NUPna7DJBWWdn3pwf497PQQlr60ePTvnOi2jFlGsip693wLTcNqfQHqsyjbErav5pjoz9xGicmO
nW/7wtJy2HEMO698+VbYdiB4Orqp88/B+x6d834Wj0fKSKMsK+o0qTzWl+ojgFH3uzrrSHhcEjRc
qu3W8/l6Dz7daTfR91HTSnWeaol6nlb1HIy6D2F5Q+T5q3BeVTWPQvBZ2lWt/dw7j8kR+Ra6BGLu
DdfmY1J1VfAEgeBrQfC+qnmq6AkCwRMEgs9TwevqGARPEAieIBB8jndVq6vluQdPEAieIBB8njWy
cx+V4zE5gkDwBIHgc1zwdpeG3IOv3ahub2rZ0oCsrmw3gk9fmMe+cmU9dTHNIvgc7YvelOD1q360
RIsGwWef6MyztnVB8JnK8BF87YXbG2E2DzKUrCc7AsFnteBNxwvmMwSfmdAXVL6OKEynL3bG5A5L
605jd4JTKVOL+zO1PaZLItUo04ety53O1zFHWMZr9tG3X+YYZGIkPwSf3nRv8h79vqKQUd67pvvb
2+knWTq1n9l200jYenxp3SzH3dZkadZ0hJNoH1I6p4ri3n3zHRd3n3zLy4Z+IBB8BgebMSV2BpvJ
cLVkPF7Rn7wZIcouLZgesHyC901jRrIyGVJFRuUZiMXNoILequLxSvP6SiyJpvety/TcV5HBxuN7
9O/t22631zzfftnfI/jcF7z53ww9a//2RlI67ej3YWnBTatuGglbj71ddg+IdrpzBe+mSf3edO1q
n6vuPiQ6p9x9c89bu+9++7yyC2qJztFkF9MIPs97skv0iByCT2+499yTjbQWNp60r+9pN9Nz54/S
T3WibUs2vW8QEZPpRNnHZIPmJNoXBJ8bVfRRxiBIlO5MV61hgg8bRTBRF8Vh52SUQWTceY3sw9Jn
lH2Lcn5EOa8SDXqF4PP8MTmdOMz/OpEmGlEOwdfcvWf7JDTViokGgXGn8WWYehpTmnAHjrD7x3YH
DPHfh0w8vW9dUfp8r4rgTR/0Jr0i+LoheDsNB/PEwgXvSyNRR2usiuDdc8Ktzk92Tvn2Largw0Zp
9J3TYWNCIPg8vgdv/jfVOQi+5sMextQeNCVsbHn7pPRNY1dV60zNrerztdJP9co+0fS+dbkZkb3P
vgwwquBzsVoewae3BG/SuKlud88jXxpJJviqjPPuG5Y4Wc1csnPK7FtYSTzRfvhuyaW6TQg+TwRv
xhW3/0fwmQtz790dZtOMQuUKPtE0ZoxpM/KVuc9v2lb4xr02n9nThQ3pmmx637p8rZZ15lXW1iNW
ZcHr/TQNiHz3NxF89gvepBfzW0YRvJ3G7N/cpCn7PPKlkSg1SmaETfuC2t7WRLfO7NE5TYO4RFX0
YedUpcZz5Z/rfQwrwftGe/Odo768AMHn+T14uqolci3CxoNH8HR0ky9ppC4Ggq/BRna6Soiuaolc
CNNi2bQ8pooewedbGkHwCL7KgrefBbVbotJVLUEgeIJA8DksePO8u33PiK5qCQLBEwSCz3HBm85s
TEcIjCZHEAieIBB8npTgjeh1tTyCz+3Ixc5e6nJ/3gi+7qZB+rFH8BkRfCIQfO5Eugdm0Y+vhT2e
pC8G7UeFzG0e88ibeSRJP6aXLCMz8yB4BJ8P540r8bD0X5fTPYLPcCt6SvC5H75eqZINppFc8slH
z0ou8IKE26C3MRd7oUPwnDeJwtd/A+kewWdFX/QIPrerGe1BKHyDaZjOcgxhXVb6BG+euLB72LIH
mKlKVWRdra5E8Pl53kRN21TTI/gMtKKP0Yo+DzOqZD11VbUE73adaf63uwe1t8PXNS4ZHYLP5/MG
wSP4rBC83Y2j+xx8oip7BJ/bGdU398wr3ztPpYreV2pPNmgHGR2CrwvnDYJH8Fk3Hrw92Iy+P4Tg
KYkkEnzUoSkRPIKnBE+6R/BZ1MjOVLci+NyJPYaZrGZG5bvXaA9cYUrvZoAPW/imBX6Ue5W+gWgQ
PILP1fPGd/74llOX0z2Cz6Dgwx6R0xk3gs+d0PfCc7FVbraOSY3gOW9I9wiex+QQPEEgeIJA8Dwm
h+AJAsETBIKvxfHguQdPEAieIBB8jgveCJ3hYgkCwRMEgs8jwesGddyDJwgETxAIPk+r6CnBEwSC
JwgEn2et6LkHTxAIniAQfJ62otfPhOZ6FX2yIXABsolMnRfLli2TVatWAWQ98Xj8SwSfRsFrsds9
lJnxvHNR8FDrF1iFmRQXQBrT7kGkXcg7wetelcyAM6ZP+lytooesyCgnKHZxLCDH0i1yh/x8TE6/
InhIY2a5WcOxgFyRuy7BcywgL0eTc+8N6gFDEDxUM9PcpRjBsYAsT6dPK1ZzLCBvG9nZkteDL+Rq
IzvIypJRIccCsjR9zuZ2EtAXPYKHqmWgvbi3CVmaNotJm5C3gk/2CA+ChzRlpFcrXuNYQBbWLpVy
LCAvBW/3XGf3ZJdsXgQPVchMP1Ys41hAlqTHdxUXciwg76vodV/0dte0uiU9JXiooRJTMccCajkd
XqbYyrGAOvOYnH4W3vyvO7lB8FADGWsb7nlCLafBUtIg1LlGdu79d/M8PIKHNGewy3R1PccCeKoD
gFb0kH+Z7Gu64R3HAmqhX4YJHAuoE4LXpXQ9kpwfOrqBGi9J9eJYQIbS2/26QxuOBdSpVvQ8Jge1
lOEyKA1kKq2NIK0BVfRU0UNmM97R9CIGmagt4jgAgkfwkPnMl0FpoKZvBTGIDCB4BA+12PhpBMcC
0pyutjCIDCB4BA88vgT5lZ5m8zgmIHgED9mRITMoDaQrLTGIDCB4BA9ZljEzKA2kqzaoDccCEDyC
h+zKnBmUBqqTfhhEBhA8gocsL4ExKA1UpQaIQWQAwSN44B4q5FGaYRAZQPAIHnIkw2ZQGuApDEDw
CB7yNNNmUBqI2o8Cg8gAgkfwkIMlMwalgbD0cT89IQKCR/CQmxk4g9JAWNpgEBlA8Age8iAjZ1Aa
4MIPEDyChzzM0B+hKhacWzcMIgMIHsFDHjWmGsGxoPElg8gAgkfwwONQkF+/P4PIAIJv2rTktZoS
fNOSkof5IaCWMngGpam7vz0dIAGCLz8ZptSU4NWyB/BDQC1m9AxKU3drbxhEBhC8pm2n0o/SXj3f
vMV2fgTIgsz+XQal4fcGqLOCN1X1C89eJTc+uLla6GWUtGx5Hz8AUKKDWqixYRAZQPAA3JOFPPqN
GUQGEDxAHRUAg9Lw1AQAggfI4+eiGZQmP/s9YBAZQPAAlPQYlCaPfk8GkQEEDwD0TZ5nvyWDyACC
B4A9xMCgNFyoASB4AKp2IQtvtdCRFiB4AAhtnDWaY5GTjSUZRAYQPADweFUe/V6LeNwRAMEDRBEG
g9Lkzm9Fh0UACB4gJXEwKE3u1LbQ5TAAggdISR4MUsLvA4DgASghQoZrWBhEBgDBA3CPlzYSAAge
AGilzVMOAAgeoM48Z82gNLX/OzCIDACCB6iRkiOD0tTe8X+EngYB0ij4eDx+fXnGVmUKCmI/5OBD
HgiGvs5r79gzVgBAugTfvHXbk1c/+rQ896GkhWvvfkQaNWt5LD8CIBrgwgqglgSvT6i1T2xJm9xt
yfMjQB4Ih0FpuDUCkJuC19Xy6Za7gY4pII8aezEoTWYaN97AsQBIk+Dr1av/n5oSfHFJyRZ+COBx
LYhwfJfxeCJA+qvoBcEDJD1PSrk3XGPHlg6GABA8QK2KiEFpaq52hC6CARA8QK3KiEFPOJ4ACB7B
AyVOoEYEAMEDcM+47hxDBpEBQPAAWSmo2bT65qkEAAQPkJ+S2sJz21XuV4BBZAAQPEDWl0TpeS36
8dpMz4AACB4gZyTPcYh0nOjbHwDBAyCuPDtGDCIDgOABclJgDErDrQwABA9A47E6dVz0IDJXcywA
EDwAj3/lz/FgEBkABA+QF0JjUJpvjgUdAgEgeIC8EhtdsF5El74ACB4gP+VWpwdR0dXyDCIDgOAB
KMFSgwEACB6Ae9BZvM8MIgOA4AHqhPDq1KA0PEUAgOAB6pLkn64Lg9KU9wMwmt8cAMED1LX78b3y
eP8YRAYAwQPUXcnn6X6Npi9+AAQPUJcFn3eD0jCIDACCB4CL8m9QGgaRAUDwAFC5MdqEPNgPBpEB
yBfBxwoKpChWKIWxWMVn5VfwCB6gDj1OxiAyAHkoeCP0evXqSbywKHjV0m9Qvz6CB4guyJwdlEb3
zsd9d4A8E7w9rX5fVFgY4H6H4AEinXsX5mKXruUX+cX8hgB5VYKPBSX2ggYNAqHrV1OSR/AAVZJl
Tg1KwyAyAHncyM5IXVfLG8nr14ZFcQQPUPUScZsc2M4bGEQGII8F3zAer6ia1+jSO63oAaolzqwf
lIZBZADyXPC69bxpZGeD4AGqLdCsHpSGQWQA6kAjO/sROZ6DB0irRLNyUJry5/ZH8BsB5LHgdZW8
73E4BA+Q1pJyryzaHj2IzCP8NgB16Dl4qugBak7yWbIdExhEBqCOCF43qLMb2NnPwSN4gLSJ9aDa
FiuDyADUwVb09EUPkBHB1uqgNAwiA1BHBK+n0Z3cUEUPkPHGbRNqYb1bGUQGoI4IXrec1x3ZUEUP
kN+Pp5UPIvMuxx6AKnqq6AFqVrgZG5SGQWQA6rjgqaIHyLjk9aA0WzNUW8AgMgB1UfBG6HRVC1Ar
98WX1eDyGUQGoC4LXndyk+ieO4IHqPESdpsaWO5qBpEBoIqeEjxAHj2bziAyAAienuwAskPyaR2U
hkFkABB8JRrFG1JFD1B7kteD0qxO03P2IzimAAg+ELsptZvn4gsaNEDwALVzP75XNebXg8jcz7EE
QPAB9erVq+jsRgve3JNH8AC1I/kqzscgMgAIfs8GdmbYWAQPUOuCT3lQGgaRAUDwoaPJuQ3sdB/1
CB6g1iR/ZyqD0jCIDACCjyR53Uc9jewAal3ylQalCWsVzyAyAAieVvQAudnorrC8W1txPm/DIDIA
CJ5W9AC5KfhS+9aZfb/d/gwAEDyt6AFyR+7FbtuY8s+XOZ9TggdA8LSiB8ghwV/o6WFygGKL73OO
GQCCpxU9QG6J3i6xX+2cq6UcIwAETyt6gNwW/ezy4V931cTocwCQp43soragR/BQmzRu3PiDzZs3
C9Rd8qWf/XPOOYffE/ZI1zVyDz5RlTyCh2wSvBB1OvJF8KtXr+bHJPZI1zVSRc948IDgCQSP4Ik8
EzzjwQOCJxA8gifytARvHo8zDe6oogcETyB4BE/kuOAb1K8vRbHCPVrUI3hA8ASCR/BEDgteT2uX
2nVpHsEDgicQPIInclzwulGde/+dvugBwRMIHsETOS54V/LJHplD8IDgCQSP4IkcEfw3LepjlRrc
IXhA8ASCR/BEjgnebUxnV9HzHDwg+MyGvrjO1dANdRE8gs9kmjZDm9dEGq2NczHtgtfPv+uqef1e
33M389CKHhC86eGxoKKfiJrPDAtyufSB4LNc8FqIemhwk571k1O5nKb1/mh/1UQarY1zMe2C14PK
6B/ctJo3g8zQih4QfOUMQZ/w+rxIVHrQn9nT6AiGYI7H91i2Pa9+r8eCcDOVsMwrbD2J1hFW2tHz
6XVXWn58z+X7ptXvzTIRfG4I3k5j7m/mTQsR0rT5Plma9i0rLH1WOtecdZnvbMGHTZ8ojfr2N+xc
zNl78L6e63T1hK7OQPCA4Pd8H1wUq0xEZwTmc/1qMh+TcejpTEaia8jsUpR+NfObzM23PlfcQRuZ
8gxMz6/fm/WYTMldh2979XuzTfrVbLuZT1/sa0KnLV+vWT6Czy3B6/emytr3+6aSps1TV7ZI3TTt
pls7fOnTdJluvvdtjy1492LciN6XRpPtr3su5rTgk/Vqh+ChrlfRBye+VSrwidhkQmH3+8x0brWi
L2NKVCLWGaU9v7veZOsw793tMxmdbz7ftGH7h+Czv4pe/352uvH9vqmkafe396VpN91GuZDW7+1t
cLcnmeDDtjdsf8POxbwTPKPJAYJPnPGYkoS5+nczhLBML6rgTaYYJnBz0eETq28d7va6nwW1ASHb
5ps2UaaO4LO/BG+XkH2/byppOorg3XTrTu+mTyPiROdHMsEn2l7f/iJ4BA919h58rJIcE01rqrjt
e4pRBJ9sub6GQPZ6TEaVaB0m3O1LNJ9vWvuzTFdpIvj03oP3/b6ppOlEgveli2QXDqZ6XU+n12da
tLvbEyZ4337ZaTTK/uZ1FT2CBwSfoBReXnI29x7t0olbCnCrGV2Jmvl0acV+NMcsy63W1JmTu0xT
0jHz77EOz/ba22dKVclqF+xpTZWpKQ0h+BwQfLyy4O005Pt9o6Zp97f3pWlfuk2UPn2ydbenUiO7
uL3OyvvoS6OJ9tc9FxE8AM/BEwie5+AJBA+A4Im6IngVrynaIHgCwQMgeCK/BL+1vDp4ly16BE8g
eAAET1TOCJfpzDCHeNcZrTMQPYInEDwAgicqZ4Q/V1yYQ3zsDsetmIDgCQQPkGOCr41HbOrStudw
FX0g9lysovd168o2I3iAOiX4VEe4iiJcV7r60R/92JHOwOzuQc3AOOYRH/MMsZ4uqrhzYUS7HBX8
hFxuZJfOCz+dxvZ4tK78MTedVk0XyWHpVz9KF6T/WPJ07XssD8EjeEDwVQr3mXdTkqhqCcTNXHVG
aDLAVDJgd7Cc0AuUkOUj+Lr9mJzdf4JJJ1HSU6L0WNX0a0+bbAjYXKpNQ/CA4LNc8G4HHTpj9HXt
apfOfaX0sGXaXY26vYqZATiqm9Fle6aI4DNfK2WP2uYbkCjVdO0TvD2oTViadDvrSZTmfetB8Age
EHzaBJ+OjMZdjslsteBNjYHJFN1uY/W0qY5nj+ARvFuT5BuitTppxSd4X5/wbvp1u9t1L3SrWnOF
4BE8IPi0Cv6be+YFCS8AEi0nav/1ZfczCxA8gq9xwUdJ14nSsa9Ubqdfe15dg5CsBI/gETwg+Jwo
weuMzh6n3XcP0i7t2BmhbpSE4BF8davoa6oE77ZjCUu/qQwKk+wePYJH8IDgq9QYqbqCD7uXaaos
7czLDDjjNvIz80ZtHe9m4AgewbsXjdUVvJ2mK2RuDThj1xb40m+laePxnL5YRfAAOSR4XarO9lbo
iSIXHitC8LVbM5VL4bb+R/AIHhB8tSKXWu7uue08B4/gPTU7+rG4eDyn0nI6+6NA8AAInkDwDBdL
IHgABE8geIJA8AAInkDwBIJH8IDgCQSP4AkEj+ABwRMIHsETCB7BA4InEDyCJxA8AIInEDyCJ9In
+MbFzd6qMcE3a7EJ2QCCJxA8gidqpwS/qKYEr5Y9GtkAgicQPIInakHwmgGDD/k43XJv26n0I0QD
CJ5A8AieqEXBa0patvrwxgc3V1vsehlNm7fYhmQAwddevPvuu2SECJ5A8ACQb6jYrCjlWADk6TnO
QQBA8ACA4AEAwQMAggcABA8ACB4AEDwAIHgAQPAAgOABAMEDIHgAQPAAgOABAMEDAIIHAAQPAAge
ABA8ACB4AEDwAAiegwCA4AEAwQMAggcABA8ACB4AEDwAIHgAQPAAgOABID2CV7GouKRkS3VQy5jN
wQdA8ACQBYJXMWLl/9zy1XMfiqSDRSsu3kXmAoDgAaCWBX/t3Y9IuuRuS54fAQDBA0AtCT4ej1+f
brkbVAazjB8CIKNiv7CcrYqry9+fw7EBqIOCr1ev/n9qSvD6njw/BEBGBa/bwYhDG44NQB0UvM4A
EDxAXknelju3ygAQPIIHyMNSPKV3AASP4AHyrBRP6R0AwSN4gDwsxVN6B0DwCB7yRmwDBg0a9DGA
pnPnzl/keprW+8BvCQadxyF4qKuCHyEEUR6rV6+WXE/Teh8IwoTO4xA8IHgCwSN4AsEjeEDwBIJH
8ASCR/CA4AkEj+AJBA+A4AkEj+AJBA+A4AkEj+AJBA+A4AkETyB4BA8InkDwCJ5A8AgeEDyB4BE8
geARPOSx4PW5oqNhUVzihUU5lSnk4jaHRYP69RE86TjTUo08bawgViPTInhA8CkKXmcY9erVUyda
QUDUjLGosNBzshZUKfOo6nw6imKFkTK/sG3O0RIMgq/BdOymq0ykY3vebEzHqQm+oEaPGYIHBJ+C
4N2TTH9W8T4ej5QxNoo3DL7X3+n3FRmlms7+335vpvXNZ0JndJW2p/y9+bygQYNK37v7Yb5zt9mX
iSbKON3t8E3vm9/d/yjz+bZNL8N8huCjpeM9pilPy8kE70tX7m/iniPJ0rGexrcuvcyk86aYju3p
k9UAhJ3rbroMS3P2PGZf3N/Bdw6ETYvgAWpY8PbJbH+XiuA1OpPUYWeWZhmmmjlR5mbWrddlqvL0
tHp5PsHb22WWaT6zv9MlPTtTtrcrUc2Eux329O7/yfY/bD7ftun/9ef6M/2K4KOlY31MfZJKVfC+
38RetvltwtKxSX/uuoPlei5yq5OOdfo00nW3I8p+2OnNTvu+6d1jai4ezGeJzgF3WgQPUEOCLx87
fY8MMIrg7dKCPZ97n9ic6Cbz9C03ShWhO61btelmVr7v7GWELTfV7XD/D9v/ZPP5ts1dFoKPlo5T
Ebxb6g1Ln+57O51F+V3Mct2LC3ve6qRjLfiwmqio++GuM6rg3X2Mcg5QggfI4hJ8mODtkodbqtHf
2dWEYRmjmc5k3qkI3nfbwVcqqpypx0IzN3c7fNPb/yfa/1Tmi3JRgOCrX4JPJnhfetECC5OmWx1t
SrD2hW4UwVclHZt06la5V2c/qiL4sHMAwQNkieB978OqNu1pC2Mxb0MhX4YQljGazDBRydkWZVjp
xq7iTCZI33e+7Uj2f9j+J5vPt357WalWa9ZlwevP9LFzj1uURnbJSuZannp9ernubZtEv7Up1UYV
fFXTsU+eUffDTm+ulJMd0yjnQNi5H9ZuAMEDVFXwcU/GGC8rAejMKOo9eHs+kwHoeU2Vqf5On+z2
PeqKzM6Zzxar/lzPk0jwYSUyu7q20nfxb76zqw3NunyC922HPb1vfnf/o8zn2zZ7P91aBAQfno7t
0qmvFiiZ4O02EL70ssd5EZKO7fnt9FmpsZw1b3XSsZ7frXL3bUei/bCPm+/ixXdMzfuyPCOW8BwI
mzbq458IHhA8QQjPwRO5Ean07YDgAcETBIIn8jAQPCB4gkDwBIJH8IDgCQSP4AkEj+ABwRMIHsET
CB7pAIInEHx2CT7qI1k1Gb5uaYlaErzp7ALBA4Kv9gma1gEzwjrhCJsu2XP8qTxrjODTmna3Kq7O
hOCrMzCM72LBl058j6q5gncfqTNhtyo3j2mGTZsv53GtCt48X2iIInsEDwg+XLS1tbxkI3Kle7Q8
BJ+S4E0ee3VNCT6dotQS93U+ZEa2q2ra/abr2YLQvuUzdd6F7UdtXfzWeBW9uaIyIHhA8NEzGbvj
DtNphsZkYKbHLtOZhptx2vOHlbx1BxphfewH08UKvZ3QhJXg7WXpeaN0tZsNMXXq1ErbnoNcXVPj
wZv3pjMWu2OhdMizqoLX6dHuLMrXG5zvPLA7snHnsQuoZrvcZYSN0eCuJx3ncdYJXh88eyd0BmJ6
40LwgOBTzwzdrizdkbZ8JS+TUZQNNRkLFbM9vxnb254uUTe4YVX0YQOQZHPJPodL8JotNVGCT9YV
sx3mtk/U2z+pCt4uodvrtM8LdwTBZOdB2PZEXYa7/mQl+FTP46y9B2+G2+MePCD46mewYf2xJ7pH
bmMP0BImZjvzCVt+dQRvd7WJ4NMm+C01eQ8+TITVuVCrluCL9hS8r8TrK1W750FYidu3375lmJJ+
KlX0qZ7HWSv4RP8jeEDwqWWG7tV9sowhrDtL33w6o3IzynQK3q7mR/BpS7v3Z6IVfSqC15/Z1ITg
w2oNwi4Gkp0HUbYx0TLM+PZRBZ/qeZx1gjeDTNhVNea+AoIHBF+1DFZnIuY80lXmpio9LGOwp7cH
rgkTs3s/0q06NMN4+qrww8bcdi8Ysq1lcy4LPlOPyaWzBG/7wE6z+r2WqFvdHVXK9pCr9joSnQc6
TZuLWv/FSqxie3zL0PP4hnQNu4de1fM46wTva/yhDyYleEDw1Y9UG+Akmz7RUJzuBUOqYc9TE/cX
EXzNC14LKBueg0+UNu3PdZpz79MnOg8S7Zv7XdTjEOVcydQxrZEqen11Q0c3gOCzP0yJQktel7Cr
0zq6Kpkzgs/+jm6y4eLMlJ79JfiYEBkQvGn27yvFI3hA8ASCp6taIkcFb0rubmOLKCV6BA8InkDw
CJ7I8ip6+qIHBE8geARP5FkVfRgIHhB8/oevgROCR/C5FvkyuE3aq+jDQPCA4NMbYc/nViV8g3SY
fsNTaSCXywPOIHjCFny2P9aZccEne9YdwQOCT+vJm55St/O8uimF+zq+SRb6oiBbHqtC8EQ2nF95
VUVvOsynih4QfM1WhZsShj1QRXUzJV2ST9RRR9RlIHgEX9WLTXvQFd+gMPZnphbL/qziAtX6zKTJ
sHPFjJ1iPxKI4GlkBwi+VsLu9csdEMatuje9bxmi9hamp9PLSvU56FzNGBF8dgg+TLKJxpH33a5y
e94zcvedK76LUt/gNgjeMx48PdkBgk+/4E1JO2pvdMnCDBDlux9ZF+7DI/jsELybln2DwthDHNvT
2vfN3fEQ9Dxh54oWvK9f+Vy93VSjgjfVKW7VPYIHBJ8+wZuMKpngdcZmN3j1NR7SGVxV+gFH8Ai+
pgUfVmp3JW5qnXxDwurPTfuQRMvPlaGNa13wjCYHCL5mw2RA1S3Bmy5q3Sp8XX1pSj6pVNPnasaI
4LNP8L5BYfSrSacmXQa1T+Vp1aTfYN5YYcXTIInOFbOOZLcE6rTgw56Bp4oeEHyNnLwZyXBTvVjI
1fuWCD67xe/eNoqaVqOmR3d+BM9z8IDga7EEH8vGDCVnjyeCJ2zZJ7plVaer6GlFDwieQPAInsiz
KnpGkwMETyB4BE/kYRU9o8kBgicQPIIn8rSK3p1Ol+pNpwEIHhA8geARPJHDgrer5k2XgonmR/CA
4AkEj+CJHCnB62cQ9fOFtugRPCB4AsEjeCKHBW86ITCdByB4QPAEgkfwRI4L3ozio++7m5F8krWm
R/BQW5KHvbYopnAcyjJD0jPkW3pmPHiAunuRs1lRyrEAyNNznPHgARA8ACB4erIDQPAAgOARPACC
B4CcrqIPA8EDIHgAoAQPAAgeALKtkZ37zDsleAAEDwAIHgAQPABkm+B1D3bmUTn9avdkh+ABEDwA
0MgOABA8ANDIDgAQPAAgeABA8AAIHsEDIHgAQPAIHgDBAwCCR/AACB4AEDwAIHgAQPAAgOABEDyC
B0DwAIDgETwAggcABI/gARA8ACB4AKhRsb/r6VZ6AscGAMEjeIDcFnyhK3iOCwCCR/AA+VeKp/QO
gOARPEC+leI5HgAIHsED5F8pntI7AIJH8JA3YistUekOSl7kGJTBeQEIHsFDfgh+hBBEeaxevZrb
FIDgETwgeALBAyB4BA8InkDwAAgeAMETCB4AwQMgeALBAyB4AARPIHhA8AgeEDyB4AEQPIIHBE8g
eAAEj+ABwRMIHgDBAyB4AsEDIHiALBJ8QYMGwYAuhbFYlZeh59dRVFgYUJ1lRI2GRfGU1pXK8t1p
q7NfCB4AwQNkXPCxggJpGI8H7xvFG1b6vCblnI7IpOApwQMgeICcE3y8sGgPuRlc2dniN9MUxQor
prGlqy8czDRmHQ3q1w/+r1evXqhU9TI09jbo0Mswn+ll2+tKaRs92xU2re9iQn+n16Ffde0Hggeo
YcHHGzb+oKYE37R5y6f5ISBfq+i1bF2huZJ0P9fV+UaORpg+EbrLSCREexn2dPqiwF2erm1IJviw
bfRtV9i0YYLPdEkfwUNdL8EvqynBMx411IVGdolKwe7nrtjCBO/WBmhx6wsK+3ZAomXYn7u3DZIJ
PmwbfdsVNm3UdSF4gBoUvObExcs+T7fcBww+5GN+BKgLgg/uxxfFEwrelKzdkniyEnyUe9zJBB9V
usm20bfusGkRPECWCF5FsRZyuuTetlPpR/wAkM+CD+45l7cQd6uejex1iVvfl44VxCrunesSuH7v
3iu3RRjMp97rz4wIzf9VFbzejoDy5VRaV8Rt9G1X2LQIHiBLBO9mkNWBAw91pQQf3M8ub0nvfl4h
OM/3iT535Zjo/5RazidYX6rb6NuOKPtDK3qAWhY8AIIn6OgGAMEDIHgCwQMgeAAETyB4AAQPgOAJ
BA+A4AEQPIHgAcEDIPiMRtRn3aM8opdN+5JqZHIAGgQPCB4AwdeaFKM8E56p58ajXlhUR/CU4AEQ
PEBWCd4etCVZl7T2wCymT3hfCd7t+tUMKqMxz9OHdQ/rDihj+oQ3feT7SvruoDW+ZfgGhdF9ztv7
HuxL+eAylcTvGZDG/swd7CbRIDoIHgDBA2RE8GGDpSTroc3IK9Ve3cyFgTuN3T+9fRFgRGw6otHf
6R7q7HC7lvUtI8p+RhnYxr5oCavJqOlR5RA8IHgABJ+S4JOV4Mvex0K7ow2bR09jl+ITrU+L2Qgy
bEAYt2TsG7TGlXOU/UzULa5b42A+1xcfPsGHDaKD4AEQPEDGBW+XPH2f22KtqLaPIHh7viiiNVXh
ptTulpaj1kbYy6iu4BPd4tAXPb779zXVcBDBA4IHQPCRpKjFpCVli9Q3YIsWo55WSy1ZFb09QI15
b0rxYdOYMPfGTeiSsJlWr9sVqW/QGnMvPUqNhNmnMMH7BqQxg9Ho+d15Ew2ig+ABEDxAxlrR+4aF
NQ3J3Eil2rnSADUhg8qksrxEA9P4vota8o864E0qA+VUZxAdBA8IHgDBpzWy4bG1dIXd0I6ObgAQ
PADPwRMIHgDBAyB4AsED1JrgVfRSXFhNSjn4gOAJBA+QBYJX0ebw8ZM+ee5DkXQwYPAhH6tlFvIj
AILPvfA1GETwADkq+EUrLt6VLrkb9AUDPwIg+OpF1NbtUZaTqAOcTDyTjuABMiz4goLCS9Itd4PK
KGbzQwCCr96z9zXxqF+ipwDsTm8QPEBOCz62s6YEX1xSsoUfAhB81avK7e5dTYcw1ZV+lPlruo94
BA+QAcHrkx3BA4LPvjC9xhnB+wZ3sUvdZpx1ez5fRBm5LV+q6RE8IHgEDwg+KwVvqsrDuoatyr34
KJ3aIHgABI/gAcHXoOCN1JMJXvfzru+rG0zVflXFjeABEDyCBwRfg+Ebia6qAtbST1R171svggdA
8AgeEHyOtKKPciGQL8/CI3hA8AgeEHyWluBjdeKiAsEDIHgAerIjEDyQ1yF4QPAEgue8AASP4AHB
EwgeAMEjeEDwBIIHQPAACJ5A8AAIHgDBEwgeAMEDIHgCwQOCR/CQx4JvU6LSXV2nfv36O4qLi1/l
WJAHAYJH8AD5daGzWVHKsQBA8AgeAMEDAIJH8AAIHgAQPAAgeABA8ACA4AEAwQMAggdA8AgeAMED
AIJH8AAIHgAQPIIHQPAAgOABAMEDAIIHAAQPAAgeAMFzLAAQPIIHQPAAgOARPACCB4BcF7yeJhEI
HgDBA0AOCr6osLACPb39nhI8AIIHgByvom9Qv77EC4sq/m9YFKcED4DgASDXBa+nrVevXsX/BQ0a
IHgABA8A+dDIzr3/rkvxCB4AwQMAregBAMEDQLYJPlYQKyu5x+NB6Z0SPEBWiX2X50mXZRwbAASf
kMJYmdx1Yzsjdu7BA2SV4Nu4gue4ACD4SPffzWNzCB4gJ0rxlN4BEHxydKt5XYo3gjclegQPkJ2l
eI4HAIKveiv6OPfgAbK0FE/pHQDB04oe8kZsxYoLYa8rOQZlcF4AgqcvesgPwY8QgiiP1atXc5sC
EDx90QOCJxA8QB2toqcvekDwBIIHyNPH5OiLHhA8geAB6kIrenqyAwRPIHgAWtEDIHgCwQNkmeB1
ad1ucKex78kjeEDwBIIHyEHBxwoKeEwOEDyB4AHyvYpeN7IrihUieEDwBIIHyCfB85gcIHgCwQPk
aRW9/dgcgoe6JHjzmKgedKmqoefXYdq0VGcZUcO0pamJ5bvTVme/EDxABgWvG9RFbWCH4CGfBa8v
dvVASzoaxRtW+rwm5ZyOyKTgKcED8JgcQM4JXl/gunIzuLKzxW+m0e1XzDS2dPWFg5nGrEP3Imlq
zMKkqpdhbpvZ69bLsEd/tNeV0jZ6titsWt/FhP7O1ALq2g8ED5AFgmewGUDwe4aWrSs0V5Lu57o6
38jRCNMnQncZiYRoL8OeTl8UuMvTtQ3JBB+2jb7tCps2TPCZLukjeEDwKQw24wPBQ11uZJeoFOx+
7ootTPBubYAWt76gsG8HJFqG/bl72yCZ4MO20bddYdNGXReCB8iiKnq7a1ruwQOCL78fXxRPKHhT
snZL4slK8FHucScTfFTpJttG37rDpkXwADkmeF3lZz/3bu7tIXioa4J3h022Pzey1yVufb7ECmIV
9851CVy/d++V2yIM5lPv9WdGhOb/qgpeb0dA+XIqrSviNvq2K2xaBA+QY4I3jWt4Dh4owZffzy5v
Se9+XiE4z/eJPnflmOj/lFrOJ1hfqtvo244o+0MreoAsFrwprdjoKjoED3R0QyB4gBy/B29LXlfr
cQ8eEDyB4AHyoZFdPM5ocoDgCQQPkE+C18+88hw8IHgCwQPkYSM7LXl6sgMETyB4gDxrZKcflUPw
gODTF9UZkKW2B3PxPZ5XlUcOETxALQveN5ocVfSA4FOPsOfAo8guU8+QR5VydQVPCR4gCwTvjiZH
V7WQ74L3DaTilprN52ZAGI15Ft43wIrb3asRpN3GxYxWZ/63+5X3zesOLmP6hzf95fsuHOzlu/3I
m2X4BrDZYzv1NsQKvetx1++u0z5+vu8QPEAGW9EzmhzUFcGHDaQSJng7fAO9hPXkFqWbWnsUOd+8
+uLBvqgw2286pdHf6cdafdtowreMKAPYhE3jW7+7TvcCiRI8QIYFb7qm9BND8JCXgg8bSCVM8Po8
sUvxiaQeVfD6/HJLxr55tUDtGgK3tJ9oqFkt4jCBR+nfPtE0vvW763QvguzvEDxADQve14Md9+Ah
3wUfNpCKuVXlfm4LNB2CDyu1J5rXVKunUiLW85jSvbuM6gg+0frddYZ9h+ABqKIHSLvg7YFU3LHf
zaAybmndLsUnErw9KI0tSC0204GUnt68dy8efPOae+P29ptp3YsScwFRVjv3za0Iu61BInnb2xk2
jW/9vnXaF0judwgeAMED1FgrercxmPu5+8hYKhcQYY+dJZsm7PNky4vyXdSSf9R9TWXQnOoMqIPg
AcEjeEDwWfe8draE3dCOjm4AEDyCB56DJxA8AIIHQPAEggdA8AAInkDwAAgeEDxaq/1IV090CB4A
wQNkneBrome2GpVyin3KJ2p0mC0NEhE8IHgEDwg+K1vdZ3JgmXQOGmN3loPgARA8QN4IXldRmy5X
fQO2uIPS6HAHZnEHlvENZuOu0x2cxizHHfDGN60RvO7sxu5oxl2/3eWsuyy7at7tCRDBAyB4gJwX
vOnlzYizQqzlveLZUtcRNjBMWAk+WfW/r9vcsFoFM21Yl7lmG8K67g3blmyopkfwgOARPCD4tAs+
rD93t8tat7Rul5Ldfud9g9nY//sGpwnvDz/mHXrWnsfuE14LXm+XO+Kcee8OEoPgARA8QF4K3sgy
iuDDSsH2tGGlct/3vnXYn/umtbfTHuM9rGSebJAYBA+A4AHyspGdT5xh8g0bGMYeWMY3mI27vrDB
adx1+6b1DRpjl8pNrYQr+LBBYjLZQBDBA4JH8IDgs7oVva/lud2gLlnL9FT6kU82rW/8+LD1u58H
bQritKIHQPAAeVmCj0kuR3Wq2HkOHgDBA9CTHYHgARA8AIInEDwAggcETyB4zgtA8AgeEDyB4AEQ
PIIHBJ+R5+lTaRlf243rEDwAggdA8BmWrX7sTT++Znejm4+t/xE8IHgEDwg+68Pt/10/W16VUdrs
wW/SOS2CB0DwAAg+VSk7XceaHuO0fF0B2yPR2X3Zf1MqL6io8k9Ues+3anoEDwgewQOCz8r772ED
1qQqYNM1rQ63K1sED4DgETwg+CwVvBZ4ZWLeEnxUgSN4AASP4AHBZ6iKvjoleF1qN9X6ulV+svHk
ETwAgkfwgOAz0Iq+uoI3pXg9XzK5u+tC8AA5KviCgthOBA8IPv8fk0vlcToekwPIC8EXXlJTgleZ
02x+CEDw1aim14/FZXjYVZ6DB8gTwWtWXPHjr9It92OmzvqMHwEQPIHgAWpR8CpKT1y87PN0yf3w
8ZM+Ucss5kcABE8geIBaFLyVOR6kuLCaDODgA4InEDxAFgkeAMETCB4AwQMgeALBAyB4AARPIHgA
BA+A4AkED4DgARA8geABwQMgeALBAyB4AARPIHgABA+A4AkED1CD/D+CNYP8hpnkqwAAAABJRU5E
rkJggg==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2010-07-14 03:00:13 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-01-27 00:36:55 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-01-27 00:36:53 -0500" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-01-27 00:36:55 -0500" MODIFIED_BY="[Empty name]">
<P>1. osteoporosis/<BR/>2. osteoporo$.tw.<BR/>3. exp bone density/<BR/>4. bone loss$.tw.<BR/>5. (bone adj2 densit$).tw.<BR/>6. or/1-5<BR/>7. exp vitamin d/<BR/>8. vitamin d.tw.<BR/>9. vitamin d2.tw.<BR/>10. vitamin d3.tw.<BR/>11. exp Ergocalciferols/<BR/>12. ergocalciferol$.tw.<BR/>13. exp Cholecalciferol/<BR/>14. cholecalciferol.tw.<BR/>15. hydroxycholecalciferol.tw.<BR/>16. calcitriol.tw.<BR/>17. dihyroxyvitamin D3.tw.<BR/>18. alphacalcidol.tw.<BR/>19. or/8-18<BR/>20. 6 and 19<BR/>21. clinical trial.pt.<BR/>22. randomized.ab.<BR/>23. placebo.ab.<BR/>24. dt.fs.<BR/>25. clinical trials/<BR/>26. randomly.ab.<BR/>27. trial.ti.<BR/>28. groups.ab.<BR/>29. or/21-28<BR/>30. animals/<BR/>31. humans/<BR/>32. 30 and 31<BR/>33. 30 not 32<BR/>34. 29 not 33<BR/>35. 20 and 34<BR/>36. limit 35 to "all child (0 to 18 years)"</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>